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This PhD thesis explores the implications of genetic admixture for human health, 
fitness, and population structure in Latin America.  The motivation behind this work is 
rooted in the story of human evolution, with our origins in Africa followed by migration 
around the world.  Admixture has been a constant and ubiquitous feature of human 
evolution throughout this time, but its impact has yet to be systematically explored.  Latin 
America provides an ideal setting to explore the implications of admixture given the 
formation of modern populations via admixture among distinct African, European, and 
Native American population groups.  My research into this subject is powered by 
comparative analysis of thousands of whole genome sequences integrated with a variety of 
functional genomic and clinical genetic data sources. 
Anatomically modern humans evolved in Africa ~250,000 years ago and began to 
migrate out of Africa ~75,000 years ago, forming new, isolated populations in 
geographically distinct areas of the world.  At that time, geographic isolation of human 
populations entailed reproductive isolation, and as a consequence, remote populations 
accumulated genetic differences.  Most of the genetic divergence among isolated human 
populations is likely to have accumulated due to genetic drift, i.e. random changes in allele 
frequencies that have no bearing on fitness, but natural selection also played an important 
role in driving population differences.  This is because humans encountered vastly different 
environmental conditions, and accordingly distinct selection pressures, on their long march 
out of Africa and around the world.  Natural selection enabled human populations to adapt 
to their local environments by increasing the frequency of beneficial genetic variants.  
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Human population-specific adaptations include alleles that confer resistance to malaria in 
West Africa, lactose tolerance in Europe and East Africa, and the ability to thrive in the 
low oxygen, high altitude environments of Tibet in Asia and the Andes in South America.  
Genetic admixture is the process that occurs when populations that were previously 
reproductively isolated, and consequently genetically diverged, come back together and 
exchange genes.  Recent studies of modern and ancient genomes have underscored the 
frequency with which admixture has occurred during human evolution.  Indeed, human 
evolution has been characterized by numerous iterations of physical isolation and genetic 
divergence followed by population convergence and admixture.  Genetic admixture has 
profound implications for human evolution as it results in the creation of evolutionarily 
novel genomes that contain combinations of genetic variants (haplotypes) never seen 
before on the same genomic background.  Many of these ancestry-specific variants may 
have an outsized effect on health-related phenotypes.  In addition, when pre-selected 
genetic variants from distinct parts of the world are brought together in the same admixed 
population, they can provide raw material for rapid adaptation to the new environment.  
My PhD thesis research is focused on understanding the implications of genetic admixture 
for human health, fitness, and population structure.  The health and evolutionary 
dimensions of genetic admixture were interrogated via the analysis of modern, 
cosmopolitan populations in Latin America. 
Latin America is an ideal setting to study the implications of genetic admixture for 
human health and evolution.  Modern human populations in Latin America were formed 
as part of the Columbian Exchange, starting ~500 years ago when African, European, and 
Native American populations that were isolated for tens of thousands of years were brought 
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back together over a relatively short period.  The Columbian Exchange represents one of 
the most abrupt and massive admixture events in human history.  The conquest and 
colonization of the New World entailed the migration of tens of millions of Europeans, the 
forced migration of more than twelve million enslaved Africans, and tragically, the death 
of untold millions of Native Americans.  Modern Latin American populations emerged 
from this historical crucible, with the descendants of distinct ancestral groups containing 
varying degrees of African, European, and Native American ancestry.  As such, admixed 
Latin American genomes contain combinations of ancestry-specific haplotypes never 
before seen together on the same genomic background.   
This dissertation explores the implications of large-scale genetic admixture in Latin 
America for human health, evolution (natural selection), and population structure 
(assortative mating).  Human health and evolution are explored through the lens of 
admixture, with an emphasis on the demographic processes that serve to combine distinct 
ancestry components within genomes.  Population structure is considered with respect to 
assortative mating, which serves to limit the extent of genetic admixture within 
populations, thereby maintaining genetic diversity among distinct population groups even 
when they are co-located.  In order to understand the implications of admixture for the 
formation of the New World, comparative genomic analyses were used to characterize 
patterns of genetic ancestry and admixture for individuals from four modern Latin 
American populations: Colombia, Mexico, Peru, and Puerto Rico.  Genetic ancestry, 
characterized at both genome-wide (global) and gene (local) levels, was integrated with a 
variety of functional genomic data sources in an effort to more fully understand the 
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biological implications of the Columbian Exchange for admixed human populations in the 
Americas.   
Research advance 1:  My first study explored the implications of admixture for the 
genomic determinants of health in admixed Latin American populations.  Ancestry patterns 
for individual genetic variants were characterized for each population, and variants with 
anomalous ancestry patterns, i.e. present at higher frequency than expected based on the 
genomic ancestry background, were inspected for their impact on various health-related 
phenotypes.  The four Latin American populations shared evidence of ancestry enrichment 
for a number of health-related pathways, including cytochrome P450 metabolism, the JAK-
STAT signaling pathway, and the Leishmaniasis disease pathway.  Variants with an excess 
of African or European ancestry were also found to be associated with ancestry-specific 
gene expression.  These ancestry-enriched variants were located in genes of the adaptive 
and innate immune systems and were shown to have population-specific regulatory effects. 
Research advance 2: My second study explored the role of admixture in enabling 
rapid, adaptive evolution in Latin American populations.  Genetic ancestry was calculated 
at the gene level within populations, and gene-specific ancestry deviations, i.e. more or less 
ancestry than expected given the genomic background, were used to identify signals of 
admixture-enabled selection.  This study relied on a novel combined evidence approach 
whereby signals of ancestry-enrichment were evaluated for (i) individual genes across 
multiple populations and (ii) multiple genes that function together to encode polygenic 
phenotypes.  Cross-population signals of African ancestry enrichment were found at the 
major histocompatibility complex (MHC) locus on chromosome 6, along with concurrent 
signals of positive selection in ancestral African populations, consistent with admixture-
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enabled selection on the adaptive immune system.  In addition, a number of phenotypes 
related to inflammation and both the adaptive and innate immune systems showed evidence 
for polygenic admixture-enabled selection across the Latin American populations. 
Research advance 3: My third study explored the implications of genetic ancestry 
for the maintenance of human population structure in Latin America.  Assortative mating 
is a universal feature of human behavior, with individuals often choosing mates similar to 
themselves, and it can serve as a reproductive barrier that maintains structure among 
distinct population groups even when they are co-located.  The exact phenotypic cues and 
underlying genetic architecture of this phenomenon are unknown; however, it has been 
shown that genetic ancestry influences assortative mating.  In this study, an integrated 
analysis of local genetic ancestry and the genetic architecture of traits thought to play a role 
in assortative mating was performed.  As assortative mating creates an excess of 
homozygosity, ancestry-based assortative mating would generate an excess of local 
ancestry homozygosity.  The patterns of local genetic ancestry were utilized to assess the 
extent of assortative mating for polygenic phenotypes.  A novel test statistic, the 
Assortative Mating Index (𝐴𝑀𝐼) was created to assess the levels of ancestry homozygosity 
for each polygenic trait.  Signals of assortative mating were uncovered in each admixed 
Latin American population for a number of anthropometric and neurological traits, as well 
as in the MHC locus. 
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CHAPTER 1. A BRIEF INTRODUCTION 
Here, I provide a brief overview of the major themes that motivate my PhD thesis 
research.  I elaborate on these themes, and provide a more thorough literature review, in 
Chapter 2. 
Anatomically modern humans (AMH) evolved in Africa ~250,000-300,000 years ago 
[1, 2].  After thousands of years of living on the African continent, AMH began the out-of-
Africa migration, ~75,000-100,000 years ago [1, 2].  These early global migrations to 
Oceania, Europe, Asia, and eventually the Americas resulted in populations that were 
geographically isolated for tens of thousands of years.  During this period, geographic 
separation of populations was accompanied by reproductive isolation and genetic 
diversification.  Much this divergence can be attributed to genetic drift, whereby allele 
frequencies fluctuate randomly with no appreciable effect on fitness.  However, isolated 
human populations also adapted to their local environments via positive (diversifying) 
selection on beneficial alleles.  Both genetic drift and positive selection contributed to the 
genetic diversification of reproductively isolated human populations, with millennia of 
isolation and divergence giving rise to the major continental population groups recognized 
today, including Africans, Europeans, and Native Americans. 
In the modern era of relatively rapid global travel, the process of migration and 
subsequent isolation has been reversed.  Populations that were isolated for tens of 
thousands of years are now coming together at an ever-increasing rate.  A canonical 
example of early global travel is the Columbian Exchange, the widespread movement of 
plants, animals, pathogens, and humans across the Atlantic Ocean to the New World, begun 
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by Christopher Columbus ~500 years ago [3, 4].  The Columbian Exchange had a profound 
impact on the trajectory of human evolution: once isolated and genetically diverged 
continental population group were quickly brought together in a new environment in a way 
that forever changed the course of human evolution. 
This major transition in human global migration had profound implications for many 
aspects of human biology and evolution, including impacts on health and disease, fitness 
and adaptation, and population structure.  Prior to the Columbian Exchange, distinct 
African, European, and Native American continental population groups diverged from one 
another and adapted to their local environments; after the Columbian Exchange, novel 
admixed populations were formed as combinations of these three ancestry components.  
This pattern of three-way continental admixture is most pronounced in Latin America.  The 
formation of novel Latin American populations in the New World entailed the combination 
of numerous pre-adapted haplotypes, allowing for rapid adaptation to the local 
environment.  In modern societies, these admixed populations require different approaches 
to healthcare and treatment of diseases, as the ancestry-variant relationship and prevalence 
of diseases differ between populations depending on their admixture patterns [5, 6].  
Nevertheless, the majority of studies focusing on understanding the genetic-disease 
relationship focus on populations with single ancestries, for technical reasons, and findings 
from these studies are not necessarily portable to those with different or mixed ancestries 
[7, 8].  Accordingly, while studies of admixed populations pose technical challenges, they 
also provide unique opportunities for uncovering the genetic architecture of health and 
fitness. 
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With respect to the formation of modern, cosmopolitan American populations, two 
distinct phenomena are of particular interest: 1) admixture – which leads to the breakdown 
of previously established population structure and 2) assortative mating – which allows for 
the maintenance of previously established population structure.  Admixture occurs when 
previously isolated populations come together and interbreed, creating individuals with 
mixed genetic ancestries.  Assortative mating, on the other hand, is the process whereby 
individuals that are more similar choose to mate, yielding more coherent ancestry within 
groups and more divergent ancestry between groups.  These two demographic processes 
have distinct, yet complementary, implications for human populations and can be 
considered as two sides of the same coin.  
1.1 Admixture 
Admixture, the creation of individuals with multiple ancestries due to population 
mixture, occurs when populations meet in a new environment.  Such is the case with the 
Columbian Exchange in the New World, which resulted in three-way admixture in Latin 
American populations – individuals with African, European, and Native American 
genomic ancestry.  The population structure found among distinct ancestral source 
populations is broken down in newly admixed populations.  This structure is the result of 
thousands of years of genetic drift and/or adaptation to local environments, e.g. Malaria 
resistance in West Africa [9, 10], lactose tolerance in Europe [11, 12] and East Africa [13], 
and altitude adaptation in Asia [14-16] and South America [16].  As the ancestries were 
combined in Latin America, ancestry-specific adaptations that were also beneficial in the 
new environment were introduced at intermediate frequencies, allowing for a rapid 
population growth should selection act upon them once again [17].  
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1.2 Assortative mating 
Assortative mating, or non-random mating, is a ubiquitous feature of human behavior 
that affects population genetic structure and evolution [18-20].  It is well known that 
humans mate assortatively rather than randomly.  Mate choices based on similarities in 
levels of genetic ancestry help to maintain the structure of the ancestral population in the 
admixed population [18-20].  Human mate choice is often based on traits that another 
person can see or experience, such as height.  As many of these phenotypes vary in their 
appearance between different populations, assortative mating in admixed populations helps 
to keep ancestral population structure. 
1.3 Admixture versus assortative mating in Latin America 
This thesis explores the biological implications of admixture and assortative mating in 
modern Latin American populations.  As mentioned previously, admixture and assortative 
mating can be viewed as two sides of the same coin, with respect to the implications of the 
Columbian Exchange that brought together previously isolated continental population 
groups on a massive scale over a relatively short period of time.  Admixture breaks down 
previously established population structure among ancestral source populations, whereas 
assortative mating can maintain some degree of structure even among groups that are 
physically co-located.  Both of these distinct demographic processes have implications for 
health and fitness in modern populations. 
Latin American populations represent an ideal system to study the implications of 
admixture and assortative mating.  The modern Latin American populations were formed 
by genetic admixture among highly divergent ancestral source populations from Africa, 
 5 
Europe, and the Americas and are distinguished by different levels of continental ancestry 
from each of these groups and overall admixture.  The high levels of genetic divergence 
among the ancestral source populations that admixed to form modern Latin American 
populations allow for unambiguous characterization of the ancestral origins of admixed 
genomes across various levels of scale: genome-wide (global), gene-by-gene (local), and 
even down to the level of individual genetic variants in some cases.  Finally, there are 
numerous whole genome sequences available from different Latin American populations, 
which along with thousands of genomes from ancestral source populations provide a rich 
opportunity for a deep bioinformatic interrogation of these issues. 
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CHAPTER 2. RAPID, ADAPTIVE HUMAN EVOLUTION 
FACILITATED BY ADMIXTURE IN THE AMERICAS 
2.1 Abstract 
 Humans have migrated from their ancestral homelands in Africa to nearly every 
part of the world.  Human migration is characterized by a recurrent process of physical 
isolation and genetic diversification followed by admixture, whereby previously isolated 
populations come together and exchange genes.  Admixture results in the introgression of 
alleles from ancestral source populations into hybrid admixed populations, and we 
demonstrate how introgression can facilitate rapid adaptive evolution by introducing 
beneficial alleles at intermediate frequencies.  We provide examples of adaptive 
introgression between archaic and modern human populations and for admixed populations 
in the Americas, which were formed relatively recently via admixture among African, 
European, and Indigenous American ancestral populations.  Adaptive introgression has had 
an outsized effect on the human immune system.  In light of the ubiquity of admixture in 
human evolution, we propose that adaptive introgression is a fundamentally important 
mechanism for driving rapid adaptive evolution in human populations. 
2.2 Human migration, genetic divergence, and admixture 
The story of human evolution is one of nearly constant migration.  The impulse to 
leave one’s home, explore, and settle new territories is a seemingly universal hominid trait, 
manifest across multiple species and sub-species of the genus Homo, and one that 
ultimately allowed for humans to populate nearly every corner of the globe.  Our hominid 
ancestors, and their earliest human descendants, have embarked on numerous long distance 
migrations around the world since their origins on the African continent.  Fossil evidence 
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suggests that Homo erectus migrated out of Africa to Eurasia just over 2 million years ago 
(ya), and H. heidelbergensis, a putative ancestor to both archaic and modern humans, left 
Africa ~800,000 ya [21, 22].  The modern human sub-species – Homo sapiens sapiens – is 
thought to have originated from an African lineage of H. heidelbergensis ~300,000 ya [23], 
and began to migrate out of Africa and around the world starting ~75,000 ya [24, 25].  The 
phenomenon of migration has had a profound impact on the genetic composition of human 
populations worldwide, simultaneously driving the joint processes of genetic divergence 
and admixture.  We are particularly interested in how admixture, and the resulting 
introgression of alleles from ancestral source populations, may have accelerated adaptive 
evolution in human populations. 
H. sapiens’ long and steady march out of Africa, through Asia, Oceania, and Europe, 
and finally throughout the Americas, entailed repeated episodes of population divergence 
followed by admixture, whereby previously separated populations came together and 
mixed (Figure 1A).  Indeed, we can consider human evolution to be characterized by a 
recurrent pattern of: (1) (e) migration, (2) isolation, (3) divergence, (4) (im)migration, and 
(5) admixture (Figure 1B).  Human populations constantly migrate to new lands, often 
resulting in physical isolation, which in turns leads to genetic diversification of the isolated 
populations.  Genetic divergence of isolated populations can occur via genetic drift, owing 
to small population sizes, and/or natural selection based on local adaptations.  However, 
population isolation does not last forever; eventually, additional waves of migration bring 
previously isolated populations together again.  Any time previously isolated human 
populations encounter one another, even when those populations are from distinct sub-
species, as was the case when modern humans encountered Neandertals and Denisovans, 
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they interbreed, exchanging genes and yielding new hybrid lineages with genetic 
contributions from multiple ancestral source populations.  As David Reich has detailed in 
his recent book-length treatment of the ancient DNA revolution, this pattern of migration-
driven divergence and admixture has been repeated countless times in archaic and modern 
human populations around the world [26].  Admixture is not a bug of human evolution – it 
is in fact a ubiquitous feature of our species [27]. 
 
Figure 1. Human migration, genetic divergence, and admixture. 
(A) Out-of-Africa migration routes around the world are indicated with gray lines/arrows.  
Ancient admixture events are indicated with circles [locations taken from [26]], and the 
modern admixture event that brought together African, European, and Indigenous 
American populations, i.e. the Columbian Exchange [3, 4], is shown with red lines/arrows.  
(B) The recurrent and joint processes of migration-driven genetic divergence and 
admixture are illustrated. 
We posit that the process of genetic admixture has had a major impact on accelerating 
human adaptive evolution, in particular by stimulating the rapid evolution of introgressed 
alleles in recently admixed populations [17].  This model of human evolution shares much 
in common with Sewall Wright’s Shifting Balance Theory, which emphasized the 
importance of population sub-division and subsequent migration in facilitating adaptive 
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evolution [28].  In this chapter, we briefly review studies related to the pace of human 
adaptive evolution, explaining how admixture can speed up this process, followed by a 
more detailed treatment of adaptive introgression in both archaic and modern human 
populations.  We emphasize rapid adaptive introgression in the Americas, the region of the 
world that has experienced perhaps the greatest single admixture event in human history, 
whereby African, European, and Indigenous American populations that were previously 
isolated for tens-of-thousands of years were suddenly brought together again following 
Columbus’s arrival in the New World [3, 4]. 
2.3 Admixture and the pace of adaptive evolution in human populations 
In their book The 10,000 Year Explosion, authors Cochran and Harpending take aim 
at the anthropological doctrine which holds that human biological evolution came to a halt 
around 50,000 ya, thereafter being superseded by a far more dynamic cultural evolution 
[29].  In distilling this so-called ‘conventional wisdom’ regarding human evolution, they 
quote Stephen Jay Gould as saying “There’s been no biological change in humans in 40,000 
or 50,000 years.  Everything we call culture and civilization we’ve built with the same 
body and brain”.  The basic idea underlying this assertion is that the explosion of human 
culture and behavioral modernity that marked the Upper Paleolithic essentially liberated 
humans from the strictures of biological evolution.  This happened because rapid cultural 
evolution, in the form of tool and technology development, obviated the need to respond 
to environmental pressures by the slower process of natural selection.  The authors 
convincingly dismiss with this (perhaps slightly straw man) argument and stress instead 
that technological developments, the invention of agriculture in particular, actually 
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accelerated human adaptive evolution by allowing for larger population sizes and 
consequently more adaptive mutations [30]. 
The recent acceleration of human adaptive evolution covered in The 10,000 Year 
Explosion was based on the authors’ own research along with the work of many other 
scientists who have taken advantage of the accumulation of human genome sequence 
variation data to detect signals of adaptive evolution genome-wide in multiple populations 
around the world [31-34].  This impressive body of research has leveraged the ongoing 
growth of human population genomic datasets, along with the development of increasingly 
sensitive methods for detecting adaptive evolution, to steadily decrease the amount of 
elapsed time needed to observe adaptation events.  For instance, the agricultural revolution 
10,000 ya led to adaptive evolution for calcium absorption in European populations [35].  
Adaptive mutations that conferred lactose tolerance in Europeans [12] and increased 
energy metabolism in East Asia [36] emerged independently 8,000 ya.  Lighter skin 
pigmentation and increased height were selected for in Europeans 6,000 ya and 5,000 ya, 
respectively [37, 38].  Sickle cell mutations for protection against malaria were initially 
proposed to have arisen multiple times in African populations, with estimates around 3,000 
ya [9, 10], but a recent study has proposed that these haplotypes are derived from a common 
ancestral haplotype that emerged 7,300 ya [39].  Perhaps the most recent sequence-based 
evidence for human adaptive evolution, at the lactase and major histocompatibility loci, 
dates to 2,000 ya [37].  Here, we present evidence in support of our thesis that adaptive 
human evolution has occurred in the Americas within the last 500 years, an exceedingly 
short amount of time with respect to human evolution, via introgression of beneficial 
haplotypes from ancestral source populations.  
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Despite the findings on selection outlined in the previous paragraph, human adaptive 
evolution is still largely regarded as a slow process, which is constrained by the 
introduction of new adaptive alleles via mutation.  This can be illustrated by the classic 
population genetic model showing the rate at which the frequency of an adaptive allele will 
increase in a population (Figure 2).  A new mutant allele will be introduced at the low 
population frequency of 1 (2 × 𝑁𝑒)⁄  , where 𝑁𝑒 is the effective population size.  For 
example, a relatively small effective population size of 5,000 will yield an initial mutant 
allele frequency of 0.01%.  If the new allele is adaptive, selection will act to increase its 
population frequency (p) over time proportional to the selection (s) and dominance (h) 
coefficients, according to the recursion equation 𝑝𝑖,𝑡+1 = 𝑝𝑖,𝑡𝑤𝑖 ?̅?⁄  , where i is the allele, t 
is the current generation, p is the allele frequency, wi is the marginal fitness of the allele i, 
and ?̅? is the population mean fitness.  The increase in adaptive allele frequency happens 
extremely slowly at the end of the low end of the allele frequency spectrum.  Under an 
additive dominance model (ℎ = 0.75) with a strong selection coefficient of 𝑠 = 0.1, it will 
take more than 100 generations to see a 20% increase in the initial frequency of the adaptive 
allele.  However, as can be seen in Figure 2, the rate of adaptive allele frequency increase 
speeds up tremendously at intermediate allele frequencies.  Under the same dominance and 
selection parameters, but starting from an intermediate allele frequency of 35%, a doubling 
of the adaptive allele frequency can occur in less than 20 generations.  This feature of 
adaptive evolution is what leads us to believe that admixture can facilitate extremely rapid 
human adaptation.  When two or more previously isolated populations converge and mix, 
they introduce alleles to the newly formed admixed population at intermediate frequencies 
proportional to the percent contributions of each ancestral population.  Since admixture 
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introduces new alleles at intermediate frequencies via introgression in this way, it has the 
potential to allow for substantial increases in the frequency of adaptive alleles over a 
relatively small number of generations.   
 
Figure 2. Population genetic model showing the increase in frequency of an adaptive 
allele over time. 
Adaptive allele frequencies are shown on the y-axis, and time in generations is shown on 
the x-axis.  The model corresponds to a selection coefficient (𝑠) of 0.1, and three different 
allele increase trajectories are shown according to different dominance coefficients (ℎ).  
The gray shading corresponds to the zone at intermediate allele frequencies where the rate 
of adaptive allele frequency increase is most rapid. 
While our notion that admixture can dramatically speed up adaptive human evolution 
is based on a theoretical conjecture, there are numerous empirically observed cases of 
adaptive introgression in human populations that support this view of evolution.  A 
majority of the studies on adaptive introgression focus on the impacts of admixture between 
modern humans and archaic hominids, e.g. Neandertals and Denisovans.  In the sections 
that follow, we first discuss a few examples of ancient adaptive introgression, as they are 
by now more widely accepted.  Then we review an example of more recent adaptive 
introgression in Africans.  Finally, we discuss adaptive introgression in the Americas, 
where there are fewer studies and more contention regarding the results.  Findings from 
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admixed American populations are particularly provocative in the sense that they point to 
adaptive evolution occurring over a span of 500 years, or approximately 20-25 generations, 
an exceptionally short period of time for human evolution. 
2.4 Ancient adaptive introgression 
Evidence of adaptive introgression acting as a means of rapid human adaptive 
evolution has been shown via the admixture of modern humans with archaic hominids.  
Before the modern human out-of-Africa migration, Europe and Asia were populated by 
other Homo species: Neandertals and Denisovans.  These archaic populations had isolated 
and genetically diverged from the ancestors of modern humans hundreds of thousands of 
years before and were adapted to their respective local environments in Europe and Asia.  
As modern humans emerged from Africa, they not only encountered new environments, 
but also these new human-like populations.  Admixture of archaic and modern humans 
created new genomes that combined intermediate frequency adaptive alleles from the 
archaic populations into the genomic background of the modern humans.  This is thought 
to have helped modern human populations to more quickly adapt to new environments as 
they settled Europe and Asia, including fighting off novel pathogens.  Here we will review 
a few examples of ancient adaptive introgression; for a more comprehensive review, see 
[40]. 
2.4.1 Immune system 
A key factor in the response of the immune system is the HLA class I genes of the 
major histocompatibility complex (MHC).  These genes are involved in antigen 
presentation for immune cell recognition and are very diverse across human populations.  
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Abi-Rached et al. were interested in the evolutionary source of the deeply divergent human 
HLA-B allele, HLA-B*73:01 [41].  This allele is found mainly in west Asia and is in linkage 
with HLA-C*15:05, found in west and southeast Asia.  The authors suggested that this 
allele combination was not present in Africa prior to the out-of-Africa migration.  To test 
this hypothesis, they characterized the archaic HLA class I genes from Denisovans and 
Neandertals, finding that two HLA-A and two HLA-C alleles in Denisovans were most 
similar to modern sequences, including the HLA-C*15 allele.  Geographic locations of 
these similar modern alleles show a very low presence in Africa, with higher presence in 
Asia and Oceania.  Divergence estimates of these alleles show that they were formed before 
the out-of-Africa migration, but since the alleles are not present in Africa, they are likely 
to come from an archaic source populations, namely Denisovans.  The authors completed 
the same analysis with similar Neandertal HLA-A and HLA-C alleles and found them to be 
present in Eurasians and absent in Africans.  These findings suggest that the immune 
systems of archaic Homo populations were better adapted to local pathogens in the 
Eurasian environments, and upon migrating out of Africa, modern humans rapidly adapted 
the immune system through introgression of these sequences. 
After the study on HLA adaptive introgression, Mendez et al. interrogated STAT2, 
an immune system gene with a role in interferon-mediated responses, for signals of 
adaptive introgression with Neandertals in Europeans [42].  Initial sequencing of STAT2 
revealed the ‘N’ haplotype, a deeply divergent haplotype present only in the non-African 
populations used in this study.  When compared with the draft Neandertal reference 
sequence, the N haplotype most closely matched the Neandertal sequence.  In addition to 
this, the haplotype linkage disequilibrium (LD) including STAT2 is very long in both West 
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Eurasians (~130 kb) and East Asians and Melanesians (~260 kb), a finding expected if the 
haplotype was introduced via introgression.  The upper divergence estimate between the 
Neandertal and N haplotype of ~160 kya is more recent than the estimates of divergence 
between the Neandertal and human reference sequence of ~600 kya.  The N haplotype has 
a 10-fold higher frequency in Melanesians, particularly the long form of the haplotype, 
when compared with the rest of the Eurasian populations.  This suggests that STAT2, or 
some other gene in the haplotype, was the target of positive selection in Melanesians.  In 
either case, the introgression of STAT2 into the modern human genome affected interferon 
signaling in the immune system. 
Genome-wide studies on Neandertal and Denisovan introgression had identified a 
number of putative Neandertal introgressed regions in modern humans [43, 44].  
Dannemann et al. utilized these genomic maps to characterize the adaptive introgression 
potential of a region containing a haplotype of three Toll-like receptors (TLRs), TLR6-
TLR1-TLR10, which show some of the highest probabilities of Neandertal introgression 
[45].  These genes play an important role in the innate immune system as they are the first 
line of defense against pathogens and help to activate the adaptive immune response.  To 
characterize this region of chromosome 4 as resulting from an adaptive introgression event, 
the authors identified evidence of introgression by showing that there are seven main 
haplotypes for the TLRs and three of these are more similar to archaic sequences than to 
the rest of modern humans as determined by sequence comparisons.  In addition to this, 
the geographic distribution of the archaic-like sequences provide evidence for introgression 
as they are mostly found outside of Africa, which is to be expected if introgression occurred 
when modern humans moved into Neandertal and Denisovan environments.  A high 
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differentiation, as determined by FST, and previous studies reporting signatures of positive 
selection on SNPs in TLR10 provided the authors with evidence that the haplotype was 
under positive selection.  Expression quantitative trait loci analysis showed tissue-specific 
regulatory effects increasing the expression of these genes in white blood cells.  Overall, it 
was posited that this TLR haplotype could have been adaptively introgressed into the 
modern human population as a means to affect the innate immune system response with 
response to potential pathogens, including H. pylori.  The authors mention that a diversity 
of haplotypes for TLRs could have increased the adaptation of modern humans in novel 
environments, such as that encountered after migration out of Africa. 
2.4.2 Integumentary system 
Adaptive introgression of Neandertal sequences have also affected the hair and skin 
phenotypes of Europeans and East Asians, as published by two studies in 2014.  Vernot 
and Akey, as mentioned previously, created a catalog of putative introgressed Neandertal 
sequences in 379 Europeans and 298 East Asians, part of the Phase 1 data release of the 
1000 Genomes Project, using a modified 𝑆∗ summary statistic to identify signals of 
introgression followed by sequence comparison to a Neandertal reference [44].  The 
authors then interrogated these sequences to find significantly differentiated introgressed 
regions between Europe and East Asia as well as shared regions in the two populations 
with relatively high allele frequency.  Using FST to identify differentiated variants between 
the two populations, the authors identified two regions with genes that are part of the 
integumentary system, in addition to other regions and genes.  BCN2 on chromosome 9 
was found to be at ~70% frequency in Europeans while absent in East Asians; this gene 
has been related to skin pigmentation in Europeans.  POU2F3 on chromosome 11 was 
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found to be at ~66% frequency in East Asians and <1% in Europeans; this gene is expressed 
in the epidermis and mediates keratinocyte proliferation and differentiation.  Both 
populations shared a total of six regions with >40% allele frequency with signals of 
adaptive introgression.  One of these regions on chromosome 12q13 contains a type II 
cluster of keratin genes, providing evidence for adaptive variation of skin phenotypes. 
A second study to find evidence of adaptive introgression in the integumentary 
system used a conditional random field approach to identify putative Neandertal 
introgressed regions in 1,004 modern humans from the Phase I data release of the 1000 
Genomes Project [43].  They also created a map of Neandertal introgression events in the 
modern human genome and analyzed the top 5% of genes with the highest inferred 
Neandertal ancestry.  They found that there was a significant enrichment of genes involved 
in keratin filament formation and posit that Neandertal variants may have helped modern 
humans adapt to the novel European and Asian environments by affecting their skin and 
hair. 
2.4.3 Altitude adaptation 
A well-studied example of how archaic introgression can provide an adaptive benefit 
to a modern human population is that of altitude adaptation in Tibetans.  Early studies 
elucidated the molecular underpinnings of adaptation to high altitude living in Tibetans 
and the high-altitude Sherpa population and noted that EPAS1 and EGLN1 are crucial to 
controlling signals of hemoglobin concentration in Tibetans, compared with other lowland 
East Asian populations [46-48].  Jeong et al. [15] determined that the Tibetan population 
was a result of an ancestral “high-altitude” population admixing with a “low-altitude” 
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population.  As EPAS1 had the strongest signal of selection for Tibetans, Huerta-Sanchez 
et al. [14] moved forward to identify the source of the adaptive introgression for this gene.  
After re-sequencing 40 Tibetan individuals (high-altitude) and 40 Han Chinese individuals 
(low-altitude), the authors found that FST for this gene was highly differentiated as expected 
if there was selection on the high-altitude haplotype in Tibetans.  When comparing the 
Tibetan-specific haplotype to potential donor sequences, it was determined that the 
haplotype shared more sequence similarity with the Denisovan haplotype than any other 
extant or archaic population.  The authors concluded that introgression from a Denisovan 
population allowed the modern Tibetan population to rapidly adapt to the high-altitude of 
the Tibetan plateau. 
2.5 Adaptive introgression in modern humans 
The Bantu-speaking populations (BSPs) of Africa experienced multiple periods of 
adaptive introgression during their migration throughout Africa over the last 1,500 years 
[49].  As the BSPs migrated, they encountered other African populations, already adapted 
to their local environments.  Genetic ancestry characterization of the BSPs showed 
admixture with other African populations, including western rainforest hunter-gatherers, 
eastern African farmers, and San populations.  In each of the BSP populations – western, 
eastern and southeastern – the authors searched for evidence of excess ancestry and 
compared their findings with signals of positive selection to identify putative adaptively 
introgressed regions.  In western BSPs, there was an overlap of excess western rainforest 
hunter-gatherer ancestry with a strong signal of positive selection for the HLA region and 
a moderately strong signal for CD36.  These regions are both related to the immune system 
response, with CD36 being associated with susceptibility to malaria caused by Plasmodium 
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falciparum.  In eastern BSPs, excess eastern African ancestry overlapped a moderately 
strong signal of positive selection for the lactase gene (LCT) providing the lactase 
persistence phenotype for eastern BSPs.  Thus, both the immune system and diet-related 
phenotypes of BSPs have been influenced by recent admixture and adaptive introgression 
in these African populations. 
2.6 Adaptive introgression in the Americas 
We are particularly interested in studying adaptive introgression in admixed 
American populations [17].  Modern (cosmopolitan) human populations in the Americas 
were formed primarily by admixture among ancestral source populations from Africa, 
Europe, and the Americas (Figure 1A).  This is considered to be one of the largest and most 
abrupt admixture events in all of human evolution and one that has had a profound effect 
on world history [3, 4].  Admixed American genomes can be considered as evolutionarily 
novel in the sense that they contain combinations of ancestry-specific alleles that never 
previously existed together on the same genomic background.  The creation of such novel 
admixed genome sequences has important implications for health and fitness in modern 
American populations [50].  The possibility of adaptive introgression in the Americas can 
be considered controversial in light of the fact that the ~20-25 generations that have elapsed 
since the process of admixture in the Americas began represents a very short amount of 
time in terms of human evolution, less than 1% of the time that has elapsed since humans 
migrated out of Africa.  In principle, it should be very difficult to observe adaptive human 
evolution over such a short time scale.  Nevertheless, we contend that the Americas 
represent an ideal laboratory to study adaptive introgression and to explore the possibility 
of extremely rapid adaptation in human populations. 
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Our working hypothesis is that numerous alleles were ‘pre-selected’ in ancestral 
source populations over thousands of years based on their utility in the local environments 
of Africa, Europe, and the Americas.  Subsequently, when the ancestral source populations 
were suddenly brought back together, some of these pre-selected alleles could have also 
provided an adaptive benefit in the New World environment.  For example, alleles that 
served to protect their human hosts against infectious disease may have been particularly 
important in the pathogen-rich environment of the Americas.  In addition, neutral alleles 
that diverged in frequency among ancestral populations based on genetic drift could later 
become adaptively beneficial in the new environment.  In either case, adaptively beneficial 
alleles introduced at intermediate frequencies via introgression could quickly increase in 
frequency owing to their utility in the novel admixed populations (see Figure 2 and the 
previous discussion on how introgression can accelerate adaptive evolution). 
The analytical approach used to test this hypothesis is based on the delineation of 
genome-wide ‘local ancestry’ patterns in admixed populations.  Local ancestry refers to 
the specific ancestral origins – African, European, or Native American – for specific 
chromosomal regions (i.e. haplotypes).  Local ancestry is assigned by comparing individual 
chromosomal segments against the corresponding genomic regions from panels of 
ancestral population reference genomes [51, 52].  Once this is done for an admixed 
American population, the population’s local ancestry fractions for any given region of the 
genome can be compared to the genome-wide population ancestry averages to search for 
‘ancestry-enriched’ regions (Figure 3).  Ancestry-enriched regions are genomic segments 
that show anomalously low or high ancestry fractions, for any given ancestry component, 
compared to the genome-wide population averages.  Statistically significant local ancestry 
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deviations are taken to represent evidence of adaptive introgression.  The presence of 
independent signals of previous positive selection on these same regions in ancestral source 
populations can be used to provide additional evidence in support of adaptive introgression 
[49].  Below, we review all currently known cases of adaptive evolution in admixed 
American populations. 
 
Figure 3. Ancestry-enrichment analysis for identifying adaptive introgression 
events. 
Locus-specific ancestry patterns – African (blue), European (orange), and Native 
American (red) – are characterized across all chromosomes in the population.  Locus-
specific ancestry fractions are compared with the global ancestry fractions along the 
genome to identify ancestry-enriched (or depleted) segments.  An example is shown (gray 
shading) for a region that is enriched for African ancestry and depleted for European 
ancestry. 
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2.6.1 Puerto Rico 
One of the first studies on adaptive introgression in the Americas uncovered signals 
of recent selection and introgression in Puerto Ricans [53].  Genetic ancestry 
characterization of the study population – 192 Puerto Ricans as part of the Genetics of 
Asthma in Latino Americans study – showed that the population was mainly of European 
descent with relatively equal fractions of African and Native American ancestries.  Local 
ancestry estimates, when compared with global averages, revealed excess African ancestry 
on chromosome 6 and excess Native American ancestry on chromosomes 8 and 11.  The 
region of chromosome 6 with African enrichment harbors the major histocompatibility 
complex (MHC), the first response to invading pathogens for the adaptive immune system.  
Chromosome 11 shows Native American enrichment of an olfactory gene cluster, which 
the authors mention, has been shown to be under positive selection and reference other 
studies [54, 55].  The final Native American enrichment on chromosome 8 did not have 
any clear candidates for adaptive introgression, but the one gene in the region, CSMD3, did 
have some tissue-specific expression.  The authors suggest that the enrichment of African 
alleles of the immune system could be due to them being more advantageous in the new 
environment as they are genetically more diverse than Europeans or Native Americans and 
better able to fight off the numerous pathogens imported and endemic to the area.  Another 
reason for the ancestry enrichment could be that these genes played a role in a phenotype 
that offered a fitness advantage and thus was acted upon by natural selection upon 
admixture in the New World.  For either reason, the immune system of Puerto Rican 




A 2015 study to characterize the genetic ancestry of the Colombian population from 
the 1000 Genomes Project found that similar to Puerto Rico, the Colombian population has 
mostly European ancestry, followed by Native American and finally African ancestry 
fractions [56].  In addition to understanding the impacts of sex-biased admixture, the 
authors evaluated local ancestry patterns, looking for locus-specific patterns using a 
trinomial probability metric to signal areas with excess ancestry.  The regions with 
anomalous ancestry patterns were then interrogated for previously identified signs of 
positive selection and their phenotypic associations, specifically health-related phenotypes.  
The authors found signals of African ancestry enrichment for HLA-B on chromosome 6, 
part of the MHC.  There was also evidence of enrichment of European ancestry for 
SLC24A5 on chromosome 15, a gene that influences skin pigmentation with decreased 
melanin.  In addition to single genes with anomalous ancestry patterns, the authors 
performed a gene set enrichment analysis to identify pathways containing an abundance of 
ancestry-enriched genes.  They found both the innate and adaptive immune response 
contained signs of ancestry enrichment.  These lines of evidence provide support for the 
hypothesis that the Colombian genomes retained adaptive ancestry-specific loci that were 
better suited to combat the wide variety of pathogens in the environment. 
As a caveat to the findings, it should be noted that the program used for local 
ancestry assignment generated very short ancestry tracts, compared with the tract lengths 
generated from current local ancestry assignment programs such as RFMix [51].  It is 
unlikely that in the ~20-25 generations since the Columbian Exchange that there would be 
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sufficient genomic recombination to generate the size tracts seen in this analysis and their 
findings should be validated using contemporary programs. 
2.6.3 Mexico 
In 2014, a novel two-layer hidden Markov model was proposed for inferring local 
ancestry of admixed individuals based on the detection of haplotype structure [57].  This 
method was used to characterize the genetic ancestry and highlight regions with excess 
ancestry-specific loci in Mexican individuals from the HapMap3 Project and 1000 
Genomes Project.  For both projects, the author found excess African ancestry on 
chromosome 6 in the MHC region, as well as on chromosome 8p23.1 at a known 
chromosomal inversion. 
A follow-up study on recent selection in Mexican individuals found a significant 
excess of African ancestry of the MHC on chromosome 6 [58].  The authors analyzed 
genetic ancestry data from two cohorts of Mexican individuals and found excess ancestry 
in both cohorts.  By being able to replicate the results in a second cohort, there was more 
confidence in the findings of African ancestry enrichment.  In addition to this, the authors 
developed a technique to infer local ancestry without the concern of inaccurate Native 
American samples and estimated the amount of selection necessary for this locus to remain 
significantly enriched with African ancestry.  The results suggest that selection was at 
similar strengths to that of lactase selection in Europeans and the sickle-cell trait in 
Africans.  The authors suggest that the challenging conditions of the New World, with the 
existing pathogens and those brought over by the Spaniards and Africans could have 
provided the necessary selection pressure for the African MHC alleles to increase in 
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frequency due to the greater diversity of African MHC.  Infectious diseases and epidemics, 
in addition to harsh living conditions, caused many of the Native American populations to 
perish, leading to a lack of Native American ancestry at this important immune system 
locus. 
2.6.4 African Americans 
A study on ancestry-specific selection in 1,890 African Americans characterized 
the genetic ancestry of the population to be ~72% African and ~28% European [59].  The 
authors then identified loci with European (or African) ancestry 3 standard deviations 
above or below the genome-wide average as those potentially under natural selection.  Four 
regions were found to have excess European ancestry and two were found to have excess 
African ancestry.  The excess European ancestry was found to be related to response to 
influenza infection and the African ancestry was found to be related to general immune 
system signaling.  Using FST between African Americans and putative ancestral African 
populations, the authors identified signals of positive selection and found four regions that 
carried differentiated SNPs, including those related to malaria response and the MHC, 
suggesting the immune system of African Americans in the New World was under pressure 
with response to the novel pathogen environment.  It is important to note, however, that 
the regions with excess African ancestry do not overlap with those putatively under positive 
selection. 
In response to these findings, another group performed a genetic ancestry analysis 
on 29,141 African American individuals and found there to be no evidence of directional 
selection [60].  Instead, the authors state that the earlier findings could have been due to 
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chance or systematic biases in data handling.  When directly comparing the 2012 results to 
the authors’ calculations, the authors showed that they get much lower ancestry deviation 
estimates than previously reported, and the 2012 enrichment findings were not replicated.  
The same results are found when focusing on the positive selection estimates using FST; 
the previous results were not replicated and there were no overlaps between the two 
findings. 
2.7 Conclusions and future prospects 
Adaptive human evolution was postulated to have stopped ~40-50,000 ya, coincident 
with the emergence of cultural evolution [61, 62].  Not only has this anthropological 
doctrine been shown to be false, but there is abundant evidence that adaptive evolution has 
actually accelerated over the last 10,000 years [29].  Throughout this chapter, we have 
provided examples of adaptive introgression acting as a means for facilitating rapid human 
evolution, through admixture with Neandertals and Denisovans thousands of years ago, for 
admixture in modern Africans 1,500 years ago, and via admixture in the Americas 500 
years ago.  Admixture and introgression have allowed modern humans to colonize new 
environments, such as the Tibetan plateau, resist novel pathogens and combinations of 
pathogens throughout Europe, Africa and the Americas, and generally be better suited to 
their local environments.  The immune system has been shown to be a hotspot of adaptive 
introgression throughout time as admixture among previously adapted populations allowed 
modern humans to quickly adapt and thrive in their new environments. 
As seen in the contradictory studies of African Americans, signals of adaptive 
introgression can be due to biases in the data or small sample sizes.  To increase confidence 
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in ancestry enrichment acting as signals of adaptive introgression, future studies can ensure 
that regions with ancestry enrichment also have multiple lines of evidence of positive 
selection from ancestral populations on the same genomic regions in the admixed 
populations.  In addition, if there are multiple admixed populations with similar ancestral 
source populations, finding signals of ancestry enrichment and positive selection shared 
among the multiple populations could provide more confidence that a finding is true as 
there is likely shared selection pressures in the same area of the world.  Selection is also 
likely to occur on phenotypes which are caused by multiple genes, not just one genomic 
locus.  If the same ancestry enrichment and positive selection signals are seen in multiple 
genes encoding a polygenic phenotype, then it is likely that adaptive introgression could 
have led to rapid adaptive human evolution. 
Finally, we would like to propose the idea that admixture, now recognized as a 
ubiquitous feature of human evolution [26, 27], has had a far greater impact on human 
adaptive evolution than formerly recognized.  The linked processes of genetic divergence 
followed by admixture (Figure 1B) have provided abundant raw material for adaptive 
introgression throughout human evolutionary history, which in turn can provide for 
extremely rapid adaptive evolution unconstrained by mutation.  It may well be the case 
that, owing to admixture, adaptive evolution of human populations is far more common 
and much more dynamic than previously imagined. 
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CHAPTER 3. GENETIC ANCESTRY, ADMIXTURE AND 
HEALTH DETERMINANTS IN LATIN AMERICA 
3.1 Abstract 
3.1.1 Background 
Modern Latin American populations were formed via genetic admixture among 
ancestral source populations from Africa, the Americas and Europe.  We are interested in 
studying how combinations of genetic ancestry in admixed Latin American populations 
may impact genomic determinants of health and disease.  For this study, we characterized 
the impact of ancestry and admixture on genetic variants that underlie health- and disease-
related phenotypes in population genomic samples from Colombia, Mexico, Peru, and 
Puerto Rico. 
3.1.2 Results 
We analyzed a total of 347 admixed Latin American genomes along with 1,102 
putative ancestral source genomes from Africans, Europeans, and Native Americans.  We 
characterized the genetic ancestry, relatedness, and admixture patterns for each of the 
admixed Latin American genomes, finding a spectrum of ancestry proportions within and 
between populations.  We then identified single nucleotide polymorphisms (SNPs) with 
anomalous ancestry-enrichment patterns, i.e. SNPs that exist in any given Latin American 
population at a higher frequency than expected based on the population’s genetic ancestry 
profile.  For this set of ancestry-enriched SNPs, we inspected their phenotypic impact on 
disease, metabolism, and the immune system.  All four of the Latin American populations 
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show ancestry-enrichment for a number of shared pathways, yielding evidence of similar 
selection pressures on these populations during their evolution.  For example, all four 
populations show ancestry-enriched SNPs in multiple genes from immune system 
pathways, such as the cytokine receptor interaction, T cell receptor signaling, and antigen 
presentation pathways.  We also found SNPs with excess African or European ancestry 
that are associated with ancestry-specific gene expression patterns and play crucial roles in 
the immune system and infectious disease responses.  Genes from both the innate and 
adaptive immune system were found to be regulated by ancestry-enriched SNPs with 
population-specific regulatory effects. 
3.1.3 Conclusions 
Ancestry-enriched SNPs in Latin American populations have a substantial effect 
on health- and disease-related phenotypes.  The concordant impact observed for same 
phenotypes across populations points to a process of adaptive introgression, whereby 
ancestry-enriched SNPs with specific functional utility appear to have been retained in 
modern populations by virtue of their effects on health and fitness. 
3.2 Background 
The modern human species – Homo sapiens sapiens – originated in sub-Saharan 
Africa ~200,000 years ago and began to migrate out of Africa and spread throughout the 
world starting ~70,000 years ago [1, 2].  After heading north out of Africa, humans spread 
to the east and west, populating Melanesia, Asia, and Europe, and eventually made their 
way across the Bering Strait into the Americas ~20,000 years ago.  As human populations 
occupied different parts of the globe, they often became geographically isolated in their 
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new homelands.  Thousands of years of geographic isolation were accompanied by 
population genetic diversification, giving rise to the diverse human population groups that 
can be seen around the world to this day [63, 64].  Distinct continental population groups 
– African, Asian, and European in particular – are the most obvious examples of this 
evolutionary process.  There were, of course, a number of episodes of genetic admixture 
during this time [27], whereby previously isolated populations came into contact and began 
to mix, but for the most part, the dominant mode of human evolution since our emergence 
from Africa has been characterized by populations’ physical isolation followed by genetic 
diversification. 
This pattern of human evolution was turned upside down upon the arrival of 
Columbus in the New World a mere 500 years ago, which is less than 1% of the elapsed 
time since humans emerged from Africa.  Columbus’ voyages precipitated the so-called 
‘Columbian Exchange’ – a massive transfer of life forms, which had evolved separately 
for millennia, between the Old and New World hemispheres [3, 4].  The human dimension 
of the Columbian Exchange entailed genetic admixture between previously isolated 
populations on an unprecedented scale, in terms of both scope and rapidity [17].  The 
conquest and colonization of the Americas, along with the trans-Atlantic slave trade, 
brought African, European, and Native American populations into close and sustained 
contact for the first time.  As a consequence, these diverse population groups began to mix, 
giving rise to novel admixed American populations.  This is particularly true for Latin 
America, where populations are characterized by high levels of genetic admixture among 
African, European, and Native American ancestral source populations [65-67].  
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Latin American genomes can thus be considered to represent a recent innovation in 
human evolution.  Indeed, genomes from modern Latin American populations are 
evolutionarily novel in the sense that they contain combinations of genetic variants 
(haplotypes) that never previously existed together on the same genetic background.  Our 
group is interested in trying to understand the implications of the recent advent of novel 
Latin American genomes, particularly as it relates to the genetic determinants of health-
related phenotypes.  In other words, we are asking what it means when genomes that were 
separated for many thousands of years are suddenly brought back together and what the 
implications of this process are for human health and fitness. 
Our group and others have employed an approach that we call ancestry-enrichment 
analysis to address these kinds of questions via population-level studies of admixed 
American genomes [17].  This approach relies on the characterization of local patterns of 
genetic ancestry for individual genomic loci.  Local ancestry assignment, colloquially 
referred to as chromosome painting, entails the delineation of ancestral origins of specific 
haplotypes across the genome.  The resulting chromosome paintings reveal the genomes 
of admixed individuals as mosaics of interspersed ancestry-specific haplotypes.  When a 
population sample of admixed genomes is characterized in this way, the percent ancestry 
contributions from each ancestral source population can be computed for all haplotype loci 
genome-wide.  Ancestry-enrichment analysis then entails the identification of specific 
haplotype loci that have anomalous patterns of local ancestry, i.e. levels of locus-specific 
ancestry that are significantly higher or lower than can be expected by chance given the 
overall ancestry profile of the population.  Statistically significant signals of ancestry-
enrichment are taken as evidence of adaptive introgression, whereby introgressed 
 32 
haplotypes increase in frequency by virtue of a selective advantage that they provide to 
individuals in an admixed population. 
A number of recent studies have used ancestry-enrichment analysis to show evidence 
of adaptive introgression in admixed American genomes.  The first study of this kind 
showed an excess of African ancestry at the major histocompatibility locus (MHC) in a 
sample of Puerto Rican genomes [53], and a follow up study several years later also found 
ancestry-enrichment at the same region in a Mexican population [57].  Since that time, 
several other studies have replicated the finding of ancestry-enrichment in admixed 
populations at this and other health related loci [56, 58, 59, 68, 69].  Our own more recent 
work on Colombian genome sequences revealed even more widespread ancestry-
enrichment, which impacted various aspects of the immune system, including pathways 
involved in both innate and adaptive immunity [56]. 
All of the previous ancestry-enrichment studies were distinguished by their 
interrogation of the ancestral origins of individual haplotypes, i.e. physically linked sets of 
genetic variants that are inherited together.  For this study, we developed and applied a 
novel method based on individual genetic variants – single nucleotide polymorphisms 
(SNPs) – in an effort to expand our view of the relationship between genetic ancestry, 
admixture and health in Latin American populations.  Our approach entails the detection 
of SNPs that are found at anomalously high frequencies in admixed populations compared 
to what is expected based on their frequencies in the ancestral source populations, i.e. 
ancestry-enriched SNPs.  To find such ancestry-enriched SNPs, we consider the 
proportional contributions of ancestral source populations to admixed Latin American 
populations, together with SNP frequencies in the ancestral populations, to derive expected 
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SNP frequencies for the Latin American populations.  These expected frequencies are 
compared to observed frequencies in order to identify statistically significant ancestry-
enriched SNPs; the connection between ancestry-enriched SNPs and health-related 
phenotypes is then explored via analysis of the functional annotations of the SNPs and their 
linked genes.  In particular, we interrogated the impact of ancestry-enriched SNPs on 
disease, metabolism and immune system pathways.  This approach uncovered signals of 
ancestry-enrichment in health- and disease-related traits shared among all four of the Latin 
American populations that we analyzed, raising the possibility of shared selective pressures 
among them. 
3.3 Materials and Methods 
3.3.1 Comparative genomic data sources 
Whole genome sequences from four admixed Latin American populations – 
Colombia (n=94), Mexico (n=64), Peru (n=85), and Puerto Rico (n=104) – were taken from 
the 1000 Genomes Project (1KGP) phase 3 data release1 [70].  Genome sequences from 
the four Latin American populations were compared to whole genome sequences and 
whole genome genotypes of global reference populations from African, European, and 
Native American continental population groups to characterize their patterns of genetic 
ancestry and admixture (Figure 4 and Table 1).  The global reference whole genome 
sequences were also taken from the 1KGP, and reference whole genome genotype data was 
taken from the Human Genome Diversity Project (HGDP) [64].  The whole genome 
sequence and whole genome genotype data were merged, with sites that existed in both 
                                                 
1 http://www.internationalgenome.org/data/ 
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datasets retained for subsequent analysis, and PLINK v1.9 [71] was used to correct single 
nucleotide polymorphism (SNP) strand orientation as needed.  This resulted in a dataset of 
435,782 SNPs from 1,449 individuals, across 19 populations.  The final merged SNP 
dataset was phased with the 1KGP haplotype reference panel using the program 
SHAPEIT2 [72].  
 
Figure 4. Analysis scheme used for this study. 
(1) Genetic ancestry and admixture profiles were characterized for four Latin American 
populations.  (2) Expected SNP frequencies in the admixed Latin American populations 
are calculated based on their ancestry profiles.  (3) Ancestry-enriched SNPs are identified 
by comparing observed versus expected SNP allele frequencies in in the admixed Latin 
American populations. (4) Ancestry-enriched SNPs are mapped to genes, which in turn are 
used for gene set enrichment in order to identify impacted health-related pathways and 
phenotypes. 
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Table 1. Human populations analyzed in this study. 
Populations are organized into continental groups: African, East Asian, European, and 
Admixed American from the 1000 Genomes Project (1KGP) and Native American from the 
Human Genome Diversity Project (HGDP).  Short names, descriptions, and the numbers 
of genomes analyzed (n) are provided for each individual population. 
Dataset Short Full Description n 
1 KGP African 
(n=193) 
MSL Mende in Sierra Leone 85 
YRI Yoruba in Ibadan, Nigeria 108 
1KGP East Asian 
(n=504) 
CDX Chinese Dai in Xishuangbanna, China 93 
CHB Han Chinese in Bejing, China 103 
CHS Southern Han Chinese, China 105 
JPT Japanese in Tokyo, Japan 104 
KHV Kinh in Ho Chi Minh City, Vietnam 99 
1KGP European 
(n=297) 
CEU Utah residents with NW European ancestry 99 
IBS Iberian populations in Spain 107 
GBR British in England and Scotland 91 
1KGP Admixed 
American (n=347) 
CLM Colombian in Medellin, Colombia 94 
MXL Mexican Ancestry in Los Angeles, California 64 
PEL Peruvian in Lima, Peru 85 
PUR Puerto Rican in Puerto Rico 104 
HGDP Native 
American (n=108) 
KRT Karitiana in Brazil 24 
SRI Surui in Brazil 21 
COL Colombians in Colombia 13 
MAY Maya in Mexico 25 
PIM Pima in Mexico 25 
3.3.2 Genome ancestry assignment 
ADMIXTURE [73] was run on individuals from both the global reference and 
admixed Latin American populations to infer their genome-wide ancestry profiles.  
ADMIXTURE was run with K=3 corresponding the three ancestral continental population 
groups: African, European, and Native American.  The ADMIXTURE results for the 
admixed Latin American populations were used to infer individuals’ percent ancestry 
contributions from each of these three continental ancestry groups.  The program RFMix 
[51] was used to assign the continental ancestry origins of individual haplotypes across the 
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genome, i.e. local ancestry.  As with ADMIXTURE, African, European, and Native 
American populations were used as reference populations for RFMix.  Ancestry-specific 
haplotypes were only called for regions where RFMix certainty was at least 99%. 
3.3.3 Detection of ancestry-enriched SNPs  
Ancestry-enriched SNPs were characterized as SNPs found in higher frequencies 
in admixed Latin American populations compared to what is expected based on (1) their 
frequencies in the ancestral source populations, and (2) the proportion of ancestry derived 
from each ancestral source population.  For any given SNP, in any given Latin American 
population, the expected frequency of the SNP 𝑓(𝑆𝑁𝑃)𝐸𝑥𝑝 can be calculated as: 
 𝑓(𝑆𝑁𝑃)𝐸𝑥𝑝  =  ∑ 𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝  ×  𝑃(𝐴𝑛𝑐)𝑃𝑜𝑝
𝑃𝑜𝑝 ∈ 𝐸𝑢𝑟,𝐴𝑓𝑟,𝑁𝑎𝑡
 (1) 
where 𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝 is the frequency of the SNP in a specific ancestral source population 
and 𝑃(𝐴𝑛𝑐)𝑃𝑜𝑝 is the proportion of ancestry in the modern Latin American population 
derived from that same ancestral population.  Ancestry proportions were computed using 
the reduced, merged set of SNPs described above, with African and European reference 
populations from the 1KGP and Native American reference populations from HGDP.  SNP 
frequencies were computed using whole genome sequences, in order to provide more 
complete coverage of variants genome-wide, using the YRI African and IBS European 
reference populations with the most closely related East Asian population CHB taken as a 
surrogate for Native American ancestry.    
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The statistical significance of SNP ancestry-enrichment calculated this way was 
determined by comparing the observed (𝑂𝑏𝑠) to expected (𝐸𝑥𝑝) frequencies of the 
reference (𝑅𝑒𝑓) and alternate (𝐴𝑙𝑡) alleles for any given SNP as shown here: 
 
𝜒2  =  








The 𝜒2 distribution was used to calculate P-values for each SNP, and false discovery rate 
(FDR) q-values were used to account for multiple statistical tests.  The SNPs that had 
significant FDR values (q < 0.05) were considered to be ancestry-enriched in the Latin 
American population, i.e. present at a higher frequency than expected based on the 
population ancestry profile. 
For ancestry-enriched SNPs, the individual ancestry components (𝐴𝑛𝑐) that gave 
rise to the pattern of enrichment were also determined by jointly minimizing the frequency 
difference between the SNP in the Latin American population and a single ancestral source 
population while maximizing the distance between that single source population and the 
other two ancestral populations: 
𝐴𝑛𝑐𝑃𝑜𝑝1 = [(𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝1 − 𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝2) + (𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝1 − 𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝3)] 2⁄
− |𝑓(𝑆𝑁𝑃)𝑂𝑏𝑠 − 𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝1| 
(3) 
where 𝑓(𝑆𝑁𝑃)𝑃𝑜𝑝𝑥 is the frequency of the SNP in each of the ancestral source populations 
and 𝑓(𝑆𝑁𝑃)𝑂𝑏𝑠 is the frequency of the ancestry-enriched SNP in the Latin American 
population. 
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3.3.4  Gene set enrichment analysis 
Ancestry-enriched SNPs were mapped to genes if they mapped within the NCBI 
RefSeq [74] gene models, i.e. between transcription start and stop sites, on the UCSC 
Genome Browser human genome reference sequence build GRCh37/hg19.  Functionally 
coherent gene sets were curated from the Molecular Signatures Database (MSigDB) 
version 5.1 [75] for three broad functional categories: health- and disease-related 
phenotypes, metabolism, and immunity.  Gene set enrichment analysis (GSEA) was 
performed for each Latin American population by adopting the MSigDB statistical 
framework to find functional gene sets that were enriched for genes with mapped ancestry-
enriched SNPs.  To do this, genes that harbor ancestry-enriched SNPs were overlapped 
with genes from each functional gene set, and overlap enrichment was performed using the 
R limma package [76].  Overlap enrichment P-values were computed for each gene set 
using the Wilcoxon signed-rank test. 
3.3.5 Expression quantitative trait loci (eQTL) analysis 
RNA-seq data were taken from the GUEVADIS RNA sequencing (RNA-seq) 
project for 1KGP samples2.  A total of 445 RNA-seq samples were used in the analysis, 
including 87 African and 358 European individuals.  The RNA-seq data correspond to gene 
expression levels for the same lymphoblastoid cell lines, i.e. Epstein–Barr virus (EBV) 
transformed B-lymphocytes, which were used for the 1KGP DNA-seq characterization.  
RNA-seq sample preparation, sequencing experiments and read-to-genome mapping were 




performed as previously described [77].  The read-to-genome mapping corresponds to 
human genome build GRCh37/hg19.  Gene expression levels were quantified based on 
RNA-seq mapped reads and corresponded to ENSEMBL gene models [78].  Gene 
expression levels were quantified by using the reads per kilobase per million mapped reads 
(RPKM) approach in combination with the probabilistic estimation of expression residuals 
(PEER) method as previously described [79, 80].    
Matched whole genome sequencing based SNP genotype calls were obtained for 
the same 445 individuals from the phase 3 release of the 1KGP [70].  Only SNPs with 
minor allele frequency (MAF) greater than 5% were used for the downstream analysis to 
ensure both the confidence of genotype calls and the reliability of the eQTL association 
analyses.  Gene expression levels of 445 individuals were then regressed against their SNP 
genotypes to identify eQTLs using the program Matrix eQTL [81].  The Matrix eQTL 
program was run using the additive linear model option with gender and population labels 
included as covariates. 
3.3.6 SNP pathway meta-analysis 
Meta-analysis was used to evaluate the overall ancestry-enrichment for sets of 
SNPs that are implicated in specific health- or disease-related pathways.  For any given 
ancestry-enriched SNP that mapped to a gene found in an overrepresented pathway, a log 
odds ratio was calculated as: 
 





where the observed (𝑂𝑏𝑠) versus expected (𝐸𝑥𝑝) frequencies (𝑓) are compared for the SNP 
reference (𝑅𝑒𝑓) versus alternate (𝐴𝑙𝑡) alleles.  Then for each pathway, the set of individual 
SNP log odds ratios was combined to yield pathway-specific log odds ratio values along 
with 95% confidence intervals using the fixed-effect model with moderators via linear 
(mixed-effect) models implemented in the metafor package in R [82]. 
3.4 Results 
3.4.1 Relating genome ancestry and health in Latin America 
We developed and applied a single nucleotide polymorphism (SNP)-based 
approach to relate genome ancestry to genetic determinants of health in admixed Latin 
American populations (Figure 4).  First, patterns of genetic ancestry and admixture in Latin 
American populations were characterized via comparison with reference genome 
sequences of putative ancestral source populations from Africa, the Americas and Europe 
(Table 1).  We then computed the expected SNP frequencies in Latin American populations 
by taking into consideration the SNP frequencies in the ancestral source populations along 
with the proportional contributions of each ancestral source population to the modern Latin 
American populations.  Comparisons of observed versus expected SNP frequencies in 
admixed Latin American populations were used to identify what we refer to as ‘ancestry-
enriched’ SNPs, which are SNPs found at anomalous frequencies in Latin American 
populations compared to what can be expected based on their ancestry profiles.  Ancestry-
enriched SNPs were mapped to genes, and then genes were used in gene set enrichment 
analysis to identify impacted health-related pathways and phenotypes. 
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3.4.2 Genetic ancestry and admixture in four Latin American populations 
Genome sequences from four Latin American populations – Colombia, Mexico, 
Peru, and Puerto Rico – were compared to whole genome sequences and whole genome 
genotypes of global reference populations from African, European, and Native American 
continental population groups in order to characterize their patterns of genetic ancestry and 
admixture.  Each Latin American population has a distinct pattern of three-way continental 
genetic admixture characterized by population-specific proportions of African, European 
and Native American ancestry (Figure 5).  Puerto Rico and Colombia are characterized by 
relatively high levels of three-way admixture, with substantial ancestry contributions from 
all three continental population groups, whereas Mexico and Peru have primarily Native 
American and European ancestry.  Puerto Rico and Colombia also have the highest levels 
of European ancestry, while Peru and Mexico have majority Native American ancestry.  
The 80% Native American ancestry component for Peru is the single highest contribution 
of any ancestral population to an admixed Latin American population, and the 2% African 
ancestry fraction for this same population is the lowest.  African source populations 
contribute the least amount of ancestry to all four Latin American populations analyzed 
here.  The continental ancestry proportions for each Latin American population were used 
as described in the following section to detect ancestry-enriched SNPs that exist in any 
given population at a higher frequency than expected based on its ancestry profile. 
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Figure 5. Genetic ancestry and admixture in Latin American populations. 
The ancestry contributions of putative ancestral source populations to four modern, 
admixed Latin American populations are shown.  (A) Triangle plots showing the relative 
ancestry contributions – African, European, Native American – to admixed individuals 
from four Latin American populations.  (B) PCA plot showing the genetic relationships 
among individuals from admixed Latin American populations compared to putative 
ancestral source populations.  Each population is bounded by a minimum spanning ellipse.  
(C) Admixture plots showing the fractions of African, Native American and European 
ancestry among admixed individuals from four Latin American populations. Each 
individual is represented as a column with the admixture fractions color coded as shown 
in the legend.  (D) Violin plots showing distributions of ancestry fractions among 
individuals from four Latin American populations.  (E) Pie charts showing the average 
ancestry values for each population next to its geographic location. 
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3.4.3 Ancestry-enriched SNPs in Latin American populations 
Our approach to relating genetic ancestry to determinants of health and disease in 
modern Latin American populations relies on the detection of SNPs that are found at 
anomalously high frequencies in admixed populations compared to what is expected based 
on their frequencies in the ancestral source populations, i.e. ancestry-enriched SNPs.  We 
reasoned that such ancestry-enriched SNPs are likely to have an outsized effect on health 
and disease in modern Latin American populations, perhaps related to an initial increase in 
population frequency via adaptive introgression. 
We developed and applied a quantitative method to identify individual SNPs that 
are enriched in admixed Latin American populations with respect to ancestry from one of 
the three ancestral source populations: Africa, Europe, and the Americas.  To do so, the 
expected frequencies for each SNP were calculated using the frequency of the given SNP 
in each of the three ancestral source populations conditioned upon the proportion of each 
ancestral source population in the Latin American population of interest.  Observed SNP 
frequencies were compared to expected SNP frequencies to identify ancestry-enriched 
SNPs; the details of this approach are shown in section 3.3 Materials and Methods. 
The distributions and median values of ancestry-specific SNP 2 values are shown 
in Figure 6A.  Peru shows the strongest overall signal of SNP ancestry-enrichment, 
followed by Mexico, Colombia, and Puerto Rico.  Statistically significant ancestry-
enriched SNPs for each population were mapped to genes for subsequent analysis of their 
impact on health- and disease-related phenotypes.  There is a substantial amount of overlap 
of mapped genes among the four populations (Figure 6B).  Out of 156 total genes with 
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mapped ancestry-enriched SNPs, 102 (65%) are shared among two or more populations 
compared to 54 (35%) that are population-specific.  There are 40 genes that bear ancestry-
specific SNPs in all four Latin American populations, which is by far the single largest 
component of shared versus unique genes.  Lists of all SNPs that show significant ancestry-
enrichment – along with details regarding their observed and expected allele frequencies, 
test-statistic values, and specific ancestry enrichment patterns – can be found in Table 5. 
 
 
Figure 6. Ancestry-enriched SNPs in Latin American populations. 
An overview of the distributions of ancestry-enriched SNPs within and between the four 
admixed Latin American populations are shown, giving an indication of the overall 
numbers of ancestry-enriched SNPs along with the extent to which they are shared or 
unique to specific populations.  (A) Cumulative distributions of ancestry-enrichment 𝜒2 
values for all SNPs in the four Latin American populations. Inset: Median 𝜒2 values for 
each population ± standard error.  (B) Venn diagram showing the number of genes with 
significant ancestry-enriched SNPs exclusive to one population and those shared by more 
than one population. 
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3.4.4 Gene set enrichment analysis of overrepresented SNPs 
The genes with mapped ancestry-specific SNPs were analyzed with gene set 
enrichment analysis (GSEA) to look for overrepresented health- or disease-related 
pathways and phenotypes (Figure 7).  This approach allowed us to identify the specific 
pathways and phenotypes that are most affected by ancestry-enriched SNPs.  The presence 
of significantly overrepresented pathways and/or phenotypes in two or more populations 
was taken to indicate a higher likelihood of genetic ancestry effects on health and disease 
in modern Latin American populations. 
A number of pathways and phenotypes have significantly overrepresented 
ancestry-enriched SNP genes in all four populations (Figure 7A).  These include gene sets 
related to immunity (yellow) and metabolism (orange) as well as several disease-specific 
gene sets (blue) (Figure 7B).  Immune system pathways with ancestry-enriched SNPs 
include the cytokine receptor interaction, T cell receptor signaling, and antigen processing 
and presentation pathways.  Implicated metabolic pathways include both drug and 
xenobiotic metabolism as well as steroid hormone biosynthesis.  Diseases of note include 
several pathologies that are known to be found in high prevalence in Latin American 
populations: type I diabetes, Alzheimer’s disease and Leishmaniasis.  A number of other 
signaling pathways were implicated by this analysis – calcium, MAPK, and GNRH 
signaling – pointing a role for ancestry-enriched SNPs in mediating human-environment 
interactions.  Lists of all pathways that show significant enrichment of genes with mapped 
ancestry-enriched SNPs, for each admixed Latin American population – along with 
information regarding the overlapping genes and pathway enrichment statistical 
significance (FDR q-values) – are provided in Table 6. 
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Figure 7. Gene set enrichment analysis of ancestry-enriched SNP genes. 
Functionally coherent gene sets and pathways that are overrepresented with respect to 
ancestry-enriched SNPs are shown, giving an indication of the kinds of health-related 
phenotypes that have been shaped by genetic ancestry in the four admixed Latin American 
populations.  (A) Heatmap showing significantly enriched functional gene sets (i.e., 
pathways and phenotypes) shared by two, three or all four Latin American populations.  
The cells are color coded by the log transformed statistical significance (FDR q-value) of 
gene set enrichment analysis results.  (B) Network showing significantly enriched pathways 
and phenotypes shared by all four Latin American populations.  Nodes sizes represent the 
number of ancestry-enriched genes in each set.  Pie charts show how many genes in a given 
set are from each population.  Color coding describes the functional enrichment category 
as shown in the legend. 
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We focused on several notable examples of health- and disease-related pathways 
that were found to have significantly overrepresented ancestry-enriched SNP genes in all 
four Latin American populations (Figure 8).  For each of these pathways, and in each 
population studied, we performed additional meta-analyses of the sets of mapped ancestry-
enriched SNPs in order to evaluate the pathway’s overall ancestry enrichment.  We also 
computed analogous overall observed versus expected allele frequencies for each pathway 
in all four populations.  There are 15 genes from the Leishmaniasis immune response 
pathway with mapped ancestry-enriched SNPs, including a pair of Toll-like Receptor 
encoding genes as well as several interleukin genes (Figure 8A).  The meta-analysis for 
this pathway shows an overall ancestry-enrichment for all SNPs in each of the four 
populations analyzed here.  Leishmaniasis is a parasitic disease with high prevalence in the 
tropics and subtropics including Latin America.  Similar pathway-specific analysis 
revealed overall ancestry-enrichment for SNPs linked to drug metabolism (Figure 8B), 
including multiple genes from the cytochrome P450 family, as well as the JAK-STAT 
signaling pathway, which is activated by cytokines as part of the innate immune response 
(Figure 8C).  The ancestry-enrichment observed for the drug metabolism pathway could 
represent an adaptation based on detoxification linked to local dimensions of diet and 




Figure 8. Pathways with ancestry-enriched SNP genes in functional categories of 
interest. 
These results highlight examples of specific health-related functions and pathways that 
have been shaped by genetic ancestry in the four admixed Latin American populations.  
For each functional category, a pathway schematic is shown, indicating the pathway genes 
and their roles, along with meta-analysis results and observed versus expected SNP 
frequencies for each population.  (A) Leishmaniasis, an example of a disease and health 
related pathway.  (B) Cytochrome P450 drug metabolism, an example of a metabolism 
related pathway.  (C) Jak-STAT signaling pathway, an example of an immune-related 
pathway. 
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3.4.5 Ancestry-specific expression quantitative trait loci (eQTL) 
We explored the effects of ancestry-specific SNPs on gene regulation via 
expression quantitative trait loci (eQTL) analysis.  eQTL are individual SNPs with 
genotype variants that are associated with gene expression levels; associations of this kind 
point to a role for SNP variants in gene regulation (e.g., via differential transcription factor 
binding affinities and/or allele specific expression levels) [83, 84].  To do this, we searched 
for ancestry-enriched SNPs that have ancestry-specific or shared genotype-expression 
associations.  The first step of this analysis entailed the identification of the specific 
ancestry-components that predominantly contribute to the observed patterns of SNP 
ancestry-enrichment (see section 3.3 Materials and Methods).  SNPs with highly 
asymmetric ancestry-enrichment patterns, i.e. predominant contributions from a single 
ancestral source population, were then chosen for eQTL analysis. 
Using this approach, we found a number of cases of SNPs that show 
overrepresented African or European ancestry in modern Latin American populations and 
are also associated with ancestry-specific gene regulation (Figure 9).  A number of the 
genes regulated by ancestry-specific SNPs were found to play specific roles in the immune 
system and infectious disease responses.  In particular, genes from both the innate and 
adaptive immune system were found to be regulated by ancestry-enriched SNPs that exert 
population-specific regulatory effects (Figure 9A-D).  For example, African ancestry-
enriched SNPs were found to exert African-specific regulatory control over genes for both 
immunoglobulin receptors (PVR and TYROBP) and a downstream tyrosine kinase 
(ZAP70) involved in the adaptive immune response (Figure 9E).  Similarly, European 
ancestry-enriched SNPs were also found to act as population-specific eQTLs with 
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regulatory effects on that were specific to the European populations.  Analogous patterns 
of ancestry-specific SNP enrichment and gene regulatory control were found for genes 
involved in cytokine-receptor interactions, hematopoietic cell development, and cell-cell 
immunomodulatory interactions. 
3.5 Discussion 
Latin America has a unique genetic heritage with high levels of admixture from 
African, European, and Native American ancestral source populations [65-67].  As such, 
the genome sequences of Latinos contain combinations of ancestry-specific genetic 
variants that never previously existed in the same genomic background.  In other words, 
Latin American genomes represent a very recent evolutionary innovation in the long 
trajectory of human evolution and migration around the globe.  Accordingly, the 
development and application of genomic approaches to healthcare in Latin America will 
require a deep understanding of the genetic ancestry and admixture profiles of Latin 
American populations.  This issue is particularly pressing given the fact that the vast 
majority of studies aimed at uncovering genetic variants associated with health- and 





Figure 9. Ancestry-specific effects on gene expression. 
These results give an indication of how ancestry-enriched SNPs can impact health-related 
phenotypes by virtue of their gene regulatory effects.  SNP-by-ancestry interactions were 
characterized using an expression quantitative trait loci (eQTL) approach.  Examples of 
(A) African-specific and (B) European-specific eQTL are shown along with (C) eQTL 
shared between populations.  (D) eQTL related to immune system and infectious disease 
found in the African and European populations are shown in a CIRCOS plot with links 
indicated between eQTLs and their regulated genes.  (E) Examples of immune-related 
pathways that include multiple eQTL-regulated genes for African and/or European 
populations. 
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Here, we have tried to address this issue by relating patterns of genetic ancestry and 
admixture to health and disease determinants in Latin American genomes.  To do so, we 
developed and applied a novel SNP-based approach to ancestry enrichment analysis.  Our 
approach leverages information on the genetic ancestry of the modern Latin American 
populations to discover SNP variants that exist in a given population at higher frequencies 
than expected, i.e. ancestry-enriched SNPs.  We found that specific sets of ancestry-
enriched genetic variants, from each of the three ancestral source populations, have been 
preferentially retained in modern Latin American populations based on a variety of roles 
that they play in health and fitness.  These findings have relevance for the development of 
genomic approaches to healthcare, i.e. personalized or precision medicine, in Latin 
America. 
Gene set enrichment analysis uncovered a number of immunity, metabolism, and 
disease-related pathways that are significantly overrepresented with respect to genes that 
contain ancestry-enriched SNPs (Figures 7 and 8).  These results suggest that these 
particular pathways, and their related phenotypes, could underlie population-specific 
health disparities in the four admixed Latin American populations studied here.  They also 
give an indication that populations with particular ancestry profiles may be more or less 
disposed to some of these diseases and phenotypes; information of this kind could 
ultimately help to guide targeted health interventions.  As these results represent basic 
research into the relationship between genetic ancestry and determinants of health, more 
clinically facing (translational) research will need to be done in order to precisely define 
the role of individual ancestry-enriched variants in disease etiology, prevention and 
treatment. 
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Expression quantitative trait loci (eQTL) analysis revealed ancestry-enriched SNPs 
in modern Latin American populations that are associated with African- or European-
specific patterns of gene regulation (Figure 9).  This includes SNPs that are associated with 
ancestry-specific regulation of genes involved in both the innate and adaptive immune 
systems as well as targeted infectious disease responses.  These results underscore the 
relevance of gene regulatory control as an underlying driver of adaptive introgression in 
admixed populations. 
One important caveat with respect to the interpretation of the results that we report 
is that they can only be taken to apply to the four specific populations analyzed here: 
Colombian in Medellin, Colombia (CLM), Mexican Ancestry in Los Angeles, California 
(MXL), Peruvian in Lima, Peru (PEL), and Puerto Rican in Puerto Rico (PUR).  Given the 
diversity of Latin American populations, and in particular their distinct ancestry profiles, 
we should expect to see distinct ancestry enrichments for different countries in the region, 
such as Argentina, Chile, Brazil, etc.  This caveat not only applies to different countries 
but also applies to different populations within the same country.  Colombia, for instance, 
is an extremely diverse country with populations from different regions that show very 
distinct ancestry profiles [65].  The population of Colombia analyzed here is from Medellín 
in the state of Antioquia, and this particular population shows averages of 64% European 
ancestry, 29% Native American ancestry, and 7% African ancestry.  However, we have 
previously shown that the population from the neighboring state of Chocó has a totally 
distinct ancestry profile with 76% African ancestry, 13% European ancestry, and 11% 
Native American ancestry [5, 85, 86].  Accordingly, results from the analysis of the 
population from Medellín cannot be taken to represent the entire country of Colombia. 
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Clearly, a deeper understanding of the relationship between genetic ancestry and health 
determinants in Latin America will require analysis of many more populations within and 
between the region’s countries. 
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CHAPTER 4. ADMIXTURE-ENABLED SELECTION FOR 
RAPID ADAPTIVE EVOLUTION IN THE AMERICAS 
4.1 Abstract 
4.1.1 Background 
Admixture occurs when previously isolated populations come together and 
exchange genetic material.  We hypothesized that admixture can enable rapid adaptive 
evolution in human populations by introducing novel genetic variants (haplotypes) at 
intermediate frequencies, and we tested this hypothesis via the analysis of whole genome 
sequences sampled from admixed Latin American populations in Colombia, Mexico, Peru, 
and Puerto Rico. 
4.1.2 Results 
Our screen for admixture-enabled selection relies on the identification of loci that 
contain more or less ancestry from a given source population than would be expected given 
the genome-wide ancestry frequencies.  We employed a combined evidence approach to 
evaluate levels of ancestry enrichment at (1) single loci across multiple populations and (2) 
multiple loci that function together to encode polygenic traits.  We found cross-population 
signals of African ancestry enrichment at the major histocompatibility locus on 
chromosome 6, consistent with admixture-enabled selection for enhanced adaptive 
immune response.  Several of the human leukocyte antigen genes at this locus (HLA-A, 
HLA-DRB51 and HLA-DRB5) showed independent evidence of positive selection prior to 
admixture, based on extended haplotype homozygosity in African populations.  A number 
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of traits related to inflammation, blood metabolites, and both the innate and adaptive 
immune system showed evidence of admixture-enabled polygenic selection in Latin 
American populations. 
4.1.3 Conclusions 
The results reported here, considered together with the ubiquity of admixture in 
human evolution, suggest that admixture serves as a fundamental mechanism that drives 
rapid adaptive evolution in human populations. 
4.2 Background 
Admixture is increasingly recognized as a ubiquitous feature of human evolution 
[27].  Recent studies on ancient DNA have underscored the extent to which human 
evolution has been characterized by recurrent episodes of population isolation and 
divergence followed by convergence and admixture.  In this study, we considered the 
implications of admixture for human adaptive evolution [26].  We hypothesized that 
admixture is a critical mechanism that enables rapid adaptive evolution in human 
populations, and we tested this hypothesis via the analysis of admixed genome sequences 
from four Latin American populations: Colombia, Mexico, Peru, and Puerto Rico.  We 
refer to the process whereby the presence of distinct ancestry-specific haplotypes on a 
shared population genomic background facilitates adaptive evolution as ‘admixture-
enabled selection’. 
The conquest and colonization of the Americas represents a major upheaval in the 
global migration of our species and is one of the most abrupt and massive admixture events 
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known to have occurred in human evolution [3, 4].  The ancestral source populations – 
from Africa, Europe, and the Americas – that admixed to form modern Latin American 
populations evolved separately for tens-of-thousands of years before coming together over 
the last 500 years.  This 500-year time frame, corresponding to approximately 20 
generations, amounts to less than 1% of the time that has elapsed since modern humans 
first emerged from Africa [1, 2].  Considered together, these facts point to admixed Latin 
American populations as an ideal system to study the effects of admixture on rapid adaptive 
evolution in humans [17]. 
A number of previous studies have considered the possibility of admixture-enabled 
selection in the Americas, yielding conflicting results.  On the one hand, independent 
studies have turned up evidence for admixture-enabled selection at the major 
histocompatibility complex (MHC) locus in Puerto Rico [53], Colombia [56], and Mexico 
[58], and another study found evidence for admixture-enabled selection on immune system 
signaling in African-Americans, particularly as it relates to influenza and malaria response 
[59].  Together, these studies highlighted the importance of the immune system as a target 
for admixture-enabled selection among a diverse group of admixed American populations.  
However, a follow up study on a different cohort of African-Americans found no evidence 
for admixture-enabled selection in the Americas [60].  The latter study concluded that the 
observed differences in local ancestry reported by previous studies, which were taken as 
evidence for selection, could have occurred by chance alone given the large number of 
hypotheses that were tested (i.e. the number of loci analyzed across the genome).  This 
work underscored the importance of controlling for multiple hypothesis testing when 
investigating the possibility of admixture-enabled selection in the Americas.   
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We attempted to resolve this conundrum by performing integrated analyses that 
combine information from (1) single loci across multiple populations and (2) multiple loci 
that encode polygenic traits.  We also used admixture simulation, along with additional 
lines of evidence from haplotype-based selection scans, to increase the stringency of, and 
confidence in, our screen for admixture-enabled selection.  This combined evidence 
approach has proven to be effective for the discovery of admixture-enabled selection 
among diverse African populations [49, 87].  We found evidence for admixture-enabled 
selection at the MHC locus across multiple Latin American populations, consistent with 
previous results, and our polygenic screen uncovered novel evidence for adaptive evolution 
on a number of inflammation, blood, and immune related traits. 
4.3 Results 
4.3.1 Genetic ancestry and admixture in Latin America 
We inferred patterns of genetic ancestry and admixture for four Latin American 
(LA) populations characterized as part of the 1000 Genomes Project: Colombia (n=94), 
Mexico (n=64), Peru (n=85), and Puerto Rico (n=104) (Figure 10).  Genome-wide 
continental ancestry fractions were inferred using the program ADMIXTURE [73], and 
local (haplotype-specific) ancestry was inferred using the program RFMix [51].  The 
results from both programs are highly concordant (Figure 16).  As expected [65, 85, 88, 
89], the four LA populations show genetic ancestry contributions from African, European, 
and Native American source populations, and they are distinguished by the relative 
proportions of each ancestry.  Overall, these populations show primarily European ancestry 
followed by Native American and African components.  Puerto Rico has the highest 
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European ancestry, whereas Peru shows the highest Native American ancestry.  Mexico 
shows relatively even levels of Native American and European ancestry, while Colombia 
shows the highest levels of three-way admixture.  Individual genomes vary greatly with 
respect to the genome-wide patterns of local ancestry, i.e. the chromosomal locations of 
ancestry-specific haplotypes (Figure 17).  If the process of admixture is largely neutral, 
then we expect ancestry-specific haplotypes to be randomly distributed throughout the 
genome in proportions corresponding to the genome-wide ancestry fractions. 
4.3.2 Ancestry enrichment and admixture-enabled selection 
For each of the four LA populations, local ancestry patterns were used to search for 
specific loci that show contributions from one of the three ancestral source populations 
which are greater than can be expected based on the genome-wide ancestry proportions for 
the entire population (Figure 18).  The ancestry enrichment metric that we use for this 
screen (𝑧𝑎𝑛𝑐) is expressed as the number of standard deviations above or below the 
genome-wide ancestry fraction.  Previous studies have used this general approach to look 
for evidence of admixture-enabled selection at individual genes within specific 
populations, yielding mixed results [53, 56, 58-60].  For this study, we have added two new 
dimensions to this general approach in an effort to simultaneously increase the confidence 
for admixture-enabled selection inferences and to broaden the functional scope of previous 
studies.  To achieve these ends, we searched for (1) concordant signals of ancestry 
enrichment for single genes (loci) across multiple populations, and (2) concordant signals 
of ancestry enrichment across multiple genes that function together to encode polygenic 
phenotypes.  The first approach can be considered to increase specificity, whereas the 
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second approach increases sensitivity.  Loci that showed evidence for ancestry enrichment 
using this combined approach were interrogated for signals of positive selection using the 
integrated haplotype score (iHS) [55] to further narrow the list of potential targets of 
admixture-enabled selection. 
4.3.3 Single gene admixture-enabled selection 
Gene-specific ancestry enrichment values (𝑧𝑎𝑛𝑐) were computed for each of the 
three continental ancestry components within each of the four admixed LA populations 
analyzed here.  We then integrated gene-specific 𝑧𝑎𝑛𝑐 values across the four LA 
populations using a Fisher combined score (𝐹𝐶𝑆).  The strongest signals of single gene 
ancestry enrichment were seen for African ancestry at the major histocompatibility 
complex (MHC) locus on the short arm of chromosome 6 (Figure 11A).  Three out of the 
four LA populations show relatively high and constant ancestry enrichment across this 
locus, with the highest levels of enrichment seen for Mexico and Colombia (Figure 11B).  
This signal is robust to control for multiple statistical tests using the Benjamini–Hochberg 




Figure 10. Genetic ancestry and admixture in Latin America. 
(A) The global locations of the four LA populations analyzed here (green) are shown along 
with the locations of the African (blue), European (orange), and Native American (red) 
reference populations.  The sources of the genomic data are indicated in the key.  (B) 
ADMIXTURE plot showing the three-way continental ancestry components for individuals 
from the four LA populations – Colombia, Mexico, Peru, and Puerto Rico – compared to 
global reference populations.  (C) The mean (±𝑠𝑒) continental ancestry fractions for the 
four LA populations.  (D) Chromosome painting showing the genomic locations of 
ancestry-specific haplotypes for an admixed LA genome. 
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Figure 11. African ancestry enrichment at the major histocompatibility complex 
(MHC) locus. 
(A) Manhattan plot showing the statistical significance of African ancestry enrichment 
across the genome.  (B)  Haplotype on chromosome 6 with significant African ancestry 
enrichment for three of the four LA populations: Colombia, Mexico, and Puerto Rico.  This 
region corresponds to the largest peak of African ancestry enrichment on chromosome 6 
seen in panel A.  Population-specific African (blue), European (orange), and Native 
American (red) ancestry enrichment values (𝑧𝑎𝑛𝑐) are shown for chromosome 6 and the 
MHC locus.  (C) Integrated haplotype score (iHS) values for African continental 
population from the 1KGP are shown for the MHC locus; peaks correspond to putative 
positively selected human leukocyte antigen (HLA) genes. 
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We simulated random admixture across the four LA populations, parameterized by 
their genome-wide ancestry proportions, to further assess the probability that this signal 
could be generated by chance alone (i.e. by genetic drift).  Based on this simulation, the 
observed levels of cross-population African ancestry enrichment at the MHC locus are 
highly unlikely to have occurred by chance (𝑃 < 5 × 10−5), whereas the observed patterns 
of European and Native American ancestry enrichment are consistent with the range of 
expected levels generated by the random admixture simulation (Figure 19).  Results of the 
admixture simulation analysis were also used to demonstrate that the cross-population 
approach to single locus ancestry-enrichment is sufficiently powered to detect selection at 
the population sizes analyzed here (Figures 20 and 21).  The statistical power of the 
ancestry enrichment approach used in this study rests on the cross-population comparisons, 
as the probability of observing the same ancestry enrichment at the same locus across 
multiple LA populations is diminishingly low. 
The MHC locus of chromosome 6 also shows a number of peaks for the iHS metric 
of positive selection from the African continental population (Figure 11).  These peaks rise 
well above the value of 2, which is taken as a threshold for putative evidence of positive 
selection [55].  The highest African iHS scores are seen for the human leukocyte antigen 
(HLA) encoding genes HLA-A, HLA-DRB5, and HLA-DRB1 (Figure 12A and 12B).  These 
HLA protein encoding genes make up part of the MHC class I (HLA-A) and MHC class II 
(HLA-DRB5, and HLA-DRB1) antigen presenting pathways of the adaptive immune system 




Figure 12. Admixture-enabled selection at human leukocyte antigen (HLA) genes. 
Integrated haplotype score (iHS) peaks for the African continental population from the 
1KGP are shown for (A) the MHC Class I gene HLA-A and (B) the MHC Class II genes 
HLA-DRB5 and HLA-DRB1.  (C) Illustration of the MHC Class I and MHC Class II 
antigen presenting pathways, with African enriched genes shown in blue. 
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We modeled the magnitude of selection pressure that would be needed to generate 
the observed levels of cross-population African ancestry enrichment at the MHC locus, 
using a tri-allelic recursive population genetics model that treats ancestry haplotype 
fractions as allele frequencies (Figure 13).  The average selection coefficient value for 
African MHC haplotypes is 𝑠=0.05 (Figure 22), indicating strong selection at this locus 
over the last several hundred years since the admixed LA populations were formed, 
consistent with previous work [58]. 
 
 
Figure 13. Model of ancestry-enabled selection at the MHC locus of the Colombian 
population. 
(A)  Modeled levels of ancestry enrichment and depletion (𝑧𝑎𝑛𝑐, y-axis) corresponding to 
a range of different selection coefficients (𝑠, x-axis): African (blue), European (orange), 
and Native American (red).  The intersection of the observed level of African ancestry 
enrichment at the MHC locus and the corresponding 𝑠-value is indicated with dashed lines.  
(B)  The trajectory of predicted ancestry enrichment and depletion (𝑧𝑎𝑛𝑐 , y-axis) over time 
(𝑡 generations, x-axis) is shown for the inferred selection coefficient of 𝑠=0.05. 
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4.3.4 Polygenic admixture-enabled selection 
For each of the three continental ancestry components, we combined gene-specific 
ancestry enrichment values (𝑧𝑎𝑛𝑐), for genes that function together to encode polygenic 
phenotypes, via the polygenic ancestry enrichment score (𝑃𝐴𝐸) (Figure 14A).  Observed 
𝑃𝐴𝐸 values were compared to expected values generated by randomly permuting size-
matched gene sets to search for functions (traits) that show evidence of admixture-enabled 
selection (Figure 23).  As with the single locus approach, we narrowed our list of targets 
to traits that showed evidence of polygenic admixture enrichment across multiple LA 
populations.  This approach yielded evidence of statistically significant enrichment and 
depletion, across multiple ancestries, for a number of inflammation, blood, and immune 
related traits (Figure 14B).  Inflammation related phenotypes that show polygenic ancestry 
enrichment include a variety of skin conditions and rheumatoid arthritis.  A number of 
different blood metabolite pathways show evidence for primarily European and Native 
American ancestry enrichment, while both the adaptive and innate components of the 
immune system show evidence of admixture-enabled selection. 
Several interconnected pathways of the innate immune system – the RIG-I-like 
receptor signaling pathway, the Toll-like receptor signaling pathway, and the cytosolic 
DNA-sensing pathway – all show evidence of Native American ancestry enrichment 
(Figure 15).  All three of these pathways are involved in rapid, first line immune response 
to a variety of RNA and DNA viruses as well as bacterial pathogens.  Genes from these 
pathways that show evidence of Native American ancestry enrichment encode a number of 
distinct interferon, interleukin, and cytokine proteins. 
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Figure 14. Polygenic ancestry enrichment (𝑷𝑨𝑬) and admixture-enabled selection. 
(A) Distributions of the 𝑃𝐴𝐸 test statistic are shown for each of the three ancestry 
components – African (blue), European (orange), and Native American (red) – across the 
four LA populations.  Points beyond the dashed lines correspond to polygenic traits with 
statistically significant 𝑃𝐴𝐸 values, after correction for multiple tests.  (B) Polygenic traits 
that show evidence of 𝑃𝐴𝐸 in multiple LA populations.  𝑃𝐴𝐸 values are color coded as 
shown in the key, and the ancestry components are indicated for each trait.  Immune system 
traits are divided into adaptive (purple), innate (green), or both (blue). 
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Figure 15. Innate immune system pathways showing Native American ancestry 
enrichment. 
Illustration of three interconnected pathways from the innate immune system – the RIG-I-
like receptor signaling pathway, the Toll-like receptor signaling pathway, and the cytosolic 





4.4.1 Rapid adaptive evolution in humans 
Human adaptive evolution is often considered to be a slow process, which is limited 
by relatively low effective population sizes and long generation times [32, 90, 91].  The 
rate of human adaptive evolution is further constrained by the introduction of new 
mutations [92].  Initially, positive selection acts very slowly to gradually increase the 
frequency of newly introduced beneficial mutations, which by definition are found at low 
population frequencies.  The process of admixture, whereby previously diverged 
populations converge, brings together haplotypes that have not previously existed on the 
same population genomic background [50].  In so doing, it can provide raw material for 
rapid adaptive evolution in the form of novel variants that are introduced at intermediate 
frequencies, many of which may have pre-evolved adaptive utility [17]. 
4.4.2 Admixture and rapid adaptive evolution 
Our results suggest that admixture can enable extremely rapid adaptive evolution 
in human populations.  In the case of the LA populations studied here, we found evidence 
of adaptive evolution within the last 500 years (or ~20 generations) since the conquest and 
colonization of the Americas began [3, 4].  We propose that, given the ubiquity of 
admixture among previously diverged populations [26, 27], it should be considered as a 
fundamental mechanism for the acceleration of human evolution.   
The haplotypes that show evidence of ancestry enrichment in our study evolved 
separately for tens-of-thousands of years in the ancestral source populations – African, 
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European, and Native American – that mixed to form modern, cosmopolitan LA 
populations.  Many of these haplotypes are likely to contain variants, or combinations of 
variants, that provided a selective advantage in their ancestral environments [34].  These 
adaptive variants would have increased in frequency over long periods of time and then 
later provided source material for rapid adaptation of admixed populations, depending on 
their utility in the New World environment.  Variants that reached high frequency in 
ancestral source populations via genetic drift could also serve as targets for positive 
selection in light of the distinct environments and selection pressures faced by modern 
admixed populations.  In either case, admixture-enabled selection can be taken as a special 
case of selection on standing variation, or soft selective sweeps, underscoring its ability to 
support rapid adaptation in the face of novel selective pressures [93, 94]. 
4.4.3 Single locus versus polygenic selection 
Our initial analysis of individual LA populations turned up numerous instances of 
apparent ancestry enrichment genome-wide, including enrichment for all three ancestry 
components in each of the four populations studied here.  However, when ancestry 
enrichment signals were combined across all four populations, only a handful of significant 
results remained after correcting for multiple tests.  Finally, when random admixture was 
simulated, only two peaks of African ancestry enrichment were found to be shared among 
populations at levels greater than expected by chance (Figures 11 and 19).  These findings 
support the conservative nature of our combined evidence approach to using cross-
population ancestry enrichment as a criterion for inferring admixture-enabled selection, 
and also reflect the fact that selection needs to be extremely strong to be detected at single 
loci.  This is especially true given the relatively short period of time that has elapsed since 
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modern LA populations were formed via admixture of ancestral source populations.  The 
results of our population genetic model support this notion, showing an average selection 
coefficient value of 𝑠=0.05 for African haplotypes at the MHC locus. 
A number of recent studies have underscored the ubiquity of polygenic selection on 
complex traits that are encoded by multiple genes, emphasizing the fact that weaker 
selection dispersed across multiple loci may be a more common mode of adaptive evolution 
than strong single locus selection [95-98].  The results of our polygenic ancestry 
enrichment analysis are consistent with these findings, as the polygenic approach yielded 
signals of admixture-enabled selection for numerous traits across different ancestry 
components and populations.  Thus, the polygenic ancestry enrichment that we employed 
to infer admixture-enabled selection is both more biologically realistic and better powered 
compared to the single locus approach. 
4.5 Conclusions 
We report abundant evidence for admixture-enabled selection within and between 
Latin American populations that were formed by admixture among diverse African, 
European, and Native American source populations within the last 500 years.  The MHC 
locus shows evidence of particularly strong admixture-enabled selection for several HLA 
genes, all of which appear to contain pre-adapted variants that were selected prior to 
admixture in the Americas.  In addition, a number of related immune system, inflammation 
and blood metabolite traits were found to evolve via polygenic admixture-enabled 
selection.   
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Over the last several years, it has become increasingly apparent that admixture is a 
ubiquitous feature of human evolution.  Considering the results of our study together with 
the prevalence of admixture leads us to conclude that admixture-enabled selection has been 
a fundamental mechanism for driving rapid adaptive evolution in human populations. 
4.6 Methods 
4.6.1 Genomic data 
Whole genome sequence data for four admixed LA populations – Colombia, 
Mexico, Peru, and Puerto Rico – were taken from the Phase 3 data release of the 1000 
Genomes Project (1KGP) [70, 99].  Whole genome sequence data and whole genome 
genotypes for proxy ancestral reference populations from Africa, Asia, Europe, and the 
Americas were taken from multiple sources, including the 1KGP, the Human Genome 
Diversity Project (HGDP) [64] and a previous study on Native American genetic ancestry 
[100] (Table 2).  Whole genome sequence and whole genome genotype data were 
harmonized using the program PLINK [71], keeping only those sites common to all 
datasets and correcting SNP strand orientations as needed.  A genotyping filter of 95% 
calls was applied to all populations. 
4.6.2 Global and local ancestry inference 
Global continental ancestry estimates for each individual from the four LA 
populations were inferred using the program ADMIXTURE [73].  The harmonized SNP 
set was pruned using PLINK [71] with window size of 50bp, a step size of 10bp, and a 
linkage disequilibrium (LD) threshold of 𝑟2 > 0.1, and ADMIXTURE was run with K=4 
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corresponding to African, European, Asian, and Native American ancestry components.  
Local continental ancestry estimates for each individual from the four LA populations were 
inferred using a modified version of the program RFMix [51] as previously described 
[101].  The chromosomal locations of ancestry-specific haplotypes were visualized with 
the program Tagore [102].  The complete harmonized SNP set was phased using the 
program SHAPEIT [72], and RFMix was run to assign African, European, or Native 
American ancestry to individual haplotypes from the LA populations. 
4.6.3 Single locus ancestry enrichment 
Single gene (locus) ancestry enrichment (𝑧𝑎𝑛𝑐) values were calculated for all three 
continental ancestry components (African, European, and Native American) across all four 
LA populations.  Genomic locations of NCBI RefSeq gene models were taken from the 
UCSC Genome Brower (hg19 build) [103], and gene locations were mapped to the 
ancestry-specific haplotypes characterized using RFMix for each individual genome.  For 
each gene, population-specific three-way ancestry fractions (𝑓𝑎𝑛𝑐) were computed as the 
number of ancestry-specific haplotypes (ℎ𝑎𝑛𝑐), divided by the total number of ancestry-
assigned haplotypes for that gene (ℎ𝑡𝑜𝑡): 𝑓𝑎𝑛𝑐 = ℎ𝑎𝑛𝑐 ℎ𝑡𝑜𝑡⁄ .  Ancestry enrichment analysis 
was limited to genes that had ℎ𝑡𝑜𝑡 values within one standard deviation of the genome-
wide average for any population.  Distributions of gene-specific ancestry fractions (𝑓𝑎𝑛𝑐) 
for each population were used to calculate population-specific genome-wide average 
(𝜇𝑎𝑛𝑐) and standard deviation (𝜎𝑎𝑛𝑐) ancestry fractions.  Then, for any given gene in any 
given population, ancestry enrichment (𝑧𝑎𝑛𝑐) was calculated as the number of standard 
deviations above (or below) the genome-wide ancestry average: 𝑧𝑎𝑛𝑐 =
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(𝑓𝑎𝑛𝑐 − 𝜇𝑎𝑛𝑐) 𝜎𝑎𝑛𝑐⁄ , with gene-specific ancestry enrichment 𝑃-values computed using the 
𝑧 distribution.  A Fisher’s combined score (𝐹𝐶𝑆) was used to combine gene-specific 
ancestry enrichment 𝑃-values across the four LA populations as: 𝐹𝐶𝑆 = −2 ∑ ln(𝑃𝑖).
4
𝑖=1   
The statistical significance of 𝐹𝐶𝑆 was computed using the χ
2 distribution with 8 (2𝑘) 
degrees of freedom.  Correction for multiple 𝐹𝐶𝑆 tests was performed using the Benjamini-
Hochberg False Discovery Rate (FDR), with a significance threshold of 𝑞 < 0.05 [104]. 
4.6.4 Admixture simulation 
Three-way admixed individuals were randomly simulated for each LA population 
– Colombia, Mexico, Peru, and Puerto Rico – and used to calculate expected levels of 
ancestry enrichment 𝑧𝑎𝑛𝑐 as described in the previous section.  Expected levels of 𝑧𝑎𝑛𝑐 
were combined across the four LA populations to yield expected Fisher’s combined scores 
(𝐹𝐶𝑆) and their associated 𝑃-values as described in the previous section.  Admixed 
populations were simulated as collections of genes (i.e. ancestry-specific haplotypes) 
randomly drawn from the genome-wide ancestry distributions for each LA population.  
Sized matched admixed populations were simulated for each LA population and combined 
to generate expected (𝐹𝐶𝑆) and their associated 𝑃-values, and admixture simulation was 
also conducted across a range of population sizes (n=10 to 10,000) to evaluate the power 
of the combined evidence cross-population approach used to detect ancestry-enabled 
selection. 
4.6.5 Polygenic ancestry enrichment 
Polygenic ancestry enrichment values (𝑃𝐴𝐸) were computed by combining single 
locus ancestry enrichment values (𝑧𝑎𝑛𝑐) across genes that function together to encode 
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polygenic traits.  Gene sets for polygenic traits were curated from a number of literature 
and database sources to represent a wide array of phenotypes (Table 3).  All gene sets were 
LD pruned with a threshold of r2 > 0.1 using PLINK.  Additional details on the curation of 
polygenic trait gene sets can be found in section 4.7.2.1 Polygenic trait gene set curation.  
For any trait trait-specific gene set, in any population, 𝑃𝐴𝐸 was calculated by summing the 
gene-specific 𝑧𝑎𝑛𝑐 values for all of the genes in the trait set: 𝑃𝐴𝐸 =  ∑ 𝑧𝑎𝑛𝑐
𝑛
1 , where 𝑛 is 
the number of genes in the set.  Since 𝑧𝑎𝑛𝑐 values can be positive or negative, depending 
on over- or under-represented ancestry, values of 𝑃𝐴𝐸 are expected to be randomly 
distributed around 0.  The statistical significance levels of observed 𝑃𝐴𝐸 values were 
calculated via comparison against distributions of expected 𝑃𝐴𝐸 values calculated from 
10,000 random permutations of size matched gene sets (Figure 23).  Observed values 
(𝑃𝐴𝐸𝑜𝑏𝑠) were compared against the mean (𝜇𝑃𝐴𝐸) and standard deviation (𝜎𝑃𝐴𝐸) of the 
expected 𝑃𝐴𝐸 values to compute the statistical significance for each trait: 𝑧𝑃𝐴𝐸 =
(𝑃𝐴𝐸𝑜𝑏𝑠 − 𝜇𝑃𝐴𝐸) 𝜎𝑃𝐴𝐸⁄ , with 𝑃-values computed using the 𝑧 distribution  Correction for 
multiple tests was performed using the Benjamini-Hochberg False Discovery Rate (FDR), 
with a significance threshold of 𝑞 < 0.05. 
4.6.6 Integrated Haplotype Scores (iHS) 
Integrated Haplotype Scores (iHS) [55] were calculated for European and African 
continental populations from the 1KGP using the software selscan (version 1.1.0a) [105].  
|iHS| scores were overlaid on genes with evidence of ancestry enrichment to scan for 
concurrent signals of selection. 
  
 76 
4.6.7 Modeling admixture-enabled selection 
Admixture-enabled selection was modeled for the African enriched chromosome 6 
MHC haplotype using a standard recursive population genetics model for positive selection 
[106].  Three allelic states were used for the selection model, each of which corresponds to 
a specific ancestry component: African, European, or Native American.  Population-
specific models were initialized with allele (ancestry) frequencies based on the genome-
wide background ancestry fractions and run across a range of selection coefficient (𝑠) 
values to determine the values of 𝑠 that correspond to the observed African ancestry 
enrichment levels.  This allowed us to compute a positive selection coefficient 
corresponding to the strength of African ancestry selection at the MHC locus for each 
population.  Additional details of this model can be found in section 4.7.1 Modeling 
admixture-enabled selection at single loci and Figure 22. 
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4.7 Supplementary Methods and Results 
 
Figure 16. Correspondence between continental ancestry estimates for LA 
populations generated by ADMIXTURE (x-axis) and RFMix (y-axis). 
Ancestry estimates generated for individuals from the four LA populations studied here – 
Colombia, Mexico, Peru, and Puerto Rico – are shown separately for (A) African, (B) 
European, and (C) Native American ancestry.  Correlation between ancestry estimates 




Figure 17. Comparison of global versus local continental ancestry inference for two 
admixed individuals. 
Continental ancestry estimates – for African (blue), European (orange), and Native 
American (red) ancestry components – were inferred using global (ADMIXTURE) and 
local (RFMix) ancestry methods.  Global ancestry estimates are shown as pie charts, and 
local ancestry estimates (i.e. ancestry-specific haplotype assignments) are shown as 
chromosome ideograms.  These two individuals have very similar levels of global ancestry 




Figure 18. Scheme of the ancestry enrichment method used for this study. 
Ten haploid chromosomes from a population are shown with corresponding regions 
aligned and ancestry-specific haplotypes indicated (as in Figure S2).  Gene-specific 
ancestry enrichment (𝑧𝑎𝑛𝑐) is expressed as the number of standard deviations above or 




Figure 19. Observed versus expected ancestry enrichment across the four LA 
populations studied here. 
Manhattan plots and QQ plots show the genome-wide distributions of observed versus 
expected ancestry enrichment −𝑙𝑜𝑔10 𝑃 values for African (A), European (B), and Native 
American (C) ancestry components.  𝑃-values correspond to the combined cross-
population ancestry enrichment values (𝐹𝐶𝑆), calculated as described in the manuscript.  
Expected values were generated based on size matched simulated admixed populations, as 
described in the Methods section.  On the African ancestry Manhattan plot, lines indicate 
genome-wide statistically significant cross-population ancestry enrichment (FDR 𝑞 <
0.05).  There were no genome-wide significant cross-population ancestry enrichment 
peaks for the European and Native American ancestry components.  Ancestry-specific QQ 
plots also illustrate the deviation of observed versus expected ancestry enrichment for the 
African component, and the similarity of observed versus expected ancestry enrichment for 
the European and Native American components. 
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Figure 20. Ancestry enrichment power analysis. 
Four admixed LA populations were simulated across a range of population sizes (see 
Methods).  Distributions of −𝑙𝑜𝑔10 𝑃 values corresponding to combined cross-population 
ancestry enrichment values (𝐹𝐶𝑆) are shown across the range of simulated population sizes 
for each ancestry component: African (A), European (B), and Native American (C).  This 
analysis was used as an additional, non-parametric method to compute the probability of 
observing ancestry-specific 𝐹𝐶𝑆 by chance alone, at different population sizes. 
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Figure 21. African ancestry enrichment power analysis. 
Four admixed LA populations were simulated across a range of population sizes (see 
Methods).  Cross-population African enrichment values (𝐹𝐶𝑆), and their corresponding 𝑃 
values, were computed across the range of population sizes (see Figure S5).  The plot 
shows the relationship of 𝐹𝐶𝑆 and 𝑃-values for different population sizes, i.e. the 
relationship between population size and the power of the cross-population ancestry 
enrichment metric.  For African ancestry, a statistically significant FDR 𝑞 < 0.05 
corresponds to 𝑃<0.001 (bright red).  Significant 𝑃 values are more common at higher 
sample sizes. The observed African 𝐹𝐶𝑆 values at the MHC locus range from 38-42 (see 
boxed cells), which are well powered to detect significant ancestry enrichment at 
population sizes of ~100 individuals. 
4.7.1 Modeling admixture-enabled selection at single loci 
A recursive triallelic model of positive selection was used to measure the strength 
of admixture-enabled selection at the chromosome 6 MHC locus in the Colombia, Mexico, 
and Peru populations.  The model treats alleles as the three ancestry fractions: African, 
European, and Native American.  This model is based on the approach to modelling 
selection used in the Populus software (https://cbs.umn.edu/populus/overview). 
Assuming an African ancestry advantage, the relative fitness (𝑤𝑖𝑗) of a locus with 
ancestries 𝑖 and 𝑗 (ancestry genotypes) is calculated as: 
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𝑤𝑖𝑗 =  {
1,                                             𝑖𝑓 𝑖 = 𝑗 = 𝐴𝑓𝑟𝑖𝑐𝑎𝑛
1 − 𝑠ℎ,            𝑖𝑓 𝑖 = 𝐴𝑓𝑟𝑖𝑐𝑎𝑛 𝑜𝑟 𝑗 = 𝐴𝑓𝑟𝑖𝑐𝑎𝑛
1 − 𝑠,          𝑖𝑓 𝑖 ≠ 𝐴𝑓𝑟𝑖𝑐𝑎𝑛 𝑎𝑛𝑑 𝑗 ≠ 𝐴𝑓𝑟𝑖𝑐𝑎𝑛
 (5) 
where 𝑠 is the selection coefficient and ℎ is the dominance coefficient.  This can be 
formulated as a fitness matrix: 
  Ancestry 𝑗 








African (𝐴) 1 1 − (𝑠ℎ) 1 − (𝑠ℎ) 
European (𝐸) 1 − (𝑠ℎ) 1 − 𝑠 1 − 𝑠 
Native American (𝑁) 1 − (𝑠ℎ) 1 − 𝑠 1 − 𝑠 
 
For each population, for each ancestry, the ancestry frequency in the next 
generation (𝑝𝑖,𝑡+1) was calculated as: 




where 𝑝𝑖,𝑡 is the ancestry frequency (𝑖) in the current generation (𝑡), 𝑤𝑖 is the marginal 
fitness of the ancestry, and ?̅? is the population mean fitness. 
For each row of the fitness matrix, the marginal fitness (𝑤𝑖) was calculated as: 




where 𝑤𝑖𝑗 is the relative fitness of the ancestry genotype and 𝑤𝑖𝑗 is the frequency of the 
ancestry in the current generation. 
For each generation, the population mean fitness (?̅?) was calculated as: 
 ?̅? = ∑ ∑ 𝑤𝑖𝑗𝑝𝑖𝑝𝑗
𝑗𝑖
 (8) 
where 𝑤𝑖𝑗 is the relative fitness of the ancestry genotype, 𝑝𝑖 is the frequency of the first 
ancestry, and 𝑝𝑗 is the second of the second ancestry. 
For each population, the model was run using 𝑠 from 0-1.0, in increments of 0.001, and 
ℎ = 0.05, until the final African ancestry frequency at 20 generations was the same as that 
observed for the chromosome 6 haplotype.  The selection coefficient at this convergence 
was taken to be the strength of selection for the given population for the chromosome 6 
African enriched haplotype. 
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Figure 22. Modeling the strength of admixture-enabled selection at the MHC locus. 
The strength of admixture-enabled selection for African haplotypes at the MHC locus was 
modelled as described on pages 8-9.  The three-ancestry population genetic model was run 
across a range of positive selection coefficient (𝑠) values to identify the strength of selection 
needed to explain the observed levels of African ancestry enrichment at the MHC locus in 
the Colombia, Mexico, and Puerto Rico populations.  The top panels for each population 
show the predicted levels of ancestry enrichment (𝑧𝑎𝑛𝑐, y-axis) across a range of different 
selection coefficients (𝑠, x-axis).  The intersection of the observed levels of African ancestry 
enrichment and their corresponding 𝑠-values are indicated with dashed lines.  The bottom 
panels show the trajectory of predicted ancestry enrichment and depletion (𝑧𝑎𝑛𝑐, y-axis) 
over time (𝑡 generations, x-axis) for each population given the inferred selection coefficient 




Table 2. Human populations analyzed as part of this study. 
Populations are organized into continental groups, for both proxy ancestral reference populations and Latin American populations, 
and the number of genome (genotype) samples from each population is shown. 
Population 
group 
Dataset1 Geographical source n 
Population 
group 
Dataset1 Geographical source n 
African 
1KGP 





Reich et al Waunana in Colombia 3 
Reich et al Kogi in Colombia 4 
1KGP Mende in Sierra Leone 85 Reich et al Mixtec in Mexico 5 
1KGP African Caribbeans in Barbados 96 Reich et al Embera in Colombia 5 
1KGP Esan in Nigeria 99 Reich et al Guahibo in Colombia 6 
1KGP Luhya in Webuye, Kenya  99 Reich et al Ticuna in Brazil 6 
1KGP Yoruba in Ibadan, Nigeria 108 Reich et al Guarani in Paraguay 6 
1KGP 
Gambian in Western Division in the 
Gambia 
113 
Reich et al Piapoco in Colombia 7 
HGDP Suruí in Brazil 8 
European 
1KGP British in England and Scotland 91 Reich et al Inga in Colombia 9 
1KGP Finnish in Finland 99 Reich et al Wayuu in Colombia 11 
1KGP 
Utah Residents (CEPH) with Northern 
and Western European Ancestry 
99 
Reich et al Kaqchikel in Guatemala 13 
HGDP Pima in Mexico 14 
1KGP Iberian Population in Spain 107 HGDP Karitiana in Brazil 14 




Mexican Ancestry in Los Angeles 
USA 
64 
HGDP Maya in Mexico 21 
Reich et al Aymara in Bolivia 23 
1KGP Peruvians from Lima, Peru 85 Reich et al Tepehuano in Mexico 25 
1KGP Colombians from Medellin, Colombia 94 Reich et al Quechua in Peru 40 
1KGP Puerto Ricans from Puerto Rico 104 Reich et al Zapotec in Mexico 43 
11KGP = 1000 Genomes Project; HGDP = Human Genome Diversity Project; Reich et al [100] 
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4.7.2 Polygenic ancestry enrichment 
4.7.2.1 Polygenic trait gene set curation 
Gene sets for polygenic traits were curated from a number of literature and database 
sources, as shown below, to represent a wide array of phenotypes. 
Table 3. Sources of the polygenic trait gene sets analyzed as part of this study. 
For each polygenic trait gene set source, the number of phenotypes and reference are 
shown. 
Phenotype source n Reference 
NHGRI-EBI GWAS Catalog 306 [107] 
InnateDB 128 [108] 
Blood Transcription Modules 209 [109] 
Blood Informative Transcripts 9 [110] 
Innate Immune System  9 [111] 
GIANT 7 [112] 
Custom gene sets of interest 10 na 
Whenever possible, the gene sets were taken directly from the literature or the database.  
If gene sets were not directly accessible, SNP-level data was collected and directly mapped 
to genes to generate the gene set.  Trait-specific gene sets from the NHGRI-EBI GWAS 
Catalog [107] were collected from SNP sets that were mapped using EBI’s in-house 
pipeline; only SNPs that fell within a gene and were implicated at a genome-wide 
significance level of P ≤ 5x10-8 with the phenotype were used to generate the gene sets.  
Each polygenic trait from the Genetic Investigation of ANthropometric Traits (GIANT) 
consortium [112] had gene sets mapped according to specifications of the individual paper.  
All remaining gene sets from the literature were mapped using NCBI’s dbSNP database as 
needed.  To control for any linkage between genes, linkage disequilibrium (LD) pruning 
was performed on each gene set using PLINK.  For each set, pruning was performed on all 
 88 
gene pairs with genic SNP 𝑟2 > 0.1; if this was found to be true then only one member of 
the gene pair was retained for polygenic ancestry enrichment analysis.  After LD pruning 
was complete, the gene sets were filtered based on size so that all phenotypes included in 
the analysis contained two or more genes. 
4.7.2.2 Statistical significance of polygenic ancestry enrichment 
 
Figure 23. Simulation of random polygenic trait gene sets used to compute statistical 
significance of polygenic ancestry enrichment (𝑷𝑨𝑬). 
Size-matched random gene sets are simulated to generate an expected (null) distribution 




CHAPTER 5. ASSORTATIVE MATING ON ANCESTRY-
VARIANT TRAITS IN ADMIXED LATIN AMERICAN 
POPULATIONS 
5.1 Abstract 
Assortative mating is a universal feature of human societies, and individuals from 
ethnically diverse populations are known to mate assortatively based on similarities in 
genetic ancestry.  However, little is currently known regarding the exact phenotypic cues, 
or their underlying genetic architecture, which inform ancestry-based assortative mating.  
We developed a novel approach, using genome-wide analysis of ancestry-specific 
haplotypes, to evaluate ancestry-based assortative mating on traits whose expression varies 
among the three continental population groups – African, European, and Native American 
– that admixed to form modern Latin American populations.  Application of this method 
to genome sequences sampled from Colombia, Mexico, Peru, and Puerto Rico revealed 
widespread ancestry-based assortative mating.  We discovered a number of anthropometric 
traits (body mass, height, and facial development) and neurological attributes (educational 
attainment and schizophrenia) that serve as phenotypic cues for ancestry-based assortative 
mating.  Major histocompatibility complex (MHC) loci show population-specific patterns 
of both assortative and disassortative mating in Latin America.  Ancestry-based assortative 
mating in the populations analyzed here appears to be driven primarily by African ancestry.  
This study serves as an example of how population genomic analyses can yield novel 
insights into human behavior. 
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5.2 Introduction 
Mate choice is a fundamental dimension of human behavior with important 
implications for population genetic structure and evolution [18-20].  It is widely known 
that humans choose to mate assortatively rather than randomly.  That is to say that humans, 
for the most part, tend to choose mates that are more similar to themselves than can be 
expected by chance.  Historically, assortative mating was based largely on geography, 
whereby partners were chosen from a limited set of physically proximal individuals [113].  
Over millennia, assortative mating within groups of geographically confined individuals 
contributed to genetic divergence between groups, and the establishment of distinct human 
populations, such as the major continental population groups recognized today [63, 64, 70]. 
However, the process of geographic isolation followed by population divergence that 
characterized human evolution has not been strictly linear.  Ongoing human migrations 
have continuously brought previously isolated populations into contact; when this occurs, 
the potential exists for once isolated populations to admix, thereby forming novel 
population groups [114].  Perhaps the most precipitous example of this process occurred 
in the Americas, starting just over 500 years ago with the arrival of Columbus in the New 
World [4].  This major historical event quickly led to the co-localization of African, 
European and Native American populations that had been (mostly) physically isolated for 
tens of thousands of years [17].  As can be expected, the geographic reunification of these 
populations was accompanied, to some extent, by genetic admixture and the resulting 
formation of novel populations.  This is particularly true for populations in Latin America, 
which often show high levels of three-way genetic admixture between continental 
population groups [56, 65-67, 115].   
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Nevertheless, modern admixed populations are still very much characterized by non-
random assortative mating.  Assortative mating in modern populations has been shown to 
rest on a variety of traits, including physical (stature and pigmentation) and neurological 
(cognition and personality) attributes.  For example, numerous studies have demonstrated 
an influence of similarities in height and body mass on mate choice [19, 116-118].  In 
addition, assortative mating has been observed for diverse neurological traits, such as 
educational attainment, introversion/extroversion and even neurotic tendencies [119-124].  
Harder to classify traits related to personal achievement (income and occupational status) 
and culture (values and political leanings) also impact patterns of assortative mating [119, 
125, 126].  Odor is one of the more interesting traits implicated in mate choice, and it has 
been linked to so-called disassortative (or negative assortative) mating, whereby less 
similar mates are preferred.  Odor-based disassortative mating has been attributed to 
differences in genes of the major histocompatibility (MHC) locus, which functions in the 
immune system, based on the idea that combinations of divergent human leukocyte antigen 
(HLA) alleles provide a selective advantage via elevated host resistance to pathogens [127, 
128]. 
The traits that influence human mate choice are shaped by multiple factors with 
contributions from genes (G) and the environment (E) along with gene-by-environment 
(GxE) interactions.  Studies that consider both genes and environment have shown different 
contributions of these factors to assortative mating patterns in human populations.  Twin 
studies were initially used in an effort to tease apart the genetic and environmental 
contributions to mate choice [129].  Comparison of monozygotic and dizygotic twin pairs 
provided the first evidence for genetic influences on human mate choice, with 10-30% of 
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the variance in mate choice explained by genetics compared to 10% shared environment 
and 60% unique environmental variance [130].  Subsequent twin design studies either did 
not find any strong genetic effects on patterns of assortative mating [131] or found genetic 
effects on assortative mating with very different relative contributions of genes versus 
environmental effects depending on the trait under consideration [132].  A more recent 
study leveraged genome-wide association study (GWAS) variants that influence height to 
show even more clear evidence for genetic effects on assortative mating [133].  
Ancestry is a particularly important determinant of assortative mating in modern 
admixed populations [134, 135].  Studies have shown that individuals in admixed Latin 
American populations tend to mate with partners that have similar ancestry profiles.  For 
example, partners from both Mexican and Puerto Rican populations have significantly 
higher ancestry similarities than expected by chance [124, 136].  In addition, a number of 
traits that have been independently linked to assortative mating show ancestry-specific 
differences in their expression [137].  Accordingly, ancestry-based mate choice has 
recently been related to a limited number of physical (facial development) and immune-
related (MHC loci) traits [124]. 
The studies that have uncovered the role of genetic ancestry in assortative mating 
among Latinos have relied on estimates of global ancestry fractions between mate pairs 
[124, 136].  Given the recent accumulation of numerous whole genome sequences from 
admixed Latin American populations – along with genome sequences from global 
reference populations [70] – it is now possible to characterize local genetic ancestry for 
individuals from admixed American populations [56, 88, 89].  In other words, the ancestral 
origins for specific chromosomal regions (haplotypes) can be assigned with high 
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confidence for admixed individuals [51].  For the first time here, we sought to evaluate the 
impact of local ancestry on assortative mating in admixed Latin American populations.  
Since the genetic variants that influence numerous phenotypes have been mapped to 
specific genomic regions, we reasoned that a focus on local ancestry could help to reveal 
the specific phenotypic drivers of ancestry-based assortative mating. 
Our approach to this question entailed an integrated analysis of local genetic ancestry 
and the genetic architecture of a variety of human traits thought to be related to assortative 
mating.  Assortative mating results in an excess of homozygosity, whereas disassortative 
mating yields excess heterozygosity.  It follows that assortative (or disassortative) mating 
based on local ancestry would yield an excess (or deficit) of ancestry homozygosity at 
specific genetic loci.  In other words, for a given population, a locus implicated in ancestry-
based assortative mating would be more likely to have the same ancestry at both pairs of 
haploid chromosomes within individuals than expected by chance.  We developed a test 
statistic – the assortative mating index (AMI) – that evaluates this prediction for individual 
gene loci, and we applied it to sets of genes that function together to encode polygenic 
phenotypes.  We find evidence of substantial local ancestry-based assortative mating, and 
far less disassortative mating, for four admixed Latin American populations across a 
variety of anthropometric, neurological and immune-related phenotypes.  Our approach 
also allowed us to assess the specific ancestry components that drive patterns of assortative 




5.3.1 Global and local genetic ancestry in Latin America 
We compared whole genome sequences from four admixed Latin American 
populations, characterized as part of the 1000 Genomes Project (1KGP) [70] to genome 
sequences and whole genome genotypes from a panel of 34 global reference populations 
from Africa, Europe and the Americas (Table 4 and Figure 30).  The program 
ADMIXTURE [73] was used to infer the continental genetic ancestry fractions – African, 
European and Native American – for individuals from the four Latin American populations 
(Figure 31).  Distributions of individuals’ continental ancestry fractions illustrate the 
distinct ancestry profiles of the four populations (Figure 24).  Puerto Rico and Colombia 
show the highest European ancestry fractions along with the highest levels of three-way 
admixture.  These two populations also have the highest African ancestry fractions, 
although all four populations have relatively small fractions of African ancestry.  Peru and 
Mexico show more exclusively Native American and European admixture, with Peru 
having by far the largest Native American ancestry fraction.   
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Table 4. Human populations analyzed in this study. 
Populations are organized into continental groups, for both ancestral and admixed Latin American populations, and the number of 
individuals in each population and group is shown. 




























HGDP Pima in Mexico 14 
1KGP Gambian in Western Division, The Gambia GWD 113 HGDP Maya in Mexico 21 
1KGP Luhya in Webuye, Kenya LWK 99 Reich et al. Tepehuano in Mexico 25 
1KGP Mende in Sierra Leone MSL 85 Reich et al. Mixtec in Mexico 5 
1KGP Yoruba in Ibadan, Nigeria YRI 108 Reich et al. Mixe in Mexico 17 
HGDP Mandenka  22 Reich et al. Zapotec in Mexico 43 











) 1KGP Finnish in Finland FIN 99 Reich et al. Kogi in Colombia 4 
1KGP British in England & Scotland GBR 90 Reich et al. Waunana in Colombia 3 
1KGP Iberian populations in Spain IBS 107 Reich et al. Embera in Colombia 5 
1KGP Toscani in Italy TSI 107 Reich et al. Guahibo in Colombia 6 
HGDP Russian  25 Reich et al. Piapoco in Colombia 7 
HGDP Orcadian  15 Reich et al. Inga in Colombia 9 













1KGP Colombian in Medellin, Colombia CLM 94 HGDP Karitiana in Brazil 14 
1KGP Peruvian in Lima, Peru PEL 85 HGDP Suruí in Brazil 8 
1KGP Mexican Ancestry in LA, California MXL 64 Reich et al. Ticuna in Brazil 6 
1KGP Puerto Rican in Puerto Rico PUR 104 Reich et al. Quechua in Peru 40 
    Reich et al. Aymara in Bolivia 23 
    Reich et al. Guarani in Paraguay 6 
1 1KGP = 1000 Genomes Project; HGDP = Human Genome Diversity Panel; Reich et al. [100] 
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Figure 24. Genetic ancestry proportions for the admixed Latin American 
populations analyzed here. 
For each population, distributions and average values are shown for African (blue), 
European (orange) and Native American (red) ancestry. 
The program RFMix [51] was used to infer local African, European and Native 
American genetic ancestry for individuals from the four admixed Latin American 
populations analyzed here.  RFMix uses global reference populations to perform 
chromosome painting, whereby the ancestral origins of specific haplotypes are 
characterized across the entire genome for admixed individuals.  Only haplotypes with high 
confidence ancestry assignments (≥99%) were taken for subsequent analysis.  Examples of 
local ancestry assignment chromosome paintings for representative admixed individuals 
from each population are shown in Figure 32.  The overall continental ancestry fractions 
for admixed genomes calculated by global and local ancestry analysis are highly correlated, 
and in fact virtually identical, across all individuals analyzed here, in support of the 
reliability of these approaches to ancestry assignment (Figure 33). 
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5.3.2 Assortative mating and local ancestry in Latin America 
We analyzed genome-wide patterns of local ancestry assignment to assess the 
evidence for assortative mating based on local ancestry in Latin America (Figure 25A).  
For each individual, the ancestry assignments for pairs of haplotypes at any given gene 
were evaluated for homozygosity (i.e., the same ancestry on both haplotypes) or 
heterozygosity (i.e., different ancestry on both haplotypes) (Figure 25B).  For each gene, 
across all four populations, the observed values of ancestry homozygosity and 
heterozygosity were compared to expected values in order to compute gene- and 
population-specific assortative mating index (AMI) values.  AMI is computed as a log odds 
ratio as described in the Materials and Methods.  The expected values of local ancestry 
homozygosity and heterozygosity used for the AMI calculations are based on a Hardy-
Weinberg (HW) triallelic model with the three allele frequencies computed as the locus-
specific ancestry fractions.  High positive AMI values result from an excess of observed 
local ancestry homozygosity and are thereby taken to indicate assortative mating based on 
shared local genetic ancestry.  Conversely, low negative AMI values indicate excess local 
ancestry heterozygosity and disassortative mating.  We performed a series of controls to 
validate the performance of the AMI test statistic and the justification of the HW model for 
locus-specific ancestry.  These controls are described in detail in section 5.6.1 Controls for 
evaluating the assortative mating index (AMI), and results of the controls can be seen in 
Figures 34-36.  
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Figure 25. Approach used to measure assortative mating on local ancestry. 
(A) Local ancestry is assigned for specific haplotypes across the genome: African (blue), 
European (orange), and Native American (red).  (B) Within individual genomes, genes are 
characterized as homozygous or heterozygous for local ancestry.  For any given 
population, at each gene locus, the assortative mating index (AMI) is computed from the 
observed and expected counts of homozygous and heterozygous gene pairs.  (C) Data from 
genome-wide association studies (GWAS) are used to evaluate polygenic phenotypes.  (D) 
Meta-analysis of AMI values is used to evaluate the significance of ancestry-based 
assortative mating for polygenic phenotypes. 
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While we were interested in exploring the relationship between local genetic 
ancestry and assortative mating, we recognized that mate choice is based on phenotypes 
rather than genotypes per se.  Since phenotypes are typically encoded by multiple genes, 
expressed in the context of their environment, we used data from genome-wide association 
studies (GWAS) to identify sets of genes that function together to encode polygenic 
phenotypes (Figure 25C).  We combined data from several GWAS database sources in 
order to curate a collection of 105 gene sets that have been linked to the polygenic genetic 
architecture of a variety of human traits.  These gene sets range in size from 2 to 212 genes 
and include a total of 923 unique genes (Figure 37).  We focused on phenotypes that are 
known or expected to influence mate choice and thereby impact assortative mating 
patterns.  These phenotypes fall into three broad categories: anthropometric traits (e.g., 
body shape, stature, and pigmentation), neurological traits (e.g., cognition, personality, and 
addiction), and immune response (HLA genes).  Finally, we used a meta-analysis of the 
AMI values for the sets of genes that underlie each polygenic phenotype in order to 
evaluate the impact of local ancestry on assortative mating (Figure 25D). 
We compared the distributions of observed AMI values versus those expected 
under random mating to assess the overall evidence for local ancestry-based assortative 
mating in Latin America.  Expected AMI values were computed via permutation analysis 
by randomly combining pairs of haplotypes into 10,000 diploid individuals for each 
population to approximate random mating.  The distribution of the expected AMI values 
under random mating is narrow and centered around 0, whereas the observed AMI values 
have a far broader distribution and tend to be positive (expected AMI =-0.01, σ=0.03, 
observed AMI =0.11, σ=0.14; Figure 26A).  When all four admixed Latin American 
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populations are considered together, the mean observed AMI value is significantly greater 
than the expected mean AMI under random mating (t=18.14, P=8.12e-56).  The same trend 
can be seen when all four populations are considered separately (Figure 38).  Mean 
observed AMI values vary substantially across populations, with Mexico showing the 
highest levels of local ancestry-based assortative mating and Puerto Rico showing the 
lowest (Figure 26B).  There is also substantial variation seen for the extent of assortative 
mating among the three broad functional categories of phenotypes (Figure 26C).  Local 
ancestry-based assortative mating is particularly variable for HLA genes, with high levels 
of assortative mating seen for Mexico and evidence for disassortative mating seen for 
Colombia and Puerto Rico.  Anthropometric traits tend to show higher levels of local 
ancestry-based assortative mating across all four populations compared to neurological 
traits. 
5.3.3 Local ancestry-based assortative mating for polygenic phenotypes 
When considered together, observed AMI levels are enriched for positive values 
compared to the expected values based on randomly paired haplotypes, indicative of an 
overall trend of assortative mating based on local ancestry in admixed Latin American 
populations (Figure 26A and Figure 39).  We evaluated polygenic phenotypes individually 
to look for the strongest examples of traits linked to local ancestry-based assortative mating 
and to evaluate traits that show either similar or variable assortative mating trends across 
populations.  We computed AMI values for 105 polygenic phenotypes across the four 
populations; the expected and observed AMI values for all traits are shown in Figure 39.  
As can be seen for the overall patterns of assortative mating, individual polygenic 
phenotypes show more extreme positive (for most cases) and negative (in a few cases) AMI 
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values in the four admixed Latin American populations than can be expected for randomly 
mating populations.   
 
Figure 26. Overview of ancestry-based assortative mating in the four admixed Latin 
American populations analyzed here. 
(A) Distributions of observed and expected AMI values for all four populations. Inset: 
Mean observed and expected AMI values (±se) for all four populations.  Significance 
between mean observed and expected AMI values (P=8.12e-56) is indicated by two 
asterisks.  (B) Observed and expected average AMI values (±se) across all polygenic 
phenotype gene sets are shown for each population.  (C) Average AMI values (±se) for 
each population are shown for the three main phenotype functional categories 
characterized here: anthropometric, neurological, and human leukocyte antigen (HLA) 
genes. 
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However, as discussed previously, it is known that admixed Latin American 
populations mate assortatively based on genetic ancestry [124, 136].  This can be expected 
to lead to an overall excess of ancestry homozygosity genome-wide compared to 
expectations based on truly random mating, and we wanted to control for this as well when 
analyzing the assortative mating signals for specific traits.  To do so, we performed an 
additional permutation analysis by choosing random sets of genes, of the same size as the 
observed trait-specific gene sets, and then computing AMI values and their significance 
levels for the randomly permuted gene sets.  This allowed us to ask whether the polygenic 
phenotypes that have statistically significant AMI values show more extreme deviations 
than can be expected based on genome-wide signals of ancestry-based assortative mating.  
The results of this additional permutation control are described below in the context of the 
specific polygenic phenotypes that were found to have significant AMI values. 
There are 11 polygenic phenotypes that yield statistically significant AMI values 
with the HW-based test, after correction for multiple tests, indicative of local ancestry-
based assortative mating for specific traits (q<0.05; Figure 27A).  A number of other traits 
shown are marginally significant after correction for multiple testing.  We compared the 
observed AMI values for the gene sets studied here to population-specific null distributions 
of expected AMI values generated using randomly permuted gene sets as described in the 
preceding paragraph (Figure 27B).  This permutation test accounts for the genome-wide 
deviations from HW that occur due to ancestry-based assortative mating.  The comparisons 
of the observed versus expected AMI values for this control indicate that the AMI signals 
that we observe here are trait-specific and cannot be attributed to the elevated levels of 
ancestry similarity seen for couples in admixed Latin American populations.      
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Figure 27. Phenotypes with statistically significant patterns of assortative mating 
within and among populations. 
(A) The top 20 phenotypes with the highest, and most statistically significant, assortative 
mating values (AMI) seen within any individual population.  All AMI values shown are 
significant at P<0.05, and the dashed line corresponds to a false discovery rate q-value 
cutoff of 0.05.  (B) The observed AMI values for all trait-specific gene sets in each 
population (red lines) are compared to distributions of expected AMI values (black lines) 
based on random permutations of 10,000 gene sets.  The top panels show the overall 
distributions of observed and permuted AMI values for each population, with steep peaks 
around the mean values for expected AMI.  The bottom panels show a more narrow range 
of observed and expected AMI values for each population, which are centered around the 
population-specific mean expected AMI values.  (C) The top 20 phenotypes with the highest 
or lowest, and most statistically significant, AMI variance levels across populations.  
Across population variance levels are normalized using the average AMI population 
variance level for all phenotypes.  All AMI variance levels shown are significant at q<0.05.  
The highest variance (most dissimilar patterns) of the AMI are at the top, while the lowest 
variance (most similar patterns) of AMI are at the bottom. 
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The majority of the statistically significant cases of assortative mating are seen in 
the Mexican and Peruvian populations (10 out of 11), and the anthropometric functional 
category is most commonly seen among the significant phenotypes (8 out of 11).  Height 
and body mass index are the most commonly observed phenotypes among the significant 
cases, each appearing in two out of the four populations analyzed here (Colombia and Peru 
for height and Mexico and Peru for body mass index).  The only neurological traits that 
show significant evidence of assortative mating are schizophrenia (Mexico and Peru) and 
educational attainment (Mexico).  A number of other neurological and anthropometric 
traits in Mexico are marginally significant.  Puerto Rico was the only population that did 
not show any individual phenotypes with significant evidence of assortative mating, 
consistent with its low overall AMI values (Figure 26B and Figure 37).  A list of these 
significant traits, including references to the literature where the trait single nucleotide 
polymorphism (SNP)-associations were originally reported, is provided in Table 7.  In 
addition to evaluating individual phenotypes for statistically significant AMI values, we 
also looked for polygenic phenotypes that showed the most similar or dissimilar patterns 
of assortative mating across the four admixed Latin American populations.  The top 20 
phenotypes with the highest and lowest population variance are shown in Figure 27C (all 
are statistically significant at q<0.05).  The polygenic phenotypes with the most variance 
in population-specific AMI values show more functional diversity compared to the 
phenotypes with the strongest signals for assortative mating.  All three functional 
categories are represented among the highly population variant phenotypes, and the highly 
variant phenotypes consist of both assortative and disassortative mating cases (specifically 
the HLA genes that are described in more detail below).  Neurological phenotypes are 
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enriched among the variant cases, including temperament and several addiction-related 
phenotypes: opioid sensitivity and drinking behavior.  A list of the population (in)variant 
traits, including references to the literature where the trait SNP-associations were originally 
reported, is provided in Table 7.   
Given the evidence of significant local ancestry-based assortative mating that we 
observed for a number of traits, we evaluated whether there were particular ancestry 
components that were most relevant to mate choice.  In other words, we asked whether the 
excess counts of observed ancestry homozygosity or heterozygosity are linked to specific 
local ancestry assignments: African, European and/or Native American.  For significant 
polygenic phenotype gene sets of interest, we computed the observed versus expected 
ancestry homozygosity for each ancestry separately across all genes in the set (Figure 28).  
Height is an anthropometric trait for which Colombia, Mexico, and Peru show significant 
evidence of assortative mating after correction for multiple tests (q<0.05; Figure 28A), and 
Puerto Rico shows nominally significant assortative mating for this same trait (P<0.05).  
In Colombia, Peru, and Puerto Rico, assortative mating for this polygenic phenotype is 
driven by an excess of African homozygosity, whereas in Mexico there is a lack of African 
homozygosity.  The neurological disease schizophrenia shows statistically significant 
assortative mating in Mexico and Peru (q<0.05), with marginally significant values in 
Colombia (Figure 28B).  Patterns of assortative mating for this trait in Mexico and Peru 
are driven mainly by European ancestry, whereas Colombia and Puerto Rico show an 
excess of African ancestry homozygosity for this same trait.  
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Figure 28. Individual examples of ancestry-based assortative mating and 
disassortative mating. 
Results of meta-analysis of (dis)assortative mating on polygenic phenotypes along with 
their ancestry drivers are shown for (A) an anthropometric trait: Height, (B) a 
neurological trait: Schizophrenia, and (C) the immune-related HLA class I and II genes.  
The meta-analysis plots show pooled AMI odds ratio values along with their 95% CIs and 
P-values.  Stars indicate false discovery rate q-values<0.05.  The ancestry driver plots 
show the extent to which individual ancestry components – African (blue), European 
(orange), and Native American (red) – have an excess (>0) or a deficit (<0) of 
homozygosity. 
Both Colombia and Puerto Rico show disassortative mating patterns for all HLA 
loci (both class I and II genes) (Figure 28C).  The combined AMI values for the HLA loci 
are only marginally significant but they are among the lowest AMI values seen for any trait 
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evaluated here (Figure 39), and they are also highly variable among populations (Figure 
27C).  HLA loci in Colombia and Puerto Rico show a distinct lack of ancestry 
homozygosity for almost all ancestry components (Figure 28C).  Mexico and Peru, on the 
other hand, have some evidence for assortative mating for the HLA loci; Mexico has the 
highest estimates of ancestry homozygosity at HLA loci for any of the four populations, 
and Peru has an excess of European and Native American ancestry homozygosity and a 
deficit of African homozygosity for these genes.  Similar results for two additional 
anthropometric phenotypes are shown in Figure 40: body mass index and facial 
development.  These phenotypes show assortative mating in all four populations, with 
varying components of ancestral homozygosity driving the relationships.  When these 
results are considered together, African ancestry consistently shows the strongest effect on 
driving assortative and disassortative mating in admixed Latin American populations 
(Figure 28 and Figure 40). 
We further evaluated the extent to which specific ancestry components may drive 
assortative mating patterns among admixed individuals by evaluating the variance of the 
three continental ancestry components among individuals within each Latin American 
population.  Assortative mating is known to increase population variance for traits that are 
involved in mate choice; thus, the ancestry components that drive assortative mating in a 
given population are expected to show higher overall variance among individual genomes.  
African ancestry fractions show the highest variation among individuals for all four 
populations (Figure 29), consistent with the results seen for the five specific cases of 
assortative mating evaluated in Figure 28 and Figure 40. 
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Figure 29. Inter-individual ancestry variance for the four admixed Latin American 
populations analyzed here. 
Variance among individuals for the African (blue), European (orange), and Native 
American (red) ancestry fractions within each population are shown. 
5.4 Discussion 
Assortative mating is a nearly universal human behavior, and scientists have long 
been fascinated by the subject [18, 20].  Studies of assortative mating in humans have most 
often entailed direct measurements of traits – such as physical stature, education, and 
ethnicity – followed by correlation of trait values between partners.  Decades of such 
studies have revealed numerous, widely varying traits that are implicated in mate choice 
and assortative mating.  Studies of this kind typically make no assumptions regarding, nor 
have any knowledge of, the genetic heredity of the traits under consideration.  Moreover, 
the extent to which the expression of these traits varies among human population groups 
has largely been ignored. 
The first attempts to evaluate the genetic contributions to assortative mating 
entailed twin studies, whereby the similarity of mate choice for dizygotic versus 
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monozygotic twins were compared [129].  While twin studies did uncover a genetic 
contribution to variance in human mate choice, they often yielded widely inconsistent 
results.  This was true for both the overall extent of heritability in mate choice, which 
ranged from 0% to 30% [130, 131], and the relative amounts of genetic versus 
environmental contributions across the different traits implicated in mate choice [132, 133].  
More recent studies of assortative mating, powered by advances in human 
genomics, have begun to explore the genetic architecture underlying the human traits that 
form the basis of mate choice in more detail [19, 121].  In addition, recent genomic analyses 
have underscored the extent to which human genetic ancestry influences assortative mating 
[124, 135, 136].  However, until this time, these two strands of inquiry have not been 
brought together.  The approach that we developed for this study allowed us to directly 
assess the connection between local genetic ancestry – i.e., ancestry assignments for 
specific genome regions or haplotypes – and the human traits that serve as cues for 
assortative mating.   
Previous studies on human mate choice have demonstrated pronounced sex 
differences in mate preference; for example, females value earning capacity more in 
potential mates, whereas males value reproductive capacity, as inferred from youth and 
physical attractiveness [138, 139].  It should be noted that the genome-based approach that 
we employed here does not allow us to consider sex differences in mate preference since 
we are essentially observing the effects of assortative mating on the offspring of mate pairs, 
by comparing ancestry homozygosity levels in the genomes of all individuals, rather than 
directly observing mate choice in couples. 
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Our approach relies on the well-established principle that assortative mating results 
in an excess of genetic homozygosity [134].  However, we do not analyze homozygosity 
of specific genetic variants per se, as is normally done; rather we evaluate excess 
homozygosity, or the lack thereof, for ancestry-specific haplotypes (Figure 25B).  By 
merging this approach with data on the genetic architecture of polygenic human 
phenotypes, we were able to uncover specific traits that inform ancestry-based assortative 
mating.  This is because, when individuals exercise mate choice decisions based on 
ancestry, they must do so using phenotypic cues that are ancestry-associated.  In other 
words, ancestry-based assortative mating is, by definition, predicated upon traits that vary 
in expression among human population groups (Figure 41).  An obvious example of this is 
skin color [137], and studies have indeed shown skin color to be an important feature of 
assortative mating [140-143].  It follows that the assortative mating traits that our study 
uncovered in admixed Latin American populations must be both genetically heritable and 
variable among African, European and Native American population groups. 
The traits we found to influence ancestry-based assortative mating vary among the 
continental population groups that admixed to form modern Latin American populations 
(Table 8).  For example, the anthropometric traits found in our study – body mass, height 
and facial development – are both heritable and known to vary among ancestry groups.  
This implies that the genetic variants that influence these traits should also vary among 
these populations.  Accordingly, it is readily apparent that mate choice decisions based on 
these physical features could track local genetic ancestry.  Interpretation of the neurological 
traits that show evidence of local ancestry-based assortative mating – schizophrenia and 
educational attainment – is not quite as straightforward.  For schizophrenia, it is far more 
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likely that we are analyzing genetic loci associated with a spectrum of personality traits 
that influence assortative mating, as opposed to mate choice based on full-blown 
schizophrenia, and indeed personality traits are widely known to impact mate choice 
decisions [119, 122, 125].  In addition, since schizophrenia prevalence does not vary 
greatly world-wide [144], it is more likely that ancestry-based assortative mating for this 
trait is tracking an underlying endophenotype rather than the disease itself.  While 
educational attainment outcomes are largely environmentally determined, recent large-
scale GWAS studies have uncovered a substantial genetic component to this trait, which is 
distributed among scores of loci across the genome [145-148].  The population distribution 
of education-associated variants is currently unknown, but our results suggest the 
possibility of ancestry-variation for some of them.  Indeed, the average allele frequencies 
for the variants that influence our top four traits of interest – height, body mass index, 
schizophrenia, and educational attainment – show significant variation among ancestry 
groups (Figure 41). 
Mate choice based on divergent MHC loci, apparently driven by body odor 
preferences, is the best known example of human disassortative mating [128].  However, 
studies of this phenomenon have largely relied on ethnically homogenous cohorts.  In one 
case where females were asked to select preferred MHC-mediated odors from males of a 
different ethnic group, they actually preferred odors of males with more similar MHC 
alleles [149].  Another study showed differences in MHC-dependent mate choice for 
human populations with distinct ancestry profiles [127].  Ours is the first study that 
addresses the role of ancestry in MHC-dependent mate choice in ethnically diverse 
admixed populations.  Unexpectedly, we found very different results for MHC-dependent 
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mate choice among the four Latin American populations that we studied.  In fact, AMI 
values for the HLA loci are among the most population variable for any trait analyzed here 
(Figure 27C).  Mexico and Peru show evidence of assortative mating at HLA loci, whereas 
Colombia and Puerto Rico show evidence for disassortative mating (Figure 28C).  
Interestingly, disassortative mating for HLA loci in Colombia and Puerto Rico is largely 
driven by African ancestry, and these two populations have substantially higher levels of 
African ancestry compared to Mexico and Peru.  The population- and ancestry-specific 
dynamics of MHC-dependent mate choice revealed here underscore the complexity of this 
issue.  Given the complexity of the results reported here, particularly as they relate to 
differences among populations, it should also be noted that anomalous patterns of linkage 
disequilibrium at MHC loci could confound the analysis at this region. 
Assortative mating alone is not expected to change the frequencies of alleles, or 
ancestry fractions in the case of our study, within a population.  Assortative mating does, 
however, change genotype frequencies, resulting in an excess of homozygous genotypes.  
Accordingly, ancestry-based assortative mating is expected to yield an excess of 
homozygosity for local ancestry assignments (i.e., ancestry-specific haplotypes) (Figure 
25B).  By increasing homozygosity in this way, assortative mating also increases the 
population genetic variance for the traits that influence mate choice.  In other words, 
assortative mating will lead to more extreme, and less intermediate, phenotypes than 
expected by chance.  This population genetic consequence of assortative mating allowed 
us to evaluate the extent to which specific continental ancestries drive mate choice 
decisions in admixed populations, since specific ancestry drivers of assortative mating are 
expected to have increased variance.  We found that the fractions of African ancestry have 
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the highest variance among individuals for all four populations, consistent with the idea 
that traits that are associated with African ancestry drive most of the local ancestry-based 
assortative mating seen in this study (Figure 29). 
It is important to reiterate that previous studies have shown evidence for assortative 
mating on both genetic ancestry and specific traits; accordingly, ancestry-based population 
stratification could lead to the appearance of trait-based assortative mating [150].  For 
example, assortative mating occurs among European-Americans along a North-South 
European ancestry cline, which happens to mirror the cline in height along this same axis 
[134].  This begs the question as to whether similarities in height among European-
American couples is due to ancestry or due to the trait itself.  Studies have shown 
conflicting results regarding this question.  On the one hand, genetic ancestry (population 
stratification) alone was posited to account for observed patterns of assortative mating in 
the US [151], whereas assortative mating for height was observed within distinct US 
population groups, independent of their ancestry [133].  Here, we have tried to tease apart 
the overall effects of ancestry-based assortative mating versus trait-specific mate choice by 
permuting random sets of genes and re-computing our AMI test statistic for each of the 
four Latin American populations analyzed here.  This procedure allowed us to control for 
the background levels of local ancestry homozygosity in these populations, which could 
have been generated by ancestry-based assortative mating alone.  We used this control to 
parameterize the significance levels for the test statistic that we used to discover trait-
specific ancestry-based assortative mating (Figure 27B).  In other words, we only find a 
specific trait to be implicated in ancestry-based assortative mating if the levels of ancestry 
homozygosity for the genes associated with that trait are significantly higher than the 
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genome-wide background levels.  In this sense, we have shown how these specific traits 
may serve as cues that underlie, to some extent, ancestry influenced mate choice in Latin 
American populations.  A corollary to this conclusion is the fact that ancestry- and trait-
based assortative mating cannot be completely disentangled for modern admixed 
populations.  Rather, the variance in the expression of these traits across ancestry groups 
may in fact be an informative marker for individuals’ ancestral origins. 
The confluence of African, European and Native American populations that marked 
the conquest and colonization of the New World yielded modern Latin American 
populations that are characterized by three-way genetic admixture [56, 65-67, 115].  
Nevertheless, mate choice in Latin America is far from random [124, 136].  Indeed, our 
results underscore the prevalence of ancestry-based assortative mating in modern Latin 
American societies.  The local ancestry approach that we developed provided new insight 
into this process by allowing us to hone in on the phenotypic cues that underlie ancestry-
based assortative mating.  Our method also illuminates the specific ancestry components 
that drive assortative mating for different traits and makes predictions regarding traits that 
should vary among continental population groups. 
5.5 Materials and Methods 
5.5.1 Whole genome sequences and genotypes 
Whole genome sequence data for the four admixed Latin American populations 
studied here were taken from the Phase 3 data release of the 1000 Genomes Project (1KGP) 
[70].  Whole genome sequence data and genotypes for the putative ancestral populations 
(Africa, Europe, and the Americas) were taken from the 1KGP, the Human Genome 
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Diversity Project [64] (HGDP), and a previous study on Native American genetic ancestry 
[100]. 
Whole genome sequence data and genotypes were merged, sites common to all 
datasets were kept, and single nucleotide polymorphism (SNP) strand orientation was 
corrected as needed, using PLINK version 1.9 [71].  The resulting dataset consisted of 
1,645 individuals from 38 populations with variants characterized for 239,989 SNPs.  The 
set of merged SNP genotypes was phased, using the program SHAPEIT version 2.r837 
[72], with the 1KGP haplotype reference panel.  This phased set of SNP genotypes was 
used for local ancestry analysis.  PLINK was used to further prune the phased SNPs for 
linkage, yielding a pruned dataset containing 58,898 linkage-independent SNPs.  This 
pruned set of SNP genotypes was used for global ancestry analysis. 
5.5.2 Global and local ancestry analysis 
To infer continental (global) ancestry of the four admixed Latin American 
populations, ADMIXTURE [73] was run on the pruned SNP genotype dataset (n=58,898).  
ADMIXTURE was run using K=4, yielding African, European, Asian and Native 
American ancestry fractions of each admixed individual; the final Asian and Native 
American fractions were summed to determine the Native American fraction of each 
individual.  For local ancestry analysis of the admixed Latin American populations, the 
program RFMix [51] version 1.5.4 was run in the PopPhased mode with a minimum node 
size of 5 and the ‘usereference-panels-in-EM’ option with 2 EM iterations for each 
individual in the dataset using the phased SNP genotypes (n=239,989).  Continental 
African, European, and Native American populations were used as reference populations, 
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and contiguous regions with the same ancestry assignment, i.e., ancestry-specific 
haplotypes, were delineated where the RFMix ancestry assignment certainty was at least 
99%.  The timing of admixture events was analyzed using the program TRACTS [152, 
153] with the local ancestry haplotype assignments from RFMix.  TRACTS was used to 
evaluate possible admixture timings across 1,000 bootstrap attempts, with the most likely 
series of admixture events chosen to represent each population.  
Autosomal NCBI RefSeq coding genes were accessed from the UCSC Genome 
Browser and mapped to the ancestry-specific haplotypes characterized for each admixed 
Latin American individual.  For each diploid genome analyzed here, individual genes can 
have 0, 1 or 2 ancestry assignments depending on the number of high confidence ancestry-
specific haplotypes at that locus.  Our assortative mating index (AMI, see below) can only 
be computed for genes that have 2 ancestry assignments in any given individual, i.e., cases 
where the ancestry is assigned for both copies of the gene.  Thus, for each Latin American 
population 𝑝, the mean (𝑥𝑝) and standard deviation (𝑠𝑑𝑝) of the number of genes with 2 
ancestry assignments were calculated and used to compute an ancestry genotype threshold 
for the inclusion of genes in subsequent analyses.  Genes were used in subsequent 
assortative mating analyses only if they were present above the ancestry genotype threshold 
of 𝑥𝑝 − 𝑠𝑑𝑝. 
5.5.3 Gene sets for polygenic phenotypes 
The polygenic genetic architectures of phenotypes that could be affected by 
assortative mating were characterized using a variety of studies taken from the NHGRI-
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EBI GWAS Catalog [107], the Genetic Investigation of ANthropometric Traits (GIANT) 
consortium3, and PubMed literature sources.   
For each polygenic phenotype, all SNPs previously implicated at genome-wide 
significance levels of P≤5x10-8 were collected as the phenotype SNP set.  The gene sets 
for the polygenic phenotypes were collected by directly mapping trait-associated SNPs to 
genes.  SNPs were used to create a gene set only if the SNP fell directly within a gene and 
thus no intergenic SNPs were used in creating gene sets.  Gene sets from the GWAS 
Catalog were mapped from SNPs using EBI’s in-house pipeline.  Sets from GIANT were 
mapped according to specifications of each individual paper.  Gene sets from literature 
searching were mapped using NCBI’s dbSNP.  For each Latin American population, 
phenotype gene sets were filtered to only include genes that passed the ancestry genotype 
threshold, as described previously.  Finally, the polygenic phenotype gene sets were filtered 
based on size, so that all polygenic phenotypes included two or more genes.   
Linkage disequilibrium (LD) pruning was performed using the program PLINK to 
ensure that gene sets consisted of independent genes.  LD pruning was done using pairwise 
r2 values between genic SNPs for all pairs of genes in any given set.  For any pair of genes 
with SNP r2 > 0.1, only one member of the pair was retained for further analysis.  The final 
data set contains gene sets for 105 polygenic phenotypes, hierarchically organized into 
three functional categories, including 923 unique genes (haplotypes) (Figure 36). 
  
                                                 
3 http://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium 
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5.5.4 Assortative mating index (AMI) 
To assess local ancestry-based assortative mating, we developed the assortative 
mating index (AMI), a log odds ratio test statistic that computes the relative local ancestry 
homozygosity compared to heterozygosity for any given gene.  Ancestry homozygosity 
occurs when both genes in a genome have the same local ancestry, whereas ancestry 
heterozygosity refers to a pair of genes in a genome with different local ancestry 
assignments.  The assortative mating index (𝐴𝑀𝐼) is calculated as: 
 








𝑒𝑥𝑝(ℎ𝑜𝑚)⁄  is the ratio of the observed and expected local ancestry 
homozygous gene pairs and 
𝑜𝑏𝑠(ℎ𝑒𝑡)
𝑒𝑥𝑝(ℎ𝑒𝑡)⁄  is the ratio of the observed and expected 
local ancestry heterozygous gene pairs.   
The observed values of local ancestry homozygous and heterozygous gene pairs are 
taken from the gene-to-ancestry mapping data for each gene in each population.  The 
expected values of local ancestry homozygous and heterozygous gene pairs are calculated 
for each gene in a population using a triallelic Hardy-Weinberg (HW) model, in which the 
gene-specific local ancestry assignment fractions are taken as the three allele frequencies.  
For the African (𝑎), European (𝑒), and Native American (𝑛) gene-specific local ancestry 
assignment fractions in a population, the HW expected genotype frequencies are: 
(𝑎 + 𝑒 + 𝑛)2 or 𝑎2 + 2𝑎𝑒 + 𝑒2 + 2𝑎𝑛 + 2𝑒𝑛 + 𝑛2.  Accordingly, the expected frequency 
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of homozygous pairs is 𝑎2 + 𝑒2 + 𝑛2 and the expected frequency of heterozygous pairs is 
2𝑎𝑒 + 2𝑎𝑛 + 2𝑒𝑛.  For each gene, in each population, the expected homozygous and 
heterozygous frequencies are multiplied by the number of individuals with two ancestry 
assignments for that gene to yield the expected counts of gene pairs in each class. 
For each polygenic phenotype, a meta-analysis of gene-specific AMI values was 
conducted to evaluate the effect of all of the genes involved in the phenotype on assortative 
mating, using the metafor [82] package in R.  95% confidence intervals for each gene, 
meta-gene AMI values, significance P-values, and false discovery rate q-values, were 
computed using the Mantel-Haenszel method under a fixed-effects model. 
5.5.5 Controls for evaluating the assortative mating index (AMI) 
Four different controls were used to evaluate the design and performance of the 
AMI test statistic: (1) a control for the use of HW as a null model in the AMI test statistic, 
(2) a permutation analysis to evaluate expected AMI values under random mating, (3) a 
population genetic simulation to evaluate the power of the AMI test statistic to detect 
ancestry-based assortative mating and its dependence on the different ancestry 
combinations of the populations we analyzed, and (4) a permutation of random gene sets 
to generate null distributions of AMI values expected given the observed genome-wide 
signals of ancestry-based assortative mating.  Each of these control analyses is described 
in detail in section 5.6 Supplementary Material and Methods. 
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5.5.6 Ancestry-specific drivers of assortative mating 
For each significant polygenic phenotype of interest, we identified the ancestry 
component related to mate choice by calculating the ancestry homozygosity (𝐴𝐻𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒
𝑎𝑛𝑐 ) 




𝑎𝑛𝑐 =  ∑ (
𝑜𝑏𝑠𝑔




𝑔 ∈ 𝑔𝑒𝑛𝑒𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒
 (10) 
where 𝑎𝑛𝑐 is one of the three ancestries – African, European or Native American, 𝑔 ∈
 𝑔𝑒𝑛𝑒𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒 are all of the genes involved in the polygenic 𝑝ℎ𝑒𝑛𝑜𝑡𝑦𝑝𝑒, 
𝑜𝑏𝑠𝑔
𝑎𝑛𝑐 is the number of observed homozygous genes for gene 𝑔 coming from 𝑎𝑛𝑐, and 
𝑒𝑥𝑝𝑔
𝑎𝑛𝑐 is the number of expected homozygous genes for gene 𝑔 coming from 𝑎𝑛𝑐 (as 
calculated using a triallelic Hardy-Weinberg model). 
5.5.7 Statistical significance testing 
Significance testing for the difference between the observed and expected AMI 
distributions (for both random mating and assortative mating) was completed using the t-
test package in R.  The metafor package, used for calculating the meta-analysis AMI 
values, also calculates a P-value and a false discovery rate q-value to correct for multiple 
statistical tests, which were used for identifying polygenic phenotypes that are significantly 
influenced by local ancestry-based assortative mating in each Latin American population.  
The variance of AMI values across the four populations for each phenotype was calculated 
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as it is implemented in R and used for identifying phenotypes that had highly similar 
(minimal variance) or highly dissimilar (maximal variance) local ancestry-based 
assortative mating patterns.  The coefficient of variation was used to measure the inter-
individual variance for each of the three continental ancestry components within the four 
admixed Latin American populations analyzed here.  
5.6 Supplementary Material and Methods 
5.6.1 Controls for evaluating the assortative mating index (AMI) 
Four different controls were used to evaluate the design and performance of the 
AMI test statistic: (1) a control for the use of HW as a null model in the AMI test statistic, 
(2) a permutation analysis to evaluate expected AMI values under random mating, (3) a 
population genetic simulation to evaluate the power of the AMI test statistic to detect 
ancestry-based assortative mating and its dependence on the different ancestry 
combinations of the populations we analyzed, and (4) a permutation of random gene sets 
to generate null distributions of AMI values expected given the observed genome-wide 
signals of ancestry-based assortative mating.  Each of these control analyses is described 
in the following text. 
5.6.1.1 Control 1: Evaluation of Hardy-Weinberg (HW) 
HW was intended as a null model against which to test our observed data; 
nevertheless, it is possible that local ancestry will deviate from HW depending on 
population history and demography.  To control for this possibility, we tested for evidence 
of (1) the Wahlund effect, which is expected to yield an excess of homozygosity, and (2) 
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recent admixture, which is expected to yield an excess of heterozygosity.  The Wahlund 
effect, along with the genome-wide distributions of homozygosity and heterozygosity, 
were measured using the genome-wide distribution of the parameter , where  =
2𝑝𝑞 √𝑝2  ×  𝑞2⁄  with p and q representing ancestry fractions [154].  Genome-wide 
distributions of heterozygosity were evaluated to look for recent admixture yielding very 
high heterozygosity.  In addition, the admixture timing for the four populations was 
analyzed using the distributions of the ancestry-specific haplotype lengths with the 
program TRACTS as described in section 5.5.2 Global and local ancestry analysis. 
5.6.1.2 Control 2: Permutation of random mating 
A standard permutation testing framework was adopted for the approximation of 
random mating in each of the four Latin American populations.  Random mating was 
approximated by randomly combining pairs of individual phased haplotypes from a 
population to yield permuted diploid genotypes.  Haploid chromosomes were permuted 
randomly within each population using the Fisher-Yates shuffle.  After permutation of the 
chromosomes, per gene AMI values were re-calculated for all genes passing the 
population-specific ancestry genotyping thresholds.  The permutations were completed 20 
times, and the population-specific mean AMI values for each gene were taken as the 
permuted AMI for the gene.  This mean permuted AMI per gene was used in AMI meta-
analysis for each gene set to determine expected AMI values. 
5.6.1.3 Control 3: Population genetic simulation of assortative mating 
To validate the performance of the AMI test statistic, we adopted a population 
genetic model that simulates assortative mating in the four Latin American populations 
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under Hardy-Weinberg equilibrium, with a fraction of the population mating assortatively.  
For each gene in a given population, the present-day local ancestry assignment fractions 
are used as the starting ancestral proportions: African = 𝑎, European = 𝑒, Native American 
= 𝑛.  Using a triallelic Hardy-Weinberg model, taking the ancestral proportions as the allele 
frequencies, the ancestry genotype frequencies for a given gene at the starting generation 
are calculated as: 
𝑃𝑎𝑎 = 𝑎
2 
𝑃𝑎𝑒 = 2𝑎𝑒 
𝑃𝑎𝑛 = 2𝑎𝑛 
𝑃𝑒𝑒 = 𝑒
2 
𝑃𝑒𝑛 = 2𝑒𝑛 
𝑃𝑛𝑛 = 𝑛
2 
where 𝑃𝑎𝑎 = African-African genotype, 𝑃𝑎𝑒 = African-European genotype, 𝑃𝑎𝑛 = African-
Native American genotype, 𝑃𝑒𝑒 = European-European genotype, 𝑃𝑒𝑛 = European-Native 
American genotype and 𝑃𝑛𝑛 = Native American-Native American genotype.  Under the 
model, the fraction of the population that mates assortatively is denoted as 𝛼 and the 
fraction that mates randomly is 1 − 𝛼.  Taking the current generation ancestry genotype 
frequencies, the subsequent generation’s ancestry genotype frequencies are calculated 
using the formulae: 
𝑃𝑎𝑎
′  =  (1 − 𝛼) × 𝑎2 +  𝛼 × (𝑃𝑎𝑎  +  0.25 ×  𝑃𝑎𝑒  +  0.25 × 𝑃𝑎𝑛) 
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𝑃𝑎𝑒
′  =  (1 − 𝛼) × 2𝑎𝑒 +  𝛼 × (0.5 × 𝑃𝑎𝑒) 
𝑃𝑎𝑛
′  =  (1 − 𝛼) × 2𝑎𝑛 +  𝛼 × (0.5 ×  𝑃𝑎𝑛) 
𝑃𝑒𝑒
′  =  (1 − 𝛼) × 𝑒2 +  𝛼 × (𝑃𝑒𝑒  +  0.25 × 𝑃𝑎𝑒  +  0.25 × 𝑃𝑒𝑛) 
𝑃𝑒𝑛
′  =  (1 − 𝛼) × 2𝑒𝑛 +  𝛼 × (0.5 ×  𝑃𝑒𝑛) 
𝑃𝑛𝑛
′  =  (1 − 𝛼) × 𝑛2 +  𝛼 × (𝑃𝑛𝑛  +  0.25 ×  𝑃𝑎𝑛  +  0.25 × 𝑃𝑒𝑛) 
Ancestry genotypes in each population were simulated for 20 generations, with the 
assumption of a generation time of 25 years, accounting for 500 years of elapsed time 
during the conquest and colonization of the Americas.  The final ancestry genotype 
frequencies after the 20 generations were used to calculate the simulated ancestry 
homozygosity and heterozygosity values.  For each Latin American simulated population, 
random gene sets, ranging in size from 2 to 20, were created by subsampling genes in the 
simulation.  A meta-analysis AMI value and P-value for each gene set was calculated using 
the fixed-effects model of the Mantel-Haenszel method. 
5.6.1.4 Control 4: Permutation test of ancestry-based assortative mating 
Permutation of random gene sets was used to generate null distributions of gene set 
AMI values expected given the observed genome-wide levels of ancestry-based assortative 
mating.  This permutation controls for the genome-wide levels of ancestry homozygosity 
based on overall levels of ancestry similarity between couples in admixed Latin American 
populations.  For these permutations, 10,000 sets of genes, of the same sizes as the gene 
sets curated for the polygenic traits analyzed here, were permutated by randomly selecting 
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genes without replacement from across the genome, and AMI values for the random gene 
sets were calculated.  The randomly permuted AMI distributions were compared to the 
observed AMI values for the significant polygenic trait gene sets to evaluate the extent to 
which observed trait gene set AMI values deviate from AMI values seen for random gene 
sets. 
5.7 Supplementary Results 
 
Figure 30. Global locations of the populations analyzed in this study. 
Global reference populations – African (blue), European (orange) and Native American 
(red) – were used to infer the continental ancestry proportions of the four admixed Latin 





Figure 31. Three-way continental genetic ancestry for the four admixed Latin 
American populations analyzed in this study. 
ADMIXTURE plot showing genome-wide continental ancestry fractions for each 
individual in each of the four Latin American populations and for each individual in the 





Figure 32. Local ancestry assignment with chromosome painting. 
Examples of local ancestry assignment chromosome paintings are shown for Colombia, 
Mexico, Peru and Puerto Rico.  Examples correspond to genomes that have close to 




Figure 33. Comparison of ancestry fractions estimated by ADMIXTURE (global 
ancestry) versus RFMix (local ancestry). 
Genome-wide continental ancestry fractions were inferred for all individuals using the 
program ADMIXTURE, which estimates global ancestry fractions, and by summing the 
lengths of local ancestry-specific tracts (haplotypes) inferred from RFMix.  Correlations 
between ADMIXTURE (x-axis) and RFMix (y-axis) ancestry estimates for individuals 
analyzed here are shown for (A) African (blue), (B) European (orange), and (C) Native 
American (red) ancestry.  Pearson correlation r-values are shown for each ancestry.  
 
5.7.1 Control 1: Evaluation of Hardy-Weinberg (HW) 
We chose HW as an idealized population genetic model against which to test the 
observed distributions of local ancestry.  Nevertheless, genome-wide patterns of local 
ancestry may deviate from HW depending on population history and demography.  On the 
one hand, population structure may lead to the so-called Wahlund effect, yielding a 
genome-wide excess of homozygosity.  On the other hand, very recent admixture could 
lead to a genome-wide excess of heterozygosity.  We controlled for these two possibilities 
to validate the use of HW as a null model for the genome-wide distribution of local 
ancestry.  Genome-wide patterns of homozygosity and heterozygosity were measured 
using the parameter  for the four admixed Latin American populations.   is expected to 
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equal 2 under HW, whereas <2 indicates an excess of homozygosity and >2 indicates 
an excess of heterozygosity [154].  All four populations show genome-wide median values 
of  very close to 2 as well as genome-wide distributions centered around 2, in support of 
the use of HW as a null model for local ancestry distribution (Figures 34A and 34B). 
We also computed the genome-wide median values and distributions of 
heterozygosity to control for the possibility of recent admixture yielding extremely high 
values of ancestry heterozygosity genome-wide.  Median values of heterozygosity are close 
to 0.5 for all four populations analyzed, and the genome-wide heterozygosity distributions 
do not show any evidence for extreme ancestry heterozygosity values caused by recent 
admixture (Figures 34C and 34D).  We further evaluated admixture timing for the four 
populations via analysis of the distribution of ancestry-specific haplotype lengths with the 
program TRACTS.  The TRACTS analysis does not show any evidence for recent 
admixture among these populations; the inferred admixture events range from 8 to 15 
generations ago, with an average of ~11 generations (Figure 35).  These estimates are 
consistent with previous studies as well as the known history of the region [85, 88, 89].  
Taken together, the results of the heterozygosity and admixture timing analyses also 
support the use of HW as a null model for local ancestry distribution. 
5.7.2 Control 2: Permutation of random mating 
Results of the chromosome permutation control for random mating are shown as 




5.7.3 Control 3: Population genetic simulation of assortative mating 
In addition to the permutation test, we also performed a simulation analysis using 
a population genetic model of assortative mating to assess the power of the AMI test 
statistic (Figure 36).  We were particularly interested in exploring the potential effects of 
different ancestry proportions among the populations analyzed here, and different gene set 
sizes, on computed AMI values.  The population genetic simulation shows that our AMI 
test statistic is sensitive even when the fraction of the population that mates assortatively 
is low.  We also found that AMI values are not biased in any particular direction based on 
the overall ancestry fractions observed for each population.  For example, according to the 
AMI power simulation, Colombia should have the highest overall AMI values, followed 
by Puerto Rico, Mexico, and Peru.  This order is completely different from what is seen 
for the observed AMI values, where Mexico shows the highest mean value, followed by 
Peru, Colombia, and Puerto Rico (Figure 26B).  The population genetic simulation does 
show that the size of the gene set being analyzed influences the sensitivity of the AMI test 
statistic.  Larger gene sets show greater evidence for assortative mating at the same α 
parameter values compared with smaller gene sets. 
5.7.4 Control 4: Permutation test of ancestry-based assortative mating 
Results of the random genet set permutation control for assortative mating are 




Figure 34. Genome-wide patterns of homozygosity and heterozygosity for the four 
admixed Latin American populations analyzed in this study. 
Genome-wide median values (A) and distributions (B) for the parameter Phi () were used 
to test for excess homozygosity and heterozygosity genome-wide.  Genome-wide median 
values (C) and distributions (D) of heterozygosity were used to test for very recent 
admixture, which are expected to yield ~100% heterozygosity genome-wide. 
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Figure 35. Admixture timing for the four admixed Latin American populations 
analyzed in this study. 
(Left panels) Observed (points) and predicted (solid lines) ancestry tract size distributions, 
with shaded areas representing 95% confidence intervals.  (Right panels) Admixture event 
timings are shown together with ancestry proportions.  Each inferred admixture event is 
indicated by a circle, which is scaled according to the size of the contribution to the 
population and also shows the relative ancestry proportions.  The y-axes of the charts show 
the inferred continental ancestry fractions, and the x-axes show admixture timing as the 
number of generations ago (GA). 
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Figure 36. Simulation of the assortative mating index (AMI) test statistic under 
assortative mating. 
Assortative mating was modeled combining Hardy-Weinberg genotype expectations with 
a single parameter 𝛼 that represents the fraction of the population that mates assortatively.  
Assortative mating 𝛼-values range from 0 (no assortative mating) to 0.3 (incomplete 
assortative mating) for polygenic phenotypes encoded by gene sets of ng=2 to 20 genes.  
For each population, statistical significance P-values for AMI are plotted for all 
combinations of 𝛼 and ng, and the area of significant (P<0.05) AMI values is indicated. 
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Figure 37. Polygenic phenotypes taken from genome-wide association studies 
(GWAS). 
(A) GWAS SNP-associations curated from (1) the NHGRI-EBI GWAS catalog, (2) the 
Genetic Investigation of ANthropometric Traits (GIANT) consortium, and (3) scientific 
literature indexed in PubMed were mapped to genes as described in the Methods in order 
to evaluate ancestry-based assortative mating on polygenic phenotypes.  (B) Distribution 
of the number of genes per polygenic phenotype (trait).  (C) Hierarchical organization 
scheme developed for the polygenic phenotypes analyzed here.  The numbers of phenotypes 
(np) and total genes (ng) are shown for each node in the scheme tree. 
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Figure 38. Distributions of observed (dark blue) versus expected (light blue) AMI 
values for the four admixed Latin American populations analyzed here. 
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Figure 39. Assortative mating index (AMI) values for all phenotypes across all four 
populations analyzed here. 
AMI values are color coded with red for positive values (corresponding to assortative 
mating) and blue for negative values (corresponding to disassortative mating).  The AMI 
value matrix is hierarchically clustered on both the y- and x-axes in order to visualize 
similar and divergent assortative mating trends across populations. 
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Figure 40. Individual examples of ancestry-based assortative mating. 
Results of meta-analysis of (dis)assortative mating of polygenic phenotypes along with 
their ancestry drivers are shown for (A) body mass index, and (B) facial development.  The 
meta-analysis plots show pooled AMI odds ratio values along with their 95% CIs and P-
values.  Stars indicate false discovery rate q-values<0.05.  The ancestry driver plots show 




Figure 41. Genetic variation in trait-specific SNP frequencies across continental 
ancestry groups. 
Average risk allele frequency distributions are shown for the top four ancestry-based 
assortative mating traits (see Figure 27A).  Average SNP risk allele frequencies for each 
trait were computed using the 1000 Genomes Project data for individuals from African 
(GWD and YRI), European (CEU and IBS), and Native American (MXL and PEL) 
populations.  To approximate Native American ancestry, only Mexican (MXL) and 
Peruvian (PEL) individuals with >75% Native American ancestry were chosen (see Figure 
31).  ANOVA was used to evaluate the significance of the differences in the ancestry-
specific distributions for each trait (see F- and P-values for each plot).  
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CHAPTER 6. CONCLUSIONS AND FUTURE PROSPECTS 
Admixture is a ubiquitous feature of human evolution, and examples of it can be found 
throughout human history.  No longer is it believed that humans solely evolved by the serial 
founder model – geographic and reproductive isolation followed by genetic divergence.  
Instead, it has been shown that the recurrent and joint processes of migration-driven genetic 
divergence and admixture have been present throughout human evolution.  Examples of 
this cycle are seen as early as anatomically modern humans admixing with Neandertals and 
Denisovans, up through the Columbian Exchange ~500 years ago, and ongoing today at an 
ever increasing rate. 
The Columbian Exchange brought together once isolated populations in a new 
environment over a short period of time.  The movement of Europeans and Africans into 
Native American lands in the New World and subsequent admixture created the modern 
populations of Latin America.  Individuals from these populations have three-way 
admixture and can be considered to possess evolutionarily novel genomes, with pre-
adapted ancestral haplotypes coinciding on genomic backgrounds that were never before 
combined.  Latin American populations, while largely sharing the same continental 
ancestral components, have different levels of admixture among the three ancestries and 
different patterns of local ancestry as well.   
The combinations of genetic ancestry seen in admixed populations play an important 
role when investigating the genomic determinants of health and disease.  Relationships 
between ancestry and disease-related variants become more complicated to study when 
looking at admixed populations, since the patterns of local ancestry vary among individuals 
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and populations.  As discussed in Chapter 3, admixture has greatly impacted the genetic 
ancestry of the immune system, both adaptive and innate, of admixed Latin American 
populations in terms of specific disease- and health-related variants and regulation of gene 
expression.  Any genomic approaches to healthcare in Latin America will require an 
understanding of the admixture profiles of the Latin American populations. 
The process of admixture also influenced the ability of the Latin American populations 
to adapt to the environment, through admixture-enabled selection.  The ancestral 
populations had previously been geographically isolated for tens of thousands of years and 
had genetically diverged from one another while adapting to their respective environments.  
Pre-adapted alleles with beneficial utility in the New World were stitched together in the 
admixed American populations such that they were better able to adapt to the environment 
in a shorter amount of time than what would be seen with new mutation.  As discussed in 
Chapter 4, rapid admixture-enabled selection occurred on both single loci and polygenic 
phenotypes in the ~500 years since the Columbian Exchange began.  There was strong 
selection on single haplotypes owing to their adaptive use in the environment and weaker 
selection on polygenic phenotypes. 
As admixture acts to break down population structure, assortative mating acts to 
maintain it.  Mate choice is a fundamental feature of human behavior and can maintain 
structure among distinct population groups even when they are co-located, such as those 
in Latin America.  Latin American populations mate assortatively, with individuals 
choosing partners more like themselves in terms of genetic ancestry based on phenotypic 
cues.  These phenotypic cues can be conscious or subconscious decisions, but ultimately 
they result in individuals choosing partners more like themselves than by random chance.  
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As discussed in Chapter 5, the development of a novel local ancestry approach to identify 
patterns of ancestry-based assortative mating yielded insights into the phenotypic cues that 
underlie this process as well as the specific ancestry components that drive assortative 
mating for different traits.  The traits with evidence of ancestry-based assortative mating 
in Latin American populations varied in their appearance across ancestral populations, 
uncovering the genetic ancestry of the trait through patterns of ancestry homozygosity at 
trait-associated loci. 
This thesis explores the implications of admixture and assortative mating in modern 
Latin American populations.  These demographic processes, however, are not isolated to 
solely Latin America.  As humans migrated out of Africa they consistently met with new 
populations.  Admixture and assortative mating in these groups aided modern humans’ 
ability to adapt to their environments and eventually migrate to other places around the 
world.  By studying the impacts of these two processes in other admixed populations, we 
will continue to see how genetic ancestry influences many aspects of human evolution.   
Further study into the relationship of genetic ancestry and health, specifically in 
admixed populations, will also help to identify ancestry-specific components that can lead 
to health disparities.  Populations can be very genetically diverse even when co-located in 
the same country or even the same city; these same groups can also have different rates of 
health outcomes, including increased rates of disease when compared with their direct 
neighbors.  This thesis has shown that there is a direct link between genetic ancestry and 
health- and disease-related phenotypes, but more work needs to be done to more deeply 
characterize this relationship.  Having more detailed information and studies understanding 
the genetic ancestry architecture of health traits may assist in getting the right interventions 
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out to the populations who would most benefit from them and can help to guide healthcare 
workers’ decisions when selecting treatments.  Understanding this relationship can help to 
reduce the extent of health disparities seen between different admixed population groups. 
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APPENDIX A. SUPPLEMENTARY TABLES FOR CHAPTER 3 
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Table 5. Lists of all SNPs that show significant ancestry-enrichment. 
For each admixed Latin population, all ancestry-enriched SNPs (q < 0.05) are given along with their meta-information, observed and 
expected reference and alternate allele frequencies, and significance values.  The allele (reference or alternate) and enriched ancestry 
(African, European, or Native American) are designated for each ancestry-enriched SNP. 

























1 11854476 rs1801131 T G 0.87 0.13 0.75 0.25 12.69 3.67E-04 6.63E-03 Ref AFR 
1 11856378 rs1801133 G A 0.46 0.54 0.57 0.43 10.53 1.17E-03 1.67E-02 Alt NAT 
1 12267292 rs3397 C T 0.32 0.68 0.50 0.50 23.17 1.48E-06 6.50E-05 Alt EUR 
1 16505320 rs1497406 A G 0.51 0.49 0.41 0.59 7.97 4.75E-03 4.60E-02 Ref AFR 
1 32756439 rs1741981 T C 0.75 0.25 0.57 0.43 23.70 1.13E-06 5.12E-05 Ref EUR 
1 56112774 rs10443215 C T 0.31 0.69 0.42 0.58 9.63 1.92E-03 2.47E-02 Alt NAT 
1 65992625 rs1751492 C T 0.33 0.67 0.44 0.56 9.51 2.04E-03 2.61E-02 Alt EUR 
1 66058513 rs1137101 A G 0.60 0.40 0.47 0.53 12.31 4.52E-04 7.68E-03 Ref EUR 
1 89849574 rs928655 G A 0.29 0.71 0.41 0.59 12.62 3.81E-04 6.70E-03 Alt EUR 
1 96943994 rs1973993 T C 0.48 0.52 0.38 0.62 8.17 4.26E-03 4.29E-02 Alt NAT 
1 114677948 rs529989 C A 0.31 0.69 0.42 0.58 7.91 4.92E-03 4.75E-02 Alt NAT 
1 155279482 rs2297480 T G 0.72 0.28 0.62 0.38 9.00 2.69E-03 3.01E-02 Ref EUR 
1 155868625 rs2282301 G A 0.74 0.26 0.63 0.37 9.16 2.48E-03 2.95E-02 Ref EUR 
1 156879580 rs3737224 C T 0.91 0.09 0.82 0.18 11.63 6.48E-04 1.02E-02 Ref EUR 
1 156881959 rs41273215 C T 0.91 0.09 0.82 0.18 10.38 1.28E-03 1.77E-02 Ref EUR 
1 156883215 rs822442 C A 0.91 0.09 0.82 0.18 10.38 1.28E-03 1.77E-02 Ref EUR 
1 196679455 rs10737680 A C 0.43 0.57 0.56 0.44 13.52 2.36E-04 4.59E-03 Alt AFR 
1 201345487 rs12564445 G A 0.84 0.16 0.75 0.25 8.09 4.46E-03 4.39E-02 Ref EUR 
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Table 5 (continued). 
1 206946407 rs1800872 T G 0.30 0.70 0.42 0.58 10.61 1.13E-03 1.62E-02 Alt EUR 
1 206946634 rs1800871 A G 0.30 0.70 0.42 0.58 10.61 1.13E-03 1.62E-02 Alt EUR 
1 226019653 rs1131873 G A 0.88 0.12 0.78 0.22 10.11 1.48E-03 2.01E-02 Ref AFR 
1 230294916 rs2144300 C T 0.42 0.58 0.54 0.46 10.36 1.29E-03 1.79E-02 Alt EUR 
1 232756026 rs10495332 T C 0.98 0.02 0.90 0.10 14.99 1.08E-04 2.38E-03 Ref AFR 
1 237028564 rs3768142 G T 0.30 0.70 0.42 0.58 9.66 1.88E-03 2.44E-02 Alt AFR 
1 247675559 rs7550918 C T 0.30 0.70 0.14 0.86 38.92 4.41E-10 4.68E-08 Alt NAT 
2 10903412 rs1198872 C T 0.55 0.45 0.65 0.35 9.41 2.16E-03 2.71E-02 Ref EUR 
2 21225281 rs1042034 C T 0.19 0.81 0.34 0.66 18.57 1.64E-05 5.26E-04 Alt AFR 
2 21231524 rs676210 G A 0.81 0.19 0.66 0.34 19.92 8.06E-06 2.86E-04 Ref AFR 
2 21288321 rs562338 A G 0.25 0.75 0.16 0.84 9.89 1.66E-03 2.20E-02 Alt NAT 
2 25131316 rs6545814 A G 0.63 0.37 0.50 0.50 12.26 4.64E-04 7.84E-03 Ref NAT 
2 56120853 rs1430193 A T 0.64 0.36 0.45 0.55 27.89 1.28E-07 7.97E-06 Ref EUR 
2 111907691 rs724710 T C 0.54 0.46 0.29 0.71 54.38 1.65E-13 2.89E-11 Ref EUR 
2 113598107 rs4848306 G A 0.63 0.37 0.53 0.47 8.53 3.48E-03 3.69E-02 Ref AFR 
2 134266001 rs16826005 A G 0.96 0.04 0.88 0.12 12.68 3.69E-04 6.65E-03 Ref EUR 
2 152981335 rs16830728 G T 0.93 0.07 0.75 0.25 32.79 1.02E-08 8.05E-07 Ref EUR 
2 159899489 rs7582141 G T 0.81 0.19 0.92 0.08 28.98 7.32E-08 4.76E-06 Ref EUR 
2 159899913 rs6432512 C T 0.81 0.19 0.92 0.08 31.95 1.58E-08 1.18E-06 Ref EUR 
2 159936391 rs264588 C A 0.81 0.19 0.93 0.07 40.00 2.54E-10 2.77E-08 Ref EUR 
2 159950865 rs264631 C G 0.80 0.20 0.92 0.08 38.32 5.99E-10 6.23E-08 Ref EUR 
2 165513091 rs10195252 T C 0.69 0.31 0.57 0.43 9.60 1.95E-03 2.51E-02 Ref NAT 
2 200638509 rs12615435 T G 0.94 0.06 0.85 0.15 10.74 1.05E-03 1.52E-02 Ref AFR 
2 234668570 rs887829 C T 0.66 0.34 0.75 0.25 8.20 4.19E-03 4.22E-02 Ref NAT 
3 12475557 rs3856806 C T 0.95 0.05 0.86 0.14 11.43 7.24E-04 1.12E-02 Ref AFR 
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3 26543420 rs2202157 C T 0.95 0.05 0.85 0.15 12.50 4.07E-04 7.04E-03 Ref AFR 
3 119537291 rs3814058 T C 0.84 0.16 0.71 0.29 14.97 1.10E-04 2.40E-03 Ref EUR 
3 119813282 rs334558 A G 0.64 0.36 0.52 0.48 10.32 1.32E-03 1.82E-02 Ref EUR 
3 160429869 rs7624766 A G 0.63 0.37 0.52 0.48 9.40 2.17E-03 2.72E-02 Ref EUR 
3 170725542 rs10513686 G A 0.77 0.23 0.87 0.13 14.95 1.11E-04 2.42E-03 Ref NAT 
4 2906707 rs4961 G T 0.84 0.16 0.74 0.26 8.09 4.46E-03 4.39E-02 Ref AFR 
4 3006043 rs1024323 C T 0.55 0.45 0.66 0.34 8.49 3.57E-03 3.76E-02 Ref NAT 
4 6058497 rs16838131 G A 0.98 0.02 1.00 0.00 9.05 2.63E-03 2.95E-02 Ref NAT 
4 9926967 rs13129697 T G 0.45 0.55 0.64 0.36 31.75 1.76E-08 1.31E-06 Alt AFR 
4 38139024 rs9852 C T 0.91 0.09 0.82 0.18 11.37 7.44E-04 1.15E-02 Ref AFR 
4 100163873 rs2201728 G A 0.45 0.55 0.65 0.35 33.71 6.38E-09 5.18E-07 Alt EUR 
4 100239319 rs1229984 T C 0.07 0.93 0.25 0.75 30.89 2.73E-08 1.95E-06 Alt AFR 
4 100495488 rs1800591 G T 0.85 0.15 0.75 0.25 10.10 1.48E-03 2.01E-02 Ref NAT 
4 139493398 rs1450439 A G 0.70 0.30 0.82 0.18 18.99 1.31E-05 4.35E-04 Ref NAT 
4 146875551 rs723794 G T 0.29 0.71 0.41 0.59 10.65 1.10E-03 1.59E-02 Alt EUR 
4 154609523 rs1816702 T C 0.15 0.85 0.09 0.91 7.83 5.15E-03 4.92E-02 Alt NAT 
4 159630817 rs8396 T C 0.86 0.14 0.73 0.27 16.82 4.12E-05 1.14E-03 Ref NAT 
5 7870973 rs1801394 A G 0.72 0.28 0.59 0.41 13.75 2.09E-04 4.15E-03 Ref NAT 
5 33951693 rs16891982 C G 0.36 0.64 0.47 0.53 9.41 2.16E-03 2.71E-02 Alt EUR 
5 63250851 rs1364043 T G 0.82 0.18 0.70 0.30 13.32 2.63E-04 5.01E-03 Ref AFR 
5 74642855 rs17244841 A T 0.95 0.05 0.99 0.01 24.76 6.48E-07 3.09E-05 Ref NAT 
5 74655498 rs17238540 T G 0.96 0.04 0.99 0.01 12.63 3.79E-04 6.66E-03 Ref NAT 
5 131819921 rs2070729 C A 0.39 0.61 0.51 0.49 11.26 7.92E-04 1.21E-02 Alt AFR 
5 137707315 rs757647 G A 0.74 0.26 0.63 0.37 10.04 1.53E-03 2.06E-02 Ref EUR 
5 167500460 rs13358864 T A 0.95 0.05 0.86 0.14 12.50 4.07E-04 7.04E-03 Ref AFR 
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5 176836532 rs1801020 A G 0.25 0.75 0.38 0.62 14.07 1.76E-04 3.60E-03 Alt EUR 
6 7102084 rs675209 T C 0.36 0.64 0.52 0.48 19.17 1.20E-05 4.02E-04 Alt EUR 
6 7801112 rs6923462 T C 0.84 0.16 0.91 0.09 10.38 1.27E-03 1.77E-02 Ref NAT 
6 12296255 rs5370 G T 0.85 0.15 0.76 0.24 8.44 3.66E-03 3.80E-02 Ref AFR 
6 31111356 rs9263739 C T 0.87 0.13 0.78 0.22 7.99 4.72E-03 4.58E-02 Ref NAT 
6 31274380 rs9264942 T C 0.70 0.30 0.60 0.40 8.83 2.96E-03 3.24E-02 Ref AFR 
6 32667910 rs2647044 G A 0.96 0.04 0.89 0.11 8.06 4.53E-03 4.43E-02 Ref NAT 
6 32975014 rs399604 T C 0.72 0.28 0.54 0.46 26.21 3.06E-07 1.74E-05 Ref AFR 
6 33283766 rs3130100 T C 0.38 0.62 0.51 0.49 13.31 2.64E-04 5.03E-03 Alt AFR 
6 35369806 rs1883322 C T 0.21 0.79 0.34 0.66 12.63 3.80E-04 6.68E-03 Alt NAT 
6 35395010 rs3734254 C T 0.20 0.80 0.31 0.69 11.00 9.13E-04 1.36E-02 Alt NAT 
6 99782879 rs17059400 A C 0.74 0.26 0.86 0.14 21.60 3.35E-06 1.33E-04 Ref EUR 
6 110777962 rs6907567 A G 0.78 0.22 0.68 0.32 8.76 3.08E-03 3.35E-02 Ref EUR 
6 110778128 rs714368 T C 0.78 0.22 0.68 0.32 7.93 4.86E-03 4.70E-02 Ref EUR 
6 121748542 rs11154022 A G 0.28 0.72 0.40 0.60 11.73 6.13E-04 9.82E-03 Alt AFR 
6 122146034 rs9398652 C A 0.89 0.11 0.79 0.21 11.68 6.32E-04 1.00E-02 Ref EUR 
6 135419018 rs9399137 T C 0.88 0.12 0.76 0.24 15.23 9.54E-05 2.14E-03 Ref AFR 
6 137102365 rs9376230 C A 0.30 0.70 0.41 0.59 8.80 3.01E-03 3.30E-02 Alt AFR 
6 154487421 rs2281617 C T 0.88 0.12 0.73 0.27 22.63 1.97E-06 8.39E-05 Ref EUR 
6 155929801 rs35229355 C T 0.98 0.02 0.85 0.15 26.23 3.03E-07 1.73E-05 Ref EUR 
7 29014195 rs2018683 G T 0.46 0.54 0.57 0.43 8.68 3.22E-03 3.47E-02 Alt EUR 
7 80236014 rs13236689 T G 0.65 0.35 0.54 0.46 10.36 1.29E-03 1.79E-02 Ref EUR 
7 102519031 rs17135875 T C 0.73 0.27 0.85 0.15 17.98 2.23E-05 6.77E-04 Ref NAT 
8 11643915 rs804292 G A 0.23 0.77 0.15 0.85 7.99 4.70E-03 4.57E-02 Alt NAT 
8 132330716 rs10108033 T C 0.16 0.84 0.26 0.74 9.06 2.61E-03 2.95E-02 Alt AFR 
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9 4744743 rs409801 T C 0.65 0.35 0.53 0.47 12.29 4.55E-04 7.74E-03 Ref AFR 
9 4763176 rs385893 T C 0.60 0.40 0.44 0.56 20.79 5.14E-06 1.94E-04 Ref AFR 
9 14446001 rs1556032 C T 0.41 0.59 0.59 0.41 23.86 1.04E-06 4.73E-05 Alt NAT 
9 35141705 rs10972341 A G 0.29 0.71 0.46 0.54 23.30 1.39E-06 6.14E-05 Alt AFR 
9 93636664 rs290227 G A 0.81 0.19 0.66 0.34 19.78 8.71E-06 3.06E-04 Ref EUR 
9 104378003 rs10121600 C T 0.62 0.38 0.72 0.28 9.49 2.07E-03 2.64E-02 Ref NAT 
9 108967088 rs2090409 C A 0.73 0.27 0.59 0.41 14.87 1.15E-04 2.51E-03 Ref AFR 
9 124565820 rs10760187 T C 0.60 0.40 0.37 0.63 42.08 8.74E-11 1.04E-08 Ref EUR 
9 132501881 rs2302821 A C 0.85 0.15 0.76 0.24 8.32 3.93E-03 4.01E-02 Ref EUR 
10 23369421 rs722258 C T 0.56 0.44 0.66 0.34 9.55 2.00E-03 2.57E-02 Ref NAT 
10 26734587 rs2992257 C T 0.88 0.12 0.69 0.31 30.54 3.26E-08 2.30E-06 Ref AFR 
10 64963449 rs4379723 T C 0.65 0.35 0.51 0.49 14.40 1.48E-04 3.10E-03 Ref AFR 
10 65104500 rs7896518 A G 0.66 0.34 0.56 0.44 7.81 5.20E-03 4.96E-02 Ref AFR 
10 65133822 rs7923609 A G 0.65 0.35 0.52 0.48 13.32 2.62E-04 5.01E-03 Ref AFR 
10 79211262 rs603788 G C 0.40 0.60 0.54 0.46 13.37 2.55E-04 4.91E-03 Alt EUR 
10 96541616 rs4244285 G A 0.89 0.11 0.80 0.20 10.69 1.08E-03 1.56E-02 Ref EUR 
10 96748495 rs1934969 A T 0.55 0.45 0.43 0.57 12.53 4.00E-04 6.98E-03 Ref NAT 
10 96798548 rs1934951 C T 0.87 0.13 0.71 0.29 23.13 1.51E-06 6.63E-05 Ref EUR 
10 101605693 rs3740065 A G 0.91 0.09 0.81 0.19 12.67 3.71E-04 6.66E-03 Ref EUR 
11 12159661 rs1994318 C A 0.52 0.48 0.42 0.58 7.88 4.99E-03 4.82E-02 Ref AFR 
11 13293905 rs900145 C T 0.45 0.55 0.35 0.65 9.41 2.16E-03 2.71E-02 Alt EUR 
11 17409572 rs5219 T C 0.20 0.80 0.35 0.65 20.87 4.91E-06 1.87E-04 Alt AFR 
11 27670108 rs10501087 T C 0.81 0.19 0.71 0.29 9.28 2.32E-03 2.86E-02 Ref AFR 
11 27679916 rs6265 C T 0.84 0.16 0.72 0.28 13.90 1.93E-04 3.86E-03 Ref AFR 
11 27684517 rs11030104 A G 0.81 0.19 0.70 0.30 10.17 1.42E-03 1.95E-02 Ref AFR 
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11 27700125 rs7103411 C T 0.20 0.80 0.32 0.68 13.98 1.85E-04 3.75E-03 Alt AFR 
11 32895664 rs10767971 T C 0.32 0.68 0.46 0.54 13.39 2.52E-04 4.87E-03 Alt AFR 
11 35123051 rs1559759 C A 0.87 0.13 0.78 0.22 9.01 2.68E-03 2.99E-02 Ref AFR 
11 61557803 rs102275 T C 0.49 0.51 0.65 0.35 18.18 2.01E-05 6.18E-04 Alt AFR 
11 69462910 rs9344 G A 0.67 0.33 0.48 0.52 29.21 6.49E-08 4.30E-06 Ref AFR 
11 80377052 rs17140547 C T 0.99 0.01 0.92 0.08 13.39 2.53E-04 4.87E-03 Ref AFR 
11 81235150 rs2032381 G T 0.95 0.05 0.84 0.16 17.03 3.67E-05 1.03E-03 Ref AFR 
11 113306765 rs4436578 C T 0.31 0.69 0.22 0.78 7.85 5.09E-03 4.89E-02 Alt EUR 
11 119099906 rs4938642 G C 0.95 0.05 0.88 0.12 8.37 3.81E-03 3.92E-02 Ref AFR 
12 2757769 rs2239128 T C 0.18 0.82 0.31 0.69 14.36 1.51E-04 3.15E-03 Alt EUR 
12 6451590 rs4149570 A C 0.29 0.71 0.40 0.60 8.91 2.83E-03 3.13E-02 Alt AFR 
12 10170727 rs11053548 A G 0.85 0.15 0.71 0.29 17.37 3.07E-05 8.87E-04 Ref AFR 
12 50350953 rs296766 T C 0.02 0.98 0.07 0.93 9.34 2.24E-03 2.78E-02 Alt EUR 
12 51357542 rs12304921 A G 0.85 0.15 0.73 0.27 14.23 1.61E-04 3.34E-03 Ref AFR 
12 54736470 rs4326844 A G 0.25 0.75 0.42 0.58 22.36 2.26E-06 9.58E-05 Alt AFR 
12 58144665 rs2069502 C T 0.79 0.21 0.64 0.36 20.61 5.64E-06 2.09E-04 Ref AFR 
12 77738005 rs6538140 G A 0.30 0.70 0.40 0.60 8.83 2.96E-03 3.24E-02 Alt AFR 
12 88890671 rs995030 A G 0.16 0.84 0.30 0.70 17.19 3.38E-05 9.58E-04 Alt EUR 
12 88953959 rs4474514 G A 0.16 0.84 0.31 0.69 18.18 2.01E-05 6.19E-04 Alt EUR 
13 42505674 rs1900442 T C 0.70 0.30 0.58 0.42 9.66 1.88E-03 2.44E-02 Ref EUR 
13 52566126 rs9535826 T G 0.55 0.45 0.44 0.56 9.54 2.01E-03 2.58E-02 Ref AFR 
14 41523462 rs1959947 A G 0.40 0.60 0.30 0.70 10.17 1.42E-03 1.95E-02 Alt NAT 
14 52781101 rs1353411 G A 0.59 0.41 0.71 0.29 12.44 4.20E-04 7.22E-03 Ref EUR 
14 81598912 rs17111530 T C 0.93 0.07 0.82 0.18 13.27 2.70E-04 5.11E-03 Ref EUR 
14 89594295 rs7158359 A G 0.68 0.32 0.77 0.23 8.71 3.16E-03 3.42E-02 Ref EUR 
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15 48392165 rs1834640 A G 0.78 0.22 0.66 0.34 11.55 6.76E-04 1.06E-02 Ref EUR 
15 51545454 rs12907866 A G 0.72 0.28 0.62 0.38 8.13 4.36E-03 4.38E-02 Ref AFR 
15 71424009 rs12904863 T C 0.96 0.04 0.84 0.16 20.98 4.64E-06 1.78E-04 Ref AFR 
16 14388305 rs1659127 G A 0.76 0.24 0.58 0.42 25.24 5.07E-07 2.68E-05 Ref AFR 
16 31110981 rs7196161 G A 0.43 0.57 0.55 0.45 11.36 7.51E-04 1.16E-02 Alt EUR 
16 53876751 rs12595985 C A 0.97 0.03 0.90 0.10 10.97 9.28E-04 1.37E-02 Ref EUR 
16 55844609 rs2244613 G T 0.20 0.80 0.33 0.67 15.04 1.05E-04 2.32E-03 Alt EUR 
16 84046715 rs11864146 A G 0.85 0.15 0.92 0.08 12.24 4.67E-04 7.86E-03 Ref EUR 
16 84987679 rs2326458 C A 0.38 0.62 0.29 0.71 8.42 3.72E-03 3.83E-02 Alt EUR 
16 88713236 rs4673 A G 0.39 0.61 0.30 0.70 8.24 4.10E-03 4.14E-02 Alt NAT 
16 89985940 rs2228479 G A 0.99 0.01 0.91 0.09 15.73 7.31E-05 1.71E-03 Ref AFR 
16 89986608 rs2228478 A G 0.93 0.07 0.84 0.16 11.46 7.10E-04 1.10E-02 Ref EUR 
17 19437187 rs2252281 T C 0.71 0.29 0.59 0.41 10.65 1.10E-03 1.59E-02 Ref NAT 
18 5978931 rs1539808 C T 0.97 0.03 0.90 0.10 11.48 7.05E-04 1.10E-02 Ref EUR 
18 55808073 rs520210 G A 0.70 0.30 0.57 0.43 12.49 4.08E-04 7.05E-03 Ref AFR 
18 57673799 rs12964056 A G 0.40 0.60 0.30 0.70 8.16 4.29E-03 4.31E-02 Alt EUR 
18 57851097 rs17782313 T C 0.89 0.11 0.76 0.24 16.83 4.09E-05 1.13E-03 Ref NAT 
18 57884750 rs12970134 G A 0.89 0.11 0.75 0.25 19.18 1.19E-05 4.01E-04 Ref AFR 
19 3595923 rs1131882 G A 0.83 0.17 0.72 0.28 10.63 1.11E-03 1.60E-02 Ref AFR 
19 39735106 rs8103142 T C 0.57 0.43 0.74 0.26 26.53 2.60E-07 1.50E-05 Ref NAT 
19 39738787 rs12979860 C T 0.59 0.41 0.75 0.25 25.18 5.23E-07 2.68E-05 Ref NAT 
19 41515702 rs2279345 T C 0.20 0.80 0.33 0.67 13.86 1.97E-04 3.93E-03 Alt AFR 
19 45403412 rs1160985 C T 0.48 0.52 0.61 0.39 12.84 3.40E-04 6.20E-03 Alt AFR 
19 46172278 rs11671664 G A 0.91 0.09 0.79 0.21 18.29 1.90E-05 5.99E-04 Ref AFR 
20 7106289 rs1884302 T C 0.53 0.47 0.63 0.37 9.16 2.48E-03 2.95E-02 Ref EUR 
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20 61981134 rs1044396 G A 0.47 0.53 0.59 0.41 11.68 6.30E-04 1.00E-02 Alt EUR 
22 37469591 rs4820268 G A 0.59 0.41 0.40 0.60 28.75 8.24E-08 5.29E-06 Ref NAT 
22 42526694 rs1065852 G A 0.81 0.19 0.71 0.29 10.28 1.34E-03 1.84E-02 Ref AFR 
22 42528976 rs28360521 C T 0.81 0.19 0.70 0.30 10.17 1.42E-03 1.95E-02 Ref EUR 
Mexico 
1 12267292 rs3397 C T 0.31 0.69 0.54 0.46 28.37 1.00E-07 2.78E-06 Alt EUR 
1 16505320 rs1497406 A G 0.54 0.46 0.33 0.67 23.67 1.14E-06 2.45E-05 Ref AFR 
1 32756439 rs1741981 T C 0.76 0.24 0.56 0.44 21.38 3.77E-06 7.12E-05 Ref EUR 
1 48098406 rs2506991 A G 0.34 0.66 0.49 0.51 11.28 7.82E-04 7.06E-03 Alt EUR 
1 55504650 rs2479409 G A 0.66 0.34 0.50 0.50 13.78 2.05E-04 2.27E-03 Ref NAT 
1 56108604 rs1165472 A G 0.91 0.09 0.80 0.20 10.86 9.83E-04 8.58E-03 Ref NAT 
1 56112774 rs10443215 C T 0.21 0.79 0.34 0.66 10.01 1.56E-03 1.26E-02 Alt NAT 
1 65992625 rs1751492 C T 0.32 0.68 0.56 0.44 30.51 3.33E-08 1.02E-06 Alt EUR 
1 66058513 rs1137101 A G 0.52 0.48 0.37 0.63 13.45 2.45E-04 2.66E-03 Ref EUR 
1 70887099 rs672203 A G 0.83 0.17 0.69 0.31 11.78 5.98E-04 5.64E-03 Ref NAT 
1 71514969 rs7551789 A T 0.95 0.05 0.84 0.16 12.82 3.43E-04 3.58E-03 Ref EUR 
1 88132380 rs983332 G T 0.87 0.13 0.73 0.27 12.74 3.58E-04 3.69E-03 Ref EUR 
1 98348885 rs1801265 G A 0.24 0.76 0.15 0.85 8.90 2.85E-03 2.04E-02 Alt NAT 
1 109818530 rs646776 C T 0.20 0.80 0.12 0.88 7.55 6.00E-03 3.75E-02 Alt NAT 
1 115837709 rs2239622 A G 0.19 0.81 0.36 0.64 16.42 5.06E-05 6.85E-04 Alt AFR 
1 149892872 rs11205277 A G 0.75 0.25 0.63 0.37 7.57 5.95E-03 3.74E-02 Ref AFR 
1 154418879 rs4537545 C T 0.45 0.55 0.59 0.41 11.69 6.28E-04 5.89E-03 Alt AFR 
1 155279482 rs2297480 T G 0.62 0.38 0.50 0.50 7.03 8.01E-03 4.74E-02 Ref EUR 
1 156869714 rs12041331 G A 0.84 0.16 0.72 0.28 9.89 1.66E-03 1.33E-02 Ref EUR 
1 156873727 rs12407843 G A 0.85 0.15 0.75 0.25 7.04 7.96E-03 4.74E-02 Ref EUR 
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1 160743749 rs12068654 T G 0.89 0.11 0.79 0.21 7.93 4.86E-03 3.13E-02 Ref NAT 
1 161915501 rs10918270 G A 0.80 0.20 0.65 0.35 13.71 2.14E-04 2.35E-03 Ref NAT 
1 162085685 rs10494366 G T 0.40 0.60 0.56 0.44 14.00 1.83E-04 2.07E-03 Alt EUR 
1 162112910 rs16857031 C G 0.92 0.08 0.81 0.19 11.18 8.25E-04 7.40E-03 Ref EUR 
1 171091875 rs1795240 A G 0.33 0.67 0.45 0.55 8.07 4.50E-03 2.96E-02 Alt AFR 
1 171254890 rs7877 C T 0.56 0.44 0.73 0.27 17.34 3.12E-05 4.56E-04 Ref NAT 
1 177852580 rs633715 T C 0.93 0.07 0.82 0.18 10.39 1.27E-03 1.07E-02 Ref AFR 
1 177913519 rs10913469 T C 0.93 0.07 0.80 0.20 12.73 3.61E-04 3.71E-03 Ref EUR 
1 186947224 rs10157410 G C 0.76 0.24 0.85 0.15 8.90 2.85E-03 2.04E-02 Ref NAT 
1 201345487 rs12564445 G A 0.83 0.17 0.72 0.28 7.57 5.92E-03 3.72E-02 Ref EUR 
1 203135452 rs16851030 C T 0.89 0.11 0.79 0.21 7.93 4.86E-03 3.13E-02 Ref EUR 
1 206946897 rs1800896 T C 0.68 0.32 0.78 0.22 7.73 5.44E-03 3.47E-02 Ref NAT 
1 218931905 rs12037343 G T 0.93 0.07 0.80 0.20 12.73 3.61E-04 3.71E-03 Ref AFR 
1 230294916 rs2144300 C T 0.48 0.52 0.62 0.38 10.71 1.06E-03 9.18E-03 Alt EUR 
1 232756026 rs10495332 T C 0.95 0.05 0.83 0.17 12.35 4.41E-04 4.36E-03 Ref AFR 
1 233719984 rs11800854 G A 0.98 0.02 0.90 0.10 8.56 3.43E-03 2.38E-02 Ref EUR 
1 241894086 rs10926554 C A 0.88 0.12 0.75 0.25 12.04 5.20E-04 5.00E-03 Ref EUR 
1 247675559 rs7550918 C T 0.34 0.66 0.10 0.90 94.16 2.91E-22 4.86E-20 Alt NAT 
2 21225281 rs1042034 C T 0.27 0.73 0.45 0.55 15.31 9.13E-05 1.13E-03 Alt AFR 
2 21231524 rs676210 G A 0.73 0.27 0.55 0.45 15.31 9.13E-05 1.13E-03 Ref AFR 
2 25131316 rs6545814 A G 0.71 0.29 0.54 0.46 15.22 9.58E-05 1.18E-03 Ref NAT 
2 27730940 rs1260326 T C 0.35 0.65 0.50 0.50 11.28 7.83E-04 7.07E-03 Alt AFR 
2 27741237 rs780094 T C 0.34 0.66 0.51 0.49 15.13 1.00E-04 1.22E-03 Alt AFR 
2 27742603 rs780093 T C 0.34 0.66 0.51 0.49 15.13 1.00E-04 1.22E-03 Alt AFR 
2 31247514 rs9679162 G T 0.37 0.63 0.55 0.45 16.68 4.43E-05 6.17E-04 Alt AFR 
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2 31249427 rs12613732 T G 0.44 0.56 0.64 0.36 22.94 1.67E-06 3.45E-05 Alt NAT 
2 56120853 rs1430193 A T 0.62 0.38 0.34 0.66 42.42 7.35E-11 3.68E-09 Ref EUR 
2 111907691 rs724710 T C 0.53 0.47 0.25 0.75 54.00 2.00E-13 1.46E-11 Ref EUR 
2 113594867 rs16944 A G 0.53 0.47 0.40 0.60 9.42 2.15E-03 1.67E-02 Ref AFR 
2 128018063 rs3738948 A G 0.88 0.12 0.71 0.29 18.40 1.79E-05 2.84E-04 Ref AFR 
2 152981335 rs16830728 G T 0.94 0.06 0.63 0.37 51.14 8.60E-13 5.85E-11 Ref EUR 
2 159899489 rs7582141 G T 0.84 0.16 0.92 0.08 8.06 4.54E-03 2.97E-02 Ref EUR 
2 159899913 rs6432512 C T 0.84 0.16 0.91 0.09 8.06 4.54E-03 2.97E-02 Ref EUR 
2 159936391 rs264588 C A 0.86 0.14 0.93 0.07 9.68 1.86E-03 1.47E-02 Ref EUR 
2 159950865 rs264631 C G 0.86 0.14 0.92 0.08 6.94 8.42E-03 4.94E-02 Ref EUR 
2 165513091 rs10195252 T C 0.83 0.17 0.66 0.34 15.44 8.50E-05 1.07E-03 Ref NAT 
2 166168503 rs2304016 A G 0.99 0.01 0.93 0.07 8.79 3.03E-03 2.15E-02 Ref AFR 
2 166909544 rs3812718 C T 0.66 0.34 0.53 0.47 9.07 2.60E-03 1.89E-02 Ref AFR 
2 170010985 rs2075252 T C 0.22 0.78 0.39 0.61 15.89 6.73E-05 8.69E-04 Alt AFR 
2 174504924 rs13028485 G A 0.94 0.06 0.84 0.16 8.53 3.49E-03 2.39E-02 Ref EUR 
2 206652300 rs10932125 C G 0.69 0.31 0.56 0.44 8.13 4.36E-03 2.88E-02 Ref AFR 
2 216205167 rs16853826 G A 0.80 0.20 0.69 0.31 7.23 7.18E-03 4.36E-02 Ref EUR 
2 234529643 rs6431558 C T 0.59 0.41 0.47 0.53 8.03 4.60E-03 3.00E-02 Ref EUR 
2 234579892 rs3806598 A C 0.95 0.05 0.86 0.14 7.82 5.16E-03 3.30E-02 Ref EUR 
2 234668570 rs887829 C T 0.63 0.37 0.80 0.20 21.29 3.96E-06 7.46E-05 Ref NAT 
2 234669144 rs4148323 G A 0.98 0.02 0.88 0.12 10.87 9.75E-04 8.53E-03 Ref AFR 
3 12267648 rs7616006 A G 0.73 0.27 0.56 0.44 15.37 8.86E-05 1.10E-03 Ref NAT 
3 22473729 rs17011371 A G 0.88 0.13 0.94 0.06 12.24 4.68E-04 4.54E-03 Ref NAT 
3 37574024 rs267567 G A 0.27 0.73 0.42 0.58 10.43 1.24E-03 1.05E-02 Alt NAT 
3 38442490 rs2070488 G A 0.74 0.26 0.62 0.38 8.46 3.62E-03 2.48E-02 Ref AFR 
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3 45300605 rs33794 A G 0.79 0.21 0.67 0.33 8.97 2.75E-03 1.98E-02 Ref NAT 
3 60001825 rs9311745 T C 0.90 0.10 0.77 0.23 11.41 7.29E-04 6.67E-03 Ref EUR 
3 86916882 rs7642134 A G 0.59 0.41 0.46 0.54 9.09 2.57E-03 1.88E-02 Ref AFR 
3 119525497 rs7643645 A G 0.41 0.59 0.61 0.39 20.51 5.92E-06 1.05E-04 Alt NAT 
3 119537291 rs3814058 T C 0.84 0.16 0.66 0.34 16.95 3.84E-05 5.48E-04 Ref EUR 
3 119631814 rs6438552 A G 0.70 0.30 0.50 0.50 19.53 9.90E-06 1.67E-04 Ref EUR 
3 119813282 rs334558 A G 0.73 0.27 0.49 0.51 30.04 4.24E-08 1.27E-06 Ref EUR 
3 132610752 rs6439371 G A 0.52 0.48 0.30 0.70 31.48 2.02E-08 6.48E-07 Ref AFR 
3 152672779 rs6785504 G T 0.38 0.62 0.54 0.46 12.58 3.91E-04 3.92E-03 Alt AFR 
3 156798473 rs1482853 C A 0.65 0.35 0.53 0.47 7.06 7.89E-03 4.70E-02 Ref AFR 
3 170725542 rs10513686 G A 0.80 0.20 0.91 0.09 15.54 8.08E-05 1.02E-03 Ref NAT 
3 184010048 rs3914188 G C 0.20 0.80 0.32 0.68 10.24 1.37E-03 1.14E-02 Alt EUR 
3 187456709 rs3733017 T G 0.98 0.02 0.88 0.12 12.76 3.54E-04 3.66E-03 Ref EUR 
4 2906707 rs4961 G T 0.77 0.23 0.65 0.35 7.79 5.25E-03 3.35E-02 Ref AFR 
4 8503359 rs1949733 A G 0.51 0.49 0.33 0.67 18.75 1.49E-05 2.41E-04 Ref NAT 
4 9926967 rs13129697 T G 0.46 0.54 0.62 0.38 13.23 2.76E-04 2.94E-03 Alt AFR 
4 15964863 rs4698433 G T 0.45 0.55 0.66 0.34 27.46 1.61E-07 4.28E-06 Alt EUR 
4 16893893 rs1483012 G A 0.58 0.42 0.69 0.31 8.30 3.97E-03 2.69E-02 Ref NAT 
4 16908004 rs6819013 A G 0.70 0.30 0.80 0.20 8.40 3.75E-03 2.55E-02 Ref NAT 
4 38139024 rs9852 C T 0.89 0.11 0.76 0.24 12.30 4.52E-04 4.44E-03 Ref AFR 
4 88213808 rs6834314 A G 0.87 0.13 0.71 0.29 15.21 9.64E-05 1.18E-03 Ref AFR 
4 100163873 rs2201728 G A 0.44 0.56 0.71 0.29 43.27 4.78E-11 2.47E-09 Alt EUR 
4 100239319 rs1229984 T C 0.09 0.91 0.39 0.61 49.92 1.60E-12 1.03E-10 Alt AFR 
4 139493398 rs1450439 A G 0.71 0.29 0.86 0.14 23.34 1.36E-06 2.86E-05 Ref NAT 
4 146794621 rs4547811 T C 0.44 0.56 0.71 0.29 46.57 8.84E-12 5.03E-10 Alt NAT 
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4 146875551 rs723794 G T 0.31 0.69 0.43 0.57 7.17 7.40E-03 4.48E-02 Alt EUR 
4 154609523 rs1816702 T C 0.13 0.88 0.06 0.94 12.24 4.68E-04 4.54E-03 Alt NAT 
4 155514879 rs13109457 G A 0.75 0.25 0.64 0.36 7.57 5.95E-03 3.74E-02 Ref EUR 
4 175071602 rs12507634 A G 0.44 0.56 0.72 0.28 50.09 1.47E-12 9.52E-11 Alt EUR 
4 182197947 rs1454694 T C 0.89 0.11 0.79 0.21 7.93 4.86E-03 3.13E-02 Ref AFR 
5 4831601 rs816475 T C 0.73 0.27 0.83 0.17 7.90 4.93E-03 3.17E-02 Ref NAT 
5 8652870 rs200113 T C 0.89 0.11 0.80 0.20 6.95 8.38E-03 4.94E-02 Ref AFR 
5 40679567 rs4133101 T C 0.35 0.65 0.47 0.53 8.02 4.63E-03 3.01E-02 Alt AFR 
5 57214817 rs10041935 A C 0.82 0.18 0.68 0.32 12.79 3.48E-04 3.61E-03 Ref AFR 
5 58713680 rs2547917 G A 0.92 0.08 0.79 0.21 13.57 2.30E-04 2.52E-03 Ref AFR 
5 59736773 rs702553 A T 0.73 0.27 0.53 0.47 21.21 4.12E-06 7.69E-05 Ref EUR 
5 63250851 rs1364043 T G 0.78 0.22 0.62 0.38 14.58 1.34E-04 1.59E-03 Ref AFR 
5 63258565 rs6295 C G 0.58 0.42 0.42 0.58 14.20 1.64E-04 1.90E-03 Ref AFR 
5 63261329 rs10042486 C T 0.55 0.45 0.37 0.63 17.79 2.47E-05 3.70E-04 Ref EUR 
5 73276903 rs6894385 A C 0.91 0.09 0.78 0.22 12.88 3.31E-04 3.46E-03 Ref AFR 
5 74642855 rs17244841 A T 0.96 0.04 0.99 0.01 16.13 5.93E-05 7.76E-04 Ref NAT 
5 74655498 rs17238540 T G 0.96 0.04 0.99 0.01 16.13 5.93E-05 7.76E-04 Ref NAT 
5 75514986 rs11960832 C T 0.48 0.52 0.65 0.35 16.59 4.65E-05 6.41E-04 Alt AFR 
5 76781471 rs163030 A C 0.27 0.73 0.44 0.56 15.37 8.86E-05 1.10E-03 Alt AFR 
5 88183651 rs17560407 A G 0.88 0.13 0.77 0.23 7.53 6.05E-03 3.78E-02 Ref AFR 
5 93810208 rs6869388 T C 0.79 0.21 0.88 0.12 10.87 9.75E-04 8.53E-03 Ref NAT 
5 137707315 rs757647 G A 0.74 0.26 0.57 0.43 15.43 8.56E-05 1.07E-03 Ref EUR 
5 148206473 rs1042714 G C 0.14 0.86 0.25 0.75 8.17 4.27E-03 2.85E-02 Alt NAT 
6 2235633 rs9378688 G A 0.96 0.04 0.83 0.17 14.58 1.34E-04 1.59E-03 Ref AFR 
6 7102084 rs675209 T C 0.48 0.52 0.63 0.37 13.45 2.45E-04 2.66E-03 Alt EUR 
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6 7801112 rs6923462 T C 0.87 0.13 0.94 0.06 10.80 1.02E-03 8.80E-03 Ref NAT 
6 18139802 rs12201199 A T 0.89 0.11 0.95 0.05 11.19 8.22E-04 7.39E-03 Ref NAT 
6 26233387 rs10946808 A G 0.69 0.31 0.48 0.52 21.15 4.26E-06 7.87E-05 Ref AFR 
6 31093587 rs3815087 G A 0.81 0.19 0.70 0.30 7.34 6.76E-03 4.13E-02 Ref EUR 
6 31253444 rs9461684 C T 0.80 0.20 0.89 0.11 9.70 1.84E-03 1.46E-02 Ref NAT 
6 31431691 rs2255221 G T 0.87 0.13 0.93 0.07 7.65 5.68E-03 3.59E-02 Ref NAT 
6 32975014 rs399604 T C 0.69 0.31 0.51 0.49 15.14 9.98E-05 1.22E-03 Ref AFR 
6 33055538 rs9277554 C T 0.77 0.23 0.54 0.46 26.44 2.71E-07 6.91E-06 Ref EUR 
6 33283766 rs3130100 T C 0.42 0.58 0.56 0.44 9.14 2.50E-03 1.88E-02 Alt AFR 
6 35369806 rs1883322 C T 0.12 0.88 0.31 0.69 22.73 1.87E-06 3.80E-05 Alt NAT 
6 35395010 rs3734254 C T 0.12 0.88 0.29 0.71 18.40 1.79E-05 2.84E-04 Alt NAT 
6 35402785 rs4713858 A G 0.06 0.94 0.20 0.80 15.64 7.67E-05 9.73E-04 Alt AFR 
6 39325078 rs20455 A G 0.68 0.32 0.54 0.46 10.19 1.41E-03 1.17E-02 Ref EUR 
6 45095163 rs9395066 A C 0.67 0.33 0.45 0.55 26.60 2.50E-07 6.43E-06 Ref AFR 
6 73749861 rs9351963 A C 0.67 0.33 0.78 0.22 8.96 2.76E-03 1.98E-02 Ref EUR 
6 110777962 rs6907567 A G 0.74 0.26 0.63 0.37 7.50 6.17E-03 3.85E-02 Ref EUR 
6 121748542 rs11154022 A G 0.23 0.77 0.44 0.56 24.80 6.37E-07 1.44E-05 Alt AFR 
6 122146034 rs9398652 C A 0.91 0.09 0.74 0.26 18.01 2.20E-05 3.34E-04 Ref EUR 
6 126964510 rs4273712 A G 0.47 0.53 0.62 0.38 11.94 5.50E-04 5.23E-03 Alt NAT 
6 130008445 rs12660691 A C 0.73 0.27 0.84 0.16 9.63 1.92E-03 1.51E-02 Ref EUR 
6 135419018 rs9399137 T C 0.86 0.14 0.74 0.26 10.25 1.36E-03 1.14E-02 Ref AFR 
6 137673302 rs6928289 G A 0.54 0.46 0.42 0.58 7.21 7.26E-03 4.41E-02 Ref EUR 
6 142767633 rs3748069 A G 0.76 0.24 0.63 0.37 8.61 3.35E-03 2.34E-02 Ref NAT 
6 147680359 rs9390459 A G 0.44 0.56 0.60 0.40 14.37 1.50E-04 1.75E-03 Alt AFR 
6 154487421 rs2281617 C T 0.90 0.10 0.68 0.32 29.80 4.78E-08 1.42E-06 Ref EUR 
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6 155929801 rs35229355 C T 0.95 0.05 0.76 0.24 25.08 5.51E-07 1.27E-05 Ref EUR 
6 160551204 rs683369 G C 0.05 0.95 0.17 0.83 14.05 1.78E-04 2.02E-03 Alt AFR 
6 160560845 rs628031 A G 0.12 0.88 0.32 0.68 24.26 8.43E-07 1.85E-05 Alt NAT 
6 166579270 rs2305089 C T 0.45 0.55 0.58 0.42 8.20 4.19E-03 2.81E-02 Alt EUR 
7 17284577 rs4410790 T C 0.63 0.37 0.51 0.49 8.00 4.67E-03 3.03E-02 Ref NAT 
7 28004198 rs4722750 C T 0.96 0.04 0.86 0.14 9.77 1.78E-03 1.42E-02 Ref EUR 
7 30699972 rs2270007 G C 0.11 0.89 0.30 0.70 23.05 1.58E-06 3.28E-05 Alt AFR 
7 33060946 rs3750117 A G 0.30 0.70 0.42 0.58 8.20 4.19E-03 2.81E-02 Alt AFR 
7 80236014 rs13236689 T G 0.67 0.33 0.49 0.51 16.54 4.78E-05 6.55E-04 Ref EUR 
7 99361466 rs2242480 C T 0.61 0.39 0.79 0.21 24.83 6.26E-07 1.42E-05 Ref EUR 
7 101809851 rs365836 A G 0.70 0.30 0.82 0.18 13.57 2.30E-04 2.52E-03 Ref NAT 
7 127164958 rs6467136 A G 0.54 0.46 0.35 0.65 21.65 3.28E-06 6.29E-05 Ref EUR 
7 154509324 rs12666280 T C 0.45 0.55 0.56 0.44 7.14 7.53E-03 4.52E-02 Alt EUR 
8 1244224 rs17669535 C G 0.96 0.04 0.88 0.12 7.55 6.00E-03 3.75E-02 Ref AFR 
8 2740502 rs641525 T G 0.91 0.09 0.77 0.23 14.11 1.73E-04 1.97E-03 Ref EUR 
8 4078353 rs2407314 G C 0.46 0.54 0.58 0.42 7.21 7.26E-03 4.41E-02 Alt AFR 
8 23059324 rs20575 C G 0.40 0.60 0.27 0.73 10.07 1.51E-03 1.23E-02 Alt NAT 
8 69389217 rs1517114 C G 0.32 0.68 0.21 0.79 9.20 2.42E-03 1.84E-02 Alt NAT 
8 118184783 rs13266634 C T 0.76 0.24 0.63 0.37 8.61 3.35E-03 2.34E-02 Ref AFR 
8 122275906 rs7834765 G T 0.45 0.55 0.62 0.38 16.00 6.32E-05 8.18E-04 Alt NAT 
8 126486409 rs17321515 A G 0.63 0.38 0.49 0.51 10.13 1.45E-03 1.20E-02 Ref EUR 
8 126490972 rs2954029 A T 0.64 0.36 0.50 0.50 9.03 2.65E-03 1.91E-02 Ref AFR 
8 129072161 rs2648875 G A 0.45 0.55 0.60 0.40 11.77 6.03E-04 5.68E-03 Alt NAT 
8 139884509 rs6988229 C T 0.82 0.18 0.92 0.08 18.33 1.86E-05 2.93E-04 Ref NAT 
9 4744743 rs409801 T C 0.66 0.34 0.47 0.53 19.61 9.51E-06 1.61E-04 Ref AFR 
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9 4763176 rs385893 T C 0.61 0.39 0.35 0.65 37.32 1.00E-09 4.21E-08 Ref AFR 
9 4814948 rs13300663 G C 0.86 0.14 0.69 0.31 17.60 2.73E-05 4.05E-04 Ref AFR 
9 27536397 rs2814707 C T 0.95 0.05 0.86 0.14 7.82 5.16E-03 3.30E-02 Ref NAT 
9 27543281 rs3849942 T C 0.05 0.95 0.15 0.85 8.90 2.85E-03 2.04E-02 Alt NAT 
9 35141705 rs10972341 A G 0.27 0.73 0.55 0.45 40.86 1.64E-10 7.73E-09 Alt AFR 
9 35648950 rs3138083 A G 0.52 0.48 0.35 0.65 15.11 1.01E-04 1.23E-03 Ref AFR 
9 86920236 rs7867504 T C 0.31 0.69 0.49 0.51 15.14 9.98E-05 1.22E-03 Alt AFR 
9 93636664 rs290227 G A 0.74 0.26 0.57 0.43 15.43 8.56E-05 1.07E-03 Ref EUR 
9 104223233 rs10819937 C G 0.51 0.49 0.29 0.71 29.80 4.78E-08 1.42E-06 Ref NAT 
9 111455575 rs10512385 A G 0.96 0.04 0.88 0.12 8.64 3.28E-03 2.30E-02 Ref NAT 
9 112521126 rs4978848 G C 0.27 0.73 0.41 0.59 10.49 1.20E-03 1.02E-02 Alt NAT 
9 114293634 rs10980926 A G 0.63 0.37 0.49 0.51 10.13 1.46E-03 1.20E-02 Ref AFR 
9 114301585 rs10441737 C T 0.63 0.37 0.48 0.52 11.29 7.78E-04 7.04E-03 Ref NAT 
9 119249339 rs7852872 C G 0.48 0.52 0.60 0.40 8.34 3.87E-03 2.63E-02 Alt NAT 
9 124565820 rs10760187 T C 0.59 0.41 0.33 0.67 40.97 1.55E-10 7.34E-09 Ref EUR 
9 125137695 rs10306135 A T 0.85 0.15 0.94 0.06 16.13 5.90E-05 7.76E-04 Ref NAT 
9 132501881 rs2302821 A C 0.89 0.11 0.66 0.34 31.17 2.37E-08 7.48E-07 Ref EUR 
10 26734587 rs2992257 C T 0.83 0.17 0.62 0.38 22.53 2.07E-06 4.16E-05 Ref AFR 
10 30834632 rs11008099 G A 0.96 0.04 0.84 0.16 13.33 2.61E-04 2.81E-03 Ref AFR 
10 52010708 rs10508921 C T 0.91 0.09 0.78 0.22 13.21 2.78E-04 2.96E-03 Ref EUR 
10 64963449 rs4379723 T C 0.70 0.30 0.55 0.45 10.25 1.37E-03 1.14E-02 Ref AFR 
10 65027610 rs10761731 A T 0.72 0.28 0.60 0.40 7.33 6.77E-03 4.13E-02 Ref AFR 
10 65104500 rs7896518 A G 0.72 0.28 0.60 0.40 7.33 6.77E-03 4.13E-02 Ref AFR 
10 65133822 rs7923609 A G 0.70 0.30 0.57 0.43 8.16 4.28E-03 2.86E-02 Ref AFR 
10 90826779 rs1937332 A G 0.52 0.48 0.67 0.33 12.79 3.48E-04 3.61E-03 Ref NAT 
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10 94839642 rs2068888 G A 0.54 0.46 0.35 0.65 19.74 8.87E-06 1.52E-04 Ref AFR 
10 96541616 rs4244285 G A 0.88 0.13 0.76 0.24 9.58 1.97E-03 1.54E-02 Ref EUR 
10 96748495 rs1934969 A T 0.63 0.38 0.47 0.53 12.55 3.96E-04 3.97E-03 Ref NAT 
10 96798548 rs1934951 C T 0.84 0.16 0.68 0.32 15.83 6.95E-05 8.93E-04 Ref EUR 
10 101605693 rs3740065 A G 0.90 0.10 0.78 0.22 10.29 1.34E-03 1.12E-02 Ref EUR 
10 101795361 rs10883437 T A 0.47 0.53 0.64 0.36 18.13 2.06E-05 3.18E-04 Alt AFR 
10 112836503 rs1800544 G C 0.34 0.66 0.48 0.52 10.15 1.45E-03 1.19E-02 Alt EUR 
11 243268 rs505404 T G 0.73 0.27 0.89 0.11 35.37 2.73E-09 1.04E-07 Ref NAT 
11 12159661 rs1994318 C A 0.65 0.35 0.45 0.55 21.38 3.77E-06 7.12E-05 Ref AFR 
11 20659757 rs2298826 G A 0.76 0.24 0.60 0.40 13.04 3.05E-04 3.21E-03 Ref AFR 
11 27670108 rs10501087 T C 0.80 0.20 0.65 0.35 12.37 4.36E-04 4.33E-03 Ref AFR 
11 27679916 rs6265 C T 0.80 0.20 0.65 0.35 13.71 2.14E-04 2.35E-03 Ref AFR 
11 27684517 rs11030104 A G 0.80 0.20 0.63 0.37 16.27 5.48E-05 7.40E-04 Ref AFR 
11 27700125 rs7103411 C T 0.20 0.80 0.38 0.62 19.05 1.28E-05 2.09E-04 Alt AFR 
11 32895664 rs10767971 T C 0.32 0.68 0.49 0.51 15.13 1.00E-04 1.22E-03 Alt AFR 
11 35123051 rs1559759 C A 0.91 0.09 0.75 0.25 19.76 8.77E-06 1.50E-04 Ref AFR 
11 61557803 rs102275 T C 0.29 0.71 0.65 0.35 72.52 1.66E-17 1.84E-15 Alt AFR 
11 64048912 rs477895 C T 0.13 0.87 0.23 0.77 7.36 6.68E-03 4.09E-02 Alt EUR 
11 69462910 rs9344 G A 0.67 0.33 0.46 0.54 22.92 1.69E-06 3.47E-05 Ref AFR 
11 81235150 rs2032381 G T 0.93 0.07 0.78 0.22 16.50 4.86E-05 6.60E-04 Ref AFR 
11 112026156 rs5744247 G C 0.90 0.10 0.71 0.29 21.90 2.88E-06 5.62E-05 Ref AFR 
11 113280274 rs2734842 G C 0.31 0.69 0.43 0.57 7.17 7.40E-03 4.48E-02 Alt EUR 
11 113281776 rs2734841 A C 0.29 0.71 0.42 0.58 9.26 2.35E-03 1.79E-02 Alt EUR 
11 113282295 rs1124493 T G 0.30 0.70 0.42 0.58 8.20 4.19E-03 2.81E-02 Alt EUR 
11 113283477 rs6275 A G 0.29 0.71 0.42 0.58 9.26 2.35E-03 1.79E-02 Alt EUR 
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11 116652207 rs12286037 C T 0.90 0.10 0.96 0.04 8.57 3.42E-03 2.38E-02 Ref NAT 
11 131807171 rs12098973 A G 0.88 0.12 0.77 0.23 8.74 3.12E-03 2.20E-02 Ref EUR 
12 988558 rs880054 C T 0.45 0.55 0.33 0.67 9.07 2.60E-03 1.88E-02 Alt NAT 
12 2757769 rs2239128 T C 0.11 0.89 0.33 0.67 27.78 1.36E-07 3.69E-06 Alt EUR 
12 6291093 rs7342306 G A 0.77 0.23 0.64 0.36 10.89 9.65E-04 8.47E-03 Ref AFR 
12 10170727 rs11053548 A G 0.91 0.09 0.73 0.27 20.80 5.09E-06 9.22E-05 Ref AFR 
12 11547532 rs2900174 A G 0.84 0.16 0.92 0.08 10.85 9.89E-04 8.62E-03 Ref EUR 
12 11855624 rs2187642 A C 0.28 0.72 0.49 0.51 22.79 1.81E-06 3.70E-05 Alt EUR 
12 20860093 rs3794271 G A 0.56 0.44 0.31 0.69 40.16 2.34E-10 1.08E-08 Ref AFR 
12 21283322 rs4149015 G A 0.98 0.02 0.90 0.10 8.56 3.43E-03 2.38E-02 Ref AFR 
12 21327740 rs4149036 C A 0.88 0.13 0.64 0.36 32.31 1.31E-08 4.36E-07 Ref EUR 
12 21329738 rs2306283 A G 0.63 0.38 0.39 0.61 29.54 5.48E-08 1.60E-06 Ref EUR 
12 21377559 rs4149080 G C 0.90 0.10 0.70 0.30 23.39 1.32E-06 2.80E-05 Ref EUR 
12 21378021 rs4149081 G A 0.90 0.10 0.70 0.30 23.39 1.32E-06 2.80E-05 Ref EUR 
12 51357542 rs12304921 A G 0.87 0.13 0.67 0.33 22.15 2.52E-06 5.01E-05 Ref AFR 
12 54736470 rs4326844 A G 0.18 0.82 0.44 0.56 36.56 1.48E-09 6.03E-08 Alt AFR 
12 58144665 rs2069502 C T 0.70 0.30 0.55 0.45 11.38 7.42E-04 6.78E-03 Ref AFR 
12 65534624 rs6581612 C A 0.27 0.73 0.13 0.87 21.98 2.76E-06 5.43E-05 Alt NAT 
12 88890671 rs995030 A G 0.13 0.88 0.29 0.71 16.77 4.23E-05 5.95E-04 Alt EUR 
12 88953959 rs4474514 G A 0.13 0.88 0.30 0.70 18.11 2.08E-05 3.20E-04 Alt EUR 
12 112190438 rs6490294 C A 0.63 0.37 0.44 0.56 19.84 8.41E-06 1.45E-04 Ref EUR 
12 112817783 rs11066280 T A 0.99 0.01 0.90 0.10 11.13 8.51E-04 7.55E-03 Ref AFR 
12 117327592 rs7294919 T C 0.90 0.10 0.80 0.20 7.16 7.46E-03 4.50E-02 Ref EUR 
13 47469940 rs6313 G A 0.67 0.33 0.51 0.49 12.51 4.04E-04 4.04E-03 Ref AFR 
13 47471478 rs6311 C T 0.67 0.33 0.51 0.49 12.51 4.04E-04 4.04E-03 Ref AFR 
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13 52566126 rs9535826 T G 0.59 0.41 0.44 0.56 11.42 7.27E-04 6.67E-03 Ref AFR 
14 23977010 rs223116 A G 0.45 0.55 0.33 0.67 7.88 5.00E-03 3.21E-02 Alt EUR 
14 48015982 rs1160351 A C 0.80 0.20 0.48 0.52 50.05 1.50E-12 9.70E-11 Ref AFR 
14 81598912 rs17111530 T C 0.94 0.06 0.79 0.21 15.64 7.67E-05 9.73E-04 Ref EUR 
14 92427222 rs7153027 A C 0.79 0.21 0.67 0.33 7.97 4.75E-03 3.07E-02 Ref NAT 
14 105263608 rs2494752 A G 0.27 0.73 0.44 0.56 16.73 4.31E-05 6.02E-04 Alt EUR 
15 29731444 rs11856574 G A 0.84 0.16 0.73 0.27 8.85 2.93E-03 2.09E-02 Ref EUR 
15 48392165 rs1834640 A G 0.66 0.34 0.51 0.49 11.28 7.82E-04 7.06E-03 Ref EUR 
15 51545454 rs12907866 A G 0.73 0.27 0.58 0.42 11.56 6.73E-04 6.25E-03 Ref AFR 
15 51631279 rs7176005 C T 0.88 0.12 0.78 0.22 7.73 5.44E-03 3.47E-02 Ref EUR 
15 71424009 rs12904863 T C 0.95 0.05 0.78 0.22 20.16 7.12E-06 1.25E-04 Ref AFR 
15 100786271 rs4533267 A G 0.38 0.62 0.23 0.77 17.83 2.41E-05 3.62E-04 Alt NAT 
16 14388305 rs1659127 G A 0.77 0.23 0.55 0.45 23.06 1.57E-06 3.27E-05 Ref AFR 
16 23634026 rs420259 A G 0.77 0.23 0.65 0.35 7.71 5.49E-03 3.49E-02 Ref EUR 
16 27375787 rs8832 A G 0.40 0.60 0.52 0.48 7.04 7.98E-03 4.74E-02 Alt EUR 
16 30918487 rs11649653 C G 0.54 0.46 0.34 0.66 23.67 1.14E-06 2.45E-05 Ref AFR 
16 31048079 rs10871454 C T 0.52 0.48 0.34 0.66 18.32 1.87E-05 2.94E-04 Ref AFR 
16 31102321 rs7294 C T 0.65 0.35 0.80 0.20 17.42 2.99E-05 4.42E-04 Ref NAT 
16 31103796 rs2359612 A G 0.47 0.53 0.66 0.34 19.95 7.96E-06 1.38E-04 Alt AFR 
16 31104509 rs8050894 C G 0.49 0.51 0.33 0.67 15.63 7.71E-05 9.77E-04 Alt NAT 
16 31104878 rs9934438 G A 0.53 0.47 0.35 0.65 19.95 7.96E-06 1.38E-04 Ref AFR 
16 31107689 rs9923231 C T 0.53 0.47 0.35 0.65 19.95 7.96E-06 1.38E-04 Ref AFR 
16 31110981 rs7196161 G A 0.48 0.52 0.67 0.33 20.41 6.24E-06 1.11E-04 Alt EUR 
16 53876751 rs12595985 C A 0.92 0.08 0.83 0.17 7.90 4.93E-03 3.17E-02 Ref EUR 
16 55793695 rs3785161 A C 0.87 0.13 0.77 0.23 7.36 6.68E-03 4.09E-02 Ref AFR 
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16 56994894 rs4783961 G A 0.48 0.52 0.67 0.33 20.41 6.24E-06 1.11E-04 Alt EUR 
16 75167579 rs7195303 G A 0.05 0.95 0.15 0.85 11.61 6.54E-04 6.11E-03 Alt AFR 
16 84046715 rs11864146 A G 0.82 0.18 0.93 0.07 23.42 1.30E-06 2.76E-05 Ref EUR 
16 85961562 rs17444745 G A 0.92 0.08 0.83 0.17 7.90 4.93E-03 3.17E-02 Ref AFR 
16 89985940 rs2228479 G A 0.95 0.05 0.87 0.13 8.21 4.17E-03 2.81E-02 Ref AFR 
17 18232096 rs1979277 G A 0.69 0.31 0.82 0.18 15.32 9.09E-05 1.13E-03 Ref NAT 
17 19437187 rs2252281 T C 0.77 0.23 0.63 0.37 9.72 1.83E-03 1.45E-02 Ref NAT 
17 19804247 rs397969 T C 0.59 0.41 0.72 0.28 12.74 3.58E-04 3.69E-03 Ref NAT 
17 48712087 rs4793665 C T 0.38 0.62 0.27 0.73 7.71 5.50E-03 3.50E-02 Alt NAT 
17 48768486 rs1051640 A G 0.96 0.04 0.88 0.12 7.55 6.00E-03 3.75E-02 Ref NAT 
17 49960309 rs967676 T C 0.77 0.23 0.65 0.35 7.71 5.49E-03 3.49E-02 Ref AFR 
17 78324259 rs12051723 G T 0.95 0.05 0.81 0.19 16.11 5.99E-05 7.83E-04 Ref AFR 
18 5978931 rs1539808 C T 0.98 0.02 0.86 0.14 14.55 1.37E-04 1.61E-03 Ref EUR 
18 29038123 rs1941184 A C 0.65 0.35 0.75 0.25 7.04 7.96E-03 4.74E-02 Ref NAT 
18 55816791 rs4149601 G A 0.88 0.12 0.69 0.31 22.73 1.87E-06 3.80E-05 Ref NAT 
19 10000322 rs1862471 C G 0.43 0.57 0.61 0.39 17.36 3.09E-05 4.52E-04 Alt EUR 
19 10395683 rs5498 A G 0.38 0.63 0.64 0.36 39.23 3.77E-10 1.69E-08 Alt EUR 
19 10397403 rs3093030 C T 0.38 0.63 0.67 0.33 51.17 8.46E-13 5.76E-11 Alt EUR 
19 29736342 rs11083866 G A 0.74 0.26 0.60 0.40 10.56 1.16E-03 9.89E-03 Ref AFR 
19 39735106 rs8103142 T C 0.54 0.46 0.81 0.19 57.46 3.44E-14 2.68E-12 Ref NAT 
19 39738787 rs12979860 C T 0.54 0.46 0.81 0.19 62.82 2.26E-15 2.03E-13 Ref NAT 
19 41515702 rs2279345 T C 0.21 0.79 0.33 0.67 7.97 4.75E-03 3.07E-02 Alt AFR 
19 45403412 rs1160985 C T 0.49 0.51 0.63 0.37 10.89 9.65E-04 8.47E-03 Alt AFR 
19 45923653 rs11615 A G 0.26 0.74 0.42 0.58 12.88 3.32E-04 3.47E-03 Alt AFR 
19 46172278 rs11671664 G A 0.93 0.07 0.70 0.30 31.48 2.02E-08 6.48E-07 Ref AFR 
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19 49206172 rs516246 C T 0.68 0.32 0.78 0.22 7.73 5.44E-03 3.47E-02 Ref NAT 
19 49206985 rs602662 G A 0.66 0.34 0.77 0.23 7.36 6.68E-03 4.09E-02 Ref NAT 
20 17122593 rs852069 A G 0.44 0.56 0.59 0.41 11.62 6.51E-04 6.09E-03 Alt EUR 
20 45288453 rs6066043 G A 0.76 0.24 0.62 0.38 9.63 1.91E-03 1.51E-02 Ref AFR 
20 60791404 rs3787429 C T 0.44 0.56 0.60 0.40 14.37 1.50E-04 1.75E-03 Alt AFR 
20 61981104 rs1044397 C T 0.43 0.57 0.58 0.42 11.56 6.73E-04 6.25E-03 Alt EUR 
20 61981134 rs1044396 G A 0.44 0.56 0.65 0.35 24.98 5.78E-07 1.33E-05 Alt EUR 
21 28217320 rs402007 C G 0.60 0.40 0.42 0.58 16.94 3.85E-05 5.48E-04 Ref NAT 
22 19951207 rs4818 C G 0.76 0.24 0.62 0.38 10.71 1.06E-03 9.18E-03 Ref AFR 
22 19952132 rs4646316 C T 0.84 0.16 0.69 0.31 13.13 2.91E-04 3.07E-03 Ref AFR 
22 42526694 rs1065852 G A 0.85 0.15 0.61 0.39 31.54 1.95E-08 6.30E-07 Ref AFR 
22 42528976 rs28360521 C T 0.85 0.15 0.61 0.39 31.54 1.95E-08 6.30E-07 Ref EUR 
22 44324727 rs738409 C G 0.45 0.55 0.68 0.32 32.30 1.32E-08 4.39E-07 Alt NAT 
22 44333694 rs2896019 T G 0.49 0.51 0.70 0.30 24.93 5.95E-07 1.37E-05 Alt NAT 
Peru 
1 11046855 rs9430161 G T 0.94 0.06 0.87 0.13 6.32 1.20E-02 3.96E-02 Ref NAT 
1 11854476 rs1801131 T G 0.92 0.08 0.77 0.23 20.80 5.11E-06 3.12E-05 Ref AFR 
1 12267292 rs3397 C T 0.16 0.84 0.62 0.38 147.68 5.57E-34 2.60E-32 Alt EUR 
1 16505320 rs1497406 A G 0.74 0.26 0.26 0.74 201.19 1.15E-45 7.90E-44 Ref AFR 
1 29174946 rs529520 A C 0.45 0.55 0.24 0.76 44.76 2.23E-11 2.62E-10 Alt NAT 
1 29175373 rs581111 A G 0.07 0.93 0.15 0.85 7.93 4.87E-03 1.75E-02 Alt NAT 
1 29190138 rs4654327 G A 0.20 0.80 0.29 0.71 7.25 7.08E-03 2.45E-02 Alt NAT 
1 32756439 rs1741981 T C 0.89 0.11 0.51 0.49 96.43 9.25E-23 2.54E-21 Ref EUR 
1 40433771 rs3103778 A G 0.34 0.66 0.44 0.56 6.90 8.64E-03 2.95E-02 Alt NAT 
1 48098406 rs2506991 A G 0.38 0.62 0.52 0.48 12.46 4.15E-04 1.86E-03 Alt EUR 
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1 55504650 rs2479409 G A 0.79 0.21 0.62 0.38 19.65 9.32E-06 5.49E-05 Ref NAT 
1 56108604 rs1165472 A G 0.93 0.07 0.84 0.16 9.91 1.65E-03 6.61E-03 Ref NAT 
1 56112774 rs10443215 C T 0.15 0.85 0.25 0.75 8.10 4.44E-03 1.60E-02 Alt NAT 
1 63049593 rs1748195 C G 0.45 0.55 0.73 0.27 68.67 1.17E-16 2.17E-15 Alt AFR 
1 65992625 rs1751492 C T 0.26 0.74 0.72 0.28 178.91 8.38E-41 4.94E-39 Alt EUR 
1 66089782 rs6700896 C T 0.39 0.61 0.23 0.77 26.09 3.26E-07 2.37E-06 Alt NAT 
1 70887099 rs672203 A G 0.91 0.09 0.74 0.26 25.42 4.62E-07 3.28E-06 Ref NAT 
1 71514969 rs7551789 A T 0.93 0.07 0.77 0.23 25.63 4.13E-07 2.95E-06 Ref EUR 
1 72765116 rs2568958 G A 0.28 0.72 0.13 0.87 31.43 2.07E-08 1.75E-07 Alt NAT 
1 76839536 rs12144344 C T 0.83 0.17 0.71 0.29 11.47 7.08E-04 3.03E-03 Ref AFR 
1 89849574 rs928655 G A 0.44 0.56 0.61 0.39 19.31 1.11E-05 6.46E-05 Alt EUR 
1 94674726 rs2274788 T C 0.80 0.20 0.67 0.33 12.89 3.31E-04 1.51E-03 Ref AFR 
1 95053353 rs12029080 T G 0.82 0.18 0.69 0.31 13.27 2.70E-04 1.25E-03 Ref AFR 
1 96943994 rs1973993 T C 0.43 0.57 0.19 0.81 64.71 8.67E-16 1.51E-14 Alt NAT 
1 97037083 rs10783050 T C 0.75 0.25 0.55 0.45 27.44 1.62E-07 1.22E-06 Ref AFR 
1 98348885 rs1801265 G A 0.16 0.84 0.10 0.90 7.91 4.92E-03 1.77E-02 Alt NAT 
1 99782957 rs12743824 C A 0.26 0.74 0.37 0.63 9.10 2.55E-03 9.86E-03 Alt NAT 
1 109818306 rs629301 G T 0.22 0.78 0.07 0.93 60.61 6.95E-15 1.12E-13 Alt NAT 
1 109818530 rs646776 C T 0.22 0.78 0.07 0.93 60.61 6.95E-15 1.12E-13 Alt NAT 
1 109822166 rs599839 G A 0.24 0.76 0.09 0.91 49.43 2.06E-12 2.68E-11 Alt NAT 
1 115837709 rs2239622 A G 0.19 0.81 0.40 0.60 30.18 3.94E-08 3.21E-07 Alt AFR 
1 149892872 rs11205277 A G 0.74 0.26 0.63 0.37 9.10 2.55E-03 9.86E-03 Ref AFR 
1 153769400 rs9426935 C T 0.79 0.21 0.86 0.14 5.87 1.54E-02 4.98E-02 Ref NAT 
1 154418879 rs4537545 C T 0.28 0.72 0.60 0.40 74.52 6.01E-18 1.22E-16 Alt AFR 
1 155279482 rs2297480 T G 0.69 0.31 0.34 0.66 91.10 1.37E-21 3.53E-20 Ref EUR 
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1 155868625 rs2282301 G A 0.73 0.27 0.37 0.63 97.59 5.14E-23 1.43E-21 Ref EUR 
1 156873727 rs12407843 G A 0.87 0.13 0.67 0.33 30.78 2.89E-08 2.39E-07 Ref EUR 
1 156877797 rs77235035 C A 0.83 0.17 0.66 0.34 22.01 2.71E-06 1.73E-05 Ref EUR 
1 156879580 rs3737224 C T 0.92 0.08 0.71 0.29 36.72 1.36E-09 1.32E-08 Ref EUR 
1 156881959 rs41273215 C T 0.92 0.08 0.70 0.30 36.72 1.36E-09 1.32E-08 Ref EUR 
1 156883215 rs822442 C A 0.92 0.08 0.72 0.28 33.56 6.91E-09 6.15E-08 Ref EUR 
1 159698549 rs7553007 G A 0.61 0.39 0.50 0.50 8.49 3.56E-03 1.32E-02 Ref AFR 
1 161479745 rs1801274 A G 0.53 0.47 0.63 0.37 7.29 6.94E-03 2.41E-02 Ref NAT 
1 162033890 rs12143842 C T 0.88 0.12 0.67 0.33 32.62 1.12E-08 9.75E-08 Ref AFR 
1 162085685 rs10494366 G T 0.39 0.61 0.63 0.37 42.68 6.45E-11 7.26E-10 Alt EUR 
1 162210610 rs4657178 C T 0.66 0.34 0.52 0.48 13.58 2.28E-04 1.07E-03 Ref EUR 
1 165448157 rs10918196 T C 0.49 0.51 0.25 0.75 52.33 4.69E-13 6.51E-12 Alt NAT 
1 169580290 rs2235302 C T 0.89 0.11 0.76 0.24 15.56 8.01E-05 4.04E-04 Ref NAT 
1 171076966 rs2266782 G A 0.70 0.30 0.79 0.21 7.93 4.86E-03 1.75E-02 Ref NAT 
1 171080080 rs1736557 G A 0.89 0.11 0.77 0.23 15.82 6.95E-05 3.54E-04 Ref AFR 
1 171083242 rs2266780 A G 0.94 0.06 0.84 0.16 12.72 3.61E-04 1.63E-03 Ref AFR 
1 171091875 rs1795240 A G 0.15 0.85 0.39 0.61 39.63 3.07E-10 3.20E-09 Alt AFR 
1 171254890 rs7877 C T 0.54 0.46 0.76 0.24 46.41 9.58E-12 1.16E-10 Ref NAT 
1 172189889 rs678962 T G 0.78 0.22 0.68 0.32 7.84 5.10E-03 1.83E-02 Ref EUR 
1 186947224 rs10157410 G C 0.76 0.24 0.86 0.14 12.42 4.25E-04 1.89E-03 Ref NAT 
1 196679455 rs10737680 A C 0.42 0.58 0.62 0.38 30.70 3.02E-08 2.49E-07 Alt AFR 
1 201345487 rs12564445 G A 0.86 0.14 0.67 0.33 27.52 1.55E-07 1.18E-06 Ref EUR 
1 203135452 rs16851030 C T 0.86 0.14 0.70 0.30 23.30 1.39E-06 9.18E-06 Ref EUR 
1 206946407 rs1800872 T G 0.37 0.63 0.65 0.35 59.81 1.05E-14 1.67E-13 Alt EUR 
1 206946634 rs1800871 A G 0.37 0.63 0.65 0.35 59.81 1.05E-14 1.67E-13 Alt EUR 
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1 206946897 rs1800896 T C 0.75 0.25 0.89 0.11 35.79 2.20E-09 2.07E-08 Ref NAT 
1 210536025 rs7527939 C T 0.71 0.29 0.87 0.13 42.60 6.73E-11 7.55E-10 Ref NAT 
1 218931905 rs12037343 G T 0.91 0.09 0.72 0.28 30.11 4.08E-08 3.31E-07 Ref AFR 
1 230294916 rs2144300 C T 0.45 0.55 0.74 0.26 73.62 9.45E-18 1.90E-16 Alt EUR 
1 230838331 rs7079 G T 0.91 0.09 0.82 0.18 9.11 2.55E-03 9.85E-03 Ref AFR 
1 232756026 rs10495332 T C 0.91 0.09 0.74 0.26 24.04 9.43E-07 6.38E-06 Ref AFR 
1 233719984 rs11800854 G A 0.95 0.05 0.87 0.13 9.18 2.44E-03 9.47E-03 Ref EUR 
1 237028564 rs3768142 G T 0.28 0.72 0.41 0.59 10.76 1.04E-03 4.32E-03 Alt AFR 
1 247675559 rs7550918 C T 0.23 0.77 0.05 0.95 105.59 9.07E-25 2.79E-23 Alt NAT 
2 10903412 rs1198872 C T 0.72 0.28 0.54 0.46 22.77 1.83E-06 1.20E-05 Ref EUR 
2 21225281 rs1042034 C T 0.38 0.62 0.59 0.41 33.40 7.52E-09 6.67E-08 Alt AFR 
2 21231524 rs676210 G A 0.62 0.38 0.41 0.59 33.40 7.52E-09 6.67E-08 Ref AFR 
2 25131316 rs6545814 A G 0.80 0.20 0.57 0.43 38.29 6.10E-10 6.16E-09 Ref NAT 
2 27730940 rs1260326 T C 0.32 0.68 0.55 0.45 36.19 1.79E-09 1.71E-08 Alt AFR 
2 27741237 rs780094 T C 0.33 0.67 0.56 0.44 34.36 4.58E-09 4.17E-08 Alt AFR 
2 27742603 rs780093 T C 0.33 0.67 0.56 0.44 34.36 4.58E-09 4.17E-08 Alt AFR 
2 31247514 rs9679162 G T 0.32 0.68 0.48 0.52 17.17 3.41E-05 1.85E-04 Alt AFR 
2 31249427 rs12613732 T G 0.38 0.62 0.58 0.42 26.24 3.02E-07 2.21E-06 Alt NAT 
2 41273631 rs17027130 T C 0.88 0.12 0.73 0.27 18.63 1.59E-05 9.04E-05 Ref AFR 
2 56120853 rs1430193 A T 0.62 0.38 0.18 0.82 221.92 3.45E-50 2.62E-48 Ref EUR 
2 56195696 rs62164511 A G 0.34 0.66 0.84 0.16 301.69 1.41E-67 1.59E-65 Alt EUR 
2 60459806 rs359268 T C 0.46 0.54 0.60 0.40 14.12 1.72E-04 8.23E-04 Alt EUR 
2 64503895 rs2698530 A C 0.65 0.35 0.46 0.54 25.85 3.69E-07 2.66E-06 Ref AFR 
2 69723710 rs7577851 C T 0.61 0.39 0.70 0.30 7.17 7.41E-03 2.56E-02 Ref EUR 
2 105897740 rs1020064 T G 0.04 0.96 0.22 0.78 32.57 1.15E-08 9.99E-08 Alt AFR 
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2 111907691 rs724710 T C 0.53 0.47 0.19 0.81 122.17 2.12E-28 7.77E-27 Ref EUR 
2 113594867 rs16944 A G 0.70 0.30 0.43 0.57 50.80 1.02E-12 1.38E-11 Ref AFR 
2 113598107 rs4848306 G A 0.75 0.25 0.50 0.50 43.51 4.21E-11 4.82E-10 Ref AFR 
2 128018063 rs3738948 A G 0.91 0.09 0.69 0.31 39.59 3.14E-10 3.26E-09 Ref AFR 
2 130468366 rs10928927 C T 0.34 0.66 0.21 0.79 17.06 3.63E-05 1.95E-04 Alt EUR 
2 134266001 rs16826005 A G 0.95 0.05 0.76 0.24 32.91 9.63E-09 8.45E-08 Ref EUR 
2 152981335 rs16830728 G T 0.95 0.05 0.47 0.53 154.91 1.46E-35 7.23E-34 Ref EUR 
2 159899489 rs7582141 G T 0.80 0.20 0.89 0.11 15.91 6.66E-05 3.40E-04 Ref EUR 
2 159899913 rs6432512 C T 0.80 0.20 0.89 0.11 15.91 6.66E-05 3.40E-04 Ref EUR 
2 159936391 rs264588 C A 0.80 0.20 0.91 0.09 26.40 2.78E-07 2.04E-06 Ref EUR 
2 159950865 rs264631 C G 0.79 0.21 0.91 0.09 29.25 6.37E-08 5.06E-07 Ref EUR 
2 162910223 rs6741949 G C 0.42 0.58 0.88 0.12 353.66 6.77E-79 9.33E-77 Alt EUR 
2 162997960 rs13429709 T C 0.16 0.84 0.40 0.60 39.22 3.79E-10 3.92E-09 Alt NAT 
2 165513091 rs10195252 T C 0.90 0.10 0.76 0.24 17.29 3.20E-05 1.74E-04 Ref NAT 
2 166168503 rs2304016 A G 0.97 0.03 0.88 0.12 12.75 3.56E-04 1.61E-03 Ref AFR 
2 169041386 rs6749447 T G 0.46 0.54 0.36 0.64 7.39 6.56E-03 2.29E-02 Alt NAT 
2 170010985 rs2075252 T C 0.24 0.76 0.49 0.51 41.53 1.16E-10 1.27E-09 Alt AFR 
2 174504924 rs13028485 G A 0.95 0.05 0.80 0.20 24.32 8.15E-07 5.56E-06 Ref EUR 
2 176289319 rs2461751 G A 0.79 0.21 0.56 0.44 40.00 2.54E-10 2.67E-09 Ref EUR 
2 199632565 rs12617311 G A 0.71 0.29 0.61 0.39 6.34 1.18E-02 3.92E-02 Ref AFR 
2 200638509 rs12615435 T G 0.93 0.07 0.81 0.19 15.40 8.71E-05 4.37E-04 Ref AFR 
2 211060050 rs2286963 T G 0.92 0.08 0.79 0.21 15.87 6.80E-05 3.46E-04 Ref AFR 
2 213824045 rs12619285 A G 0.26 0.74 0.44 0.56 21.54 3.47E-06 2.18E-05 Alt NAT 
2 216205167 rs16853826 G A 0.79 0.21 0.59 0.41 28.07 1.17E-07 8.97E-07 Ref EUR 
2 233513175 rs2140773 C A 0.56 0.44 0.67 0.33 8.55 3.45E-03 1.28E-02 Ref NAT 
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2 234526871 rs1042597 C G 0.75 0.25 0.54 0.46 29.02 7.16E-08 5.65E-07 Ref AFR 
2 234529643 rs6431558 C T 0.71 0.29 0.43 0.57 53.03 3.28E-13 4.63E-12 Ref EUR 
2 234579892 rs3806598 A C 0.99 0.01 0.80 0.20 40.04 2.49E-10 2.63E-09 Ref EUR 
2 234681544 rs1042640 G C 0.21 0.79 0.14 0.86 5.87 1.54E-02 4.98E-02 Alt NAT 
3 2624938 rs2619566 G A 0.54 0.46 0.36 0.64 24.57 7.16E-07 4.92E-06 Ref AFR 
3 12267648 rs7616006 A G 0.89 0.11 0.61 0.39 59.15 1.46E-14 2.30E-13 Ref NAT 
3 34865597 rs559356 T C 0.75 0.25 0.52 0.48 34.05 5.37E-09 4.85E-08 Ref AFR 
3 38442490 rs2070488 G A 0.80 0.20 0.71 0.29 6.45 1.11E-02 3.71E-02 Ref AFR 
3 38594973 rs7638909 T G 0.60 0.40 0.49 0.51 8.50 3.55E-03 1.32E-02 Ref EUR 
3 38624253 rs3922844 T C 0.34 0.66 0.19 0.81 26.02 3.37E-07 2.44E-06 Alt NAT 
3 45731451 rs2742417 C T 0.62 0.38 0.72 0.28 8.39 3.77E-03 1.39E-02 Ref NAT 
3 45731784 rs2251954 T C 0.62 0.38 0.72 0.28 9.53 2.02E-03 7.99E-03 Ref NAT 
3 45732515 rs2742421 T G 0.62 0.38 0.72 0.28 9.53 2.02E-03 7.99E-03 Ref NAT 
3 45733430 rs2742423 A G 0.62 0.38 0.72 0.28 9.53 2.02E-03 7.99E-03 Ref NAT 
3 45734818 rs1969624 T C 0.62 0.38 0.72 0.28 9.53 2.02E-03 7.99E-03 Ref NAT 
3 45740863 rs2742435 G A 0.64 0.36 0.76 0.24 14.17 1.67E-04 7.99E-04 Ref AFR 
3 45749722 rs2245705 T C 0.62 0.38 0.73 0.27 10.76 1.04E-03 4.32E-03 Ref NAT 
3 45756722 rs2742390 G A 0.62 0.38 0.73 0.27 10.76 1.04E-03 4.32E-03 Ref NAT 
3 53680124 rs1401492 C T 0.98 0.02 0.91 0.09 9.94 1.62E-03 6.52E-03 Ref EUR 
3 56849749 rs1354034 T C 0.66 0.34 0.49 0.51 19.79 8.64E-06 5.10E-05 Ref AFR 
3 113046640 rs13064411 A G 0.96 0.04 0.91 0.09 6.90 8.62E-03 2.95E-02 Ref AFR 
3 113879562 rs167770 G A 0.53 0.47 0.31 0.69 37.53 9.00E-10 8.87E-09 Ref AFR 
3 113885395 rs324023 T C 0.53 0.47 0.31 0.69 37.53 9.00E-10 8.87E-09 Ref AFR 
3 113890815 rs6280 C T 0.54 0.46 0.33 0.67 34.51 4.24E-09 3.88E-08 Ref AFR 
3 113891042 rs324026 C T 0.54 0.46 0.33 0.67 34.51 4.24E-09 3.88E-08 Ref AFR 
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3 117574822 rs6438424 A C 0.65 0.35 0.50 0.50 15.91 6.65E-05 3.40E-04 Ref AFR 
3 119499507 rs1523130 T C 0.42 0.58 0.31 0.69 9.90 1.66E-03 6.64E-03 Alt NAT 
3 119525497 rs7643645 A G 0.36 0.64 0.57 0.43 32.98 9.30E-09 8.16E-08 Alt NAT 
3 119537291 rs3814058 T C 0.82 0.18 0.59 0.41 36.94 1.22E-09 1.19E-08 Ref EUR 
3 119631814 rs6438552 A G 0.71 0.29 0.47 0.53 39.69 2.98E-10 3.11E-09 Ref EUR 
3 119813282 rs334558 A G 0.73 0.27 0.44 0.56 57.29 3.77E-14 5.73E-13 Ref EUR 
3 141102833 rs6763931 G A 0.51 0.49 0.64 0.36 12.37 4.35E-04 1.94E-03 Ref NAT 
3 151056598 rs6809699 A C 0.07 0.93 0.14 0.86 6.08 1.36E-02 4.46E-02 Alt AFR 
3 151090996 rs9859552 G T 0.93 0.07 0.97 0.03 10.10 1.49E-03 6.02E-03 Ref AFR 
3 152672779 rs6785504 G T 0.23 0.77 0.53 0.47 63.94 1.28E-15 2.19E-14 Alt AFR 
3 160820524 rs4557202 G C 0.44 0.56 0.23 0.77 40.76 1.72E-10 1.84E-09 Alt NAT 
3 167837748 rs4345115 T C 0.39 0.61 0.54 0.46 16.01 6.29E-05 3.23E-04 Alt NAT 
3 184010048 rs3914188 G C 0.15 0.85 0.38 0.62 38.11 6.67E-10 6.71E-09 Alt EUR 
3 184090266 rs6141 C T 0.26 0.74 0.51 0.49 39.56 3.18E-10 3.31E-09 Alt AFR 
3 185629568 rs2002675 A G 0.91 0.09 0.82 0.18 7.93 4.85E-03 1.75E-02 Ref NAT 
3 187456709 rs3733017 T G 0.94 0.06 0.84 0.16 12.36 4.39E-04 1.95E-03 Ref EUR 
4 2906707 rs4961 G T 0.81 0.19 0.54 0.46 52.24 4.92E-13 6.81E-12 Ref AFR 
4 3006043 rs1024323 C T 0.65 0.35 0.76 0.24 10.41 1.25E-03 5.13E-03 Ref NAT 
4 4252956 rs2980098 A G 0.33 0.67 0.63 0.37 65.59 5.54E-16 9.80E-15 Alt AFR 
4 8503359 rs1949733 A G 0.51 0.49 0.37 0.63 14.53 1.38E-04 6.72E-04 Ref NAT 
4 9926967 rs13129697 T G 0.26 0.74 0.57 0.43 67.68 1.93E-16 3.54E-15 Alt AFR 
4 16893893 rs1483012 G A 0.61 0.39 0.78 0.22 31.09 2.46E-08 2.06E-07 Ref NAT 
4 16908004 rs6819013 A G 0.68 0.32 0.89 0.11 72.59 1.60E-17 3.16E-16 Ref NAT 
4 18017730 rs6830062 T C 0.93 0.07 0.86 0.14 7.93 4.87E-03 1.75E-02 Ref EUR 
4 38139024 rs9852 C T 0.97 0.03 0.69 0.31 63.16 1.90E-15 3.21E-14 Ref AFR 
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4 69681936 rs61750900 G T 0.96 0.04 0.99 0.01 8.10 4.44E-03 1.60E-02 Ref NAT 
4 69962078 rs7668258 T C 0.14 0.86 0.33 0.67 28.74 8.27E-08 6.44E-07 Alt AFR 
4 71859193 rs80143932 C G 0.94 0.06 0.86 0.14 9.51 2.04E-03 8.06E-03 Ref AFR 
4 71859352 rs2306744 C T 0.94 0.06 0.86 0.14 9.51 2.04E-03 8.06E-03 Ref AFR 
4 74606024 rs4073 A T 0.27 0.73 0.44 0.56 18.76 1.48E-05 8.48E-05 Alt NAT 
4 74864550 rs352046 G C 0.09 0.91 0.04 0.96 12.07 5.13E-04 2.25E-03 Alt NAT 
4 78605369 rs958617 A G 0.46 0.54 0.36 0.64 7.39 6.56E-03 2.29E-02 Alt EUR 
4 84192168 rs4693075 G C 0.54 0.46 0.16 0.84 169.70 8.60E-39 4.73E-37 Ref AFR 
4 88213808 rs6834314 A G 0.94 0.06 0.69 0.31 50.69 1.08E-12 1.45E-11 Ref AFR 
4 89030841 rs12505410 T G 0.46 0.54 0.70 0.30 47.09 6.79E-12 8.39E-11 Alt EUR 
4 89052323 rs2231142 G T 0.85 0.15 0.74 0.26 11.07 8.78E-04 3.70E-03 Ref AFR 
4 89096061 rs7699188 G A 0.95 0.05 0.88 0.12 8.16 4.28E-03 1.56E-02 Ref NAT 
4 100163873 rs2201728 G A 0.31 0.69 0.79 0.21 231.21 3.24E-52 2.64E-50 Alt EUR 
4 100239319 rs1229984 T C 0.01 0.99 0.58 0.42 222.04 3.25E-50 2.46E-48 Alt AFR 
4 100495488 rs1800591 G T 0.91 0.09 0.83 0.17 7.03 8.03E-03 2.76E-02 Ref NAT 
4 114861300 rs4460079 C T 0.35 0.65 0.25 0.75 10.25 1.37E-03 5.59E-03 Alt NAT 
4 142709723 rs17007695 T C 0.44 0.56 0.64 0.36 31.32 2.19E-08 1.84E-07 Alt NAT 
4 146794621 rs4547811 T C 0.38 0.62 0.63 0.37 46.94 7.31E-12 9.00E-11 Alt NAT 
4 146875551 rs723794 G T 0.19 0.81 0.47 0.53 54.33 1.69E-13 2.44E-12 Alt EUR 
4 154609523 rs1816702 T C 0.21 0.79 0.03 0.97 198.02 5.64E-45 3.79E-43 Alt NAT 
4 155514879 rs13109457 G A 0.82 0.18 0.54 0.46 54.48 1.57E-13 2.27E-12 Ref EUR 
4 159630817 rs8396 T C 0.95 0.05 0.82 0.18 20.87 4.91E-06 3.01E-05 Ref NAT 
4 175071602 rs12507634 A G 0.39 0.61 0.78 0.22 155.08 1.35E-35 6.66E-34 Alt EUR 
4 182197947 rs1454694 T C 0.95 0.05 0.80 0.20 26.23 3.03E-07 2.22E-06 Ref AFR 
5 610093 rs924607 C T 0.71 0.29 0.60 0.40 7.94 4.83E-03 1.74E-02 Ref AFR 
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5 1322087 rs401681 C T 0.58 0.42 0.69 0.31 11.08 8.72E-04 3.68E-03 Ref NAT 
5 8652870 rs200113 T C 0.97 0.03 0.78 0.22 35.37 2.72E-09 2.54E-08 Ref AFR 
5 17003085 rs6870564 A G 0.05 0.95 0.14 0.86 12.42 4.25E-04 1.89E-03 Alt EUR 
5 37818139 rs2973049 T C 0.33 0.67 0.44 0.56 7.75 5.36E-03 1.91E-02 Alt AFR 
5 37828844 rs2216711 G A 0.11 0.89 0.29 0.71 27.23 1.81E-07 1.35E-06 Alt AFR 
5 57214817 rs10041935 A C 0.82 0.18 0.67 0.33 16.64 4.51E-05 2.39E-04 Ref AFR 
5 59736773 rs702553 A T 0.71 0.29 0.45 0.55 46.07 1.14E-11 1.38E-10 Ref EUR 
5 63250851 rs1364043 T G 0.68 0.32 0.51 0.49 19.80 8.60E-06 5.08E-05 Ref AFR 
5 73276903 rs6894385 A C 0.86 0.14 0.74 0.26 12.27 4.61E-04 2.05E-03 Ref AFR 
5 75514986 rs11960832 C T 0.51 0.49 0.66 0.34 17.69 2.60E-05 1.43E-04 Ref NAT 
5 76224171 rs2460504 G C 0.84 0.16 0.68 0.32 19.78 8.67E-06 5.12E-05 Ref AFR 
5 76781471 rs163030 A C 0.13 0.87 0.42 0.58 60.23 8.43E-15 1.35E-13 Alt AFR 
5 79950781 rs1650697 A G 0.28 0.72 0.37 0.63 6.46 1.11E-02 3.70E-02 Alt AFR 
5 79951496 rs442767 G T 0.39 0.61 0.52 0.48 11.41 7.29E-04 3.12E-03 Alt NAT 
5 88183651 rs17560407 A G 0.94 0.06 0.76 0.24 29.42 5.82E-08 4.64E-07 Ref AFR 
5 122685128 rs2115172 A G 0.61 0.39 0.51 0.49 7.62 5.76E-03 2.04E-02 Ref EUR 
5 131819921 rs2070729 C A 0.24 0.76 0.40 0.60 19.22 1.17E-05 6.79E-05 Alt AFR 
5 132009154 rs2243250 C T 0.52 0.48 0.37 0.63 15.76 7.18E-05 3.65E-04 Ref EUR 
5 133849177 rs13187289 C G 0.85 0.15 0.94 0.06 21.87 2.92E-06 1.85E-05 Ref NAT 
5 137707315 rs757647 G A 0.66 0.34 0.48 0.52 22.64 1.95E-06 1.27E-05 Ref EUR 
5 159820931 rs10515808 C A 0.94 0.06 0.98 0.02 9.22 2.40E-03 9.32E-03 Ref NAT 
5 161324898 rs2290732 A G 0.26 0.74 0.49 0.51 35.81 2.18E-09 2.05E-08 Alt EUR 
5 167500460 rs13358864 T A 0.95 0.05 0.80 0.20 24.85 6.19E-07 4.30E-06 Ref AFR 
5 174876002 rs2168631 G A 0.81 0.19 0.64 0.36 18.78 1.47E-05 8.42E-05 Ref EUR 
5 176836532 rs1801020 A G 0.51 0.49 0.62 0.38 8.07 4.50E-03 1.63E-02 Ref NAT 
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6 2235633 rs9378688 G A 0.94 0.06 0.84 0.16 11.27 7.87E-04 3.34E-03 Ref AFR 
6 7102084 rs675209 T C 0.62 0.38 0.79 0.21 27.63 1.47E-07 1.12E-06 Ref NAT 
6 7801112 rs6923462 T C 0.84 0.16 0.97 0.03 109.01 1.62E-25 5.16E-24 Ref NAT 
6 18139802 rs12201199 A T 0.90 0.10 0.97 0.03 43.27 4.77E-11 5.43E-10 Ref NAT 
6 20685486 rs9356744 T C 0.71 0.29 0.62 0.38 6.38 1.16E-02 3.84E-02 Ref EUR 
6 24491475 rs1883415 A C 0.92 0.08 0.82 0.18 10.36 1.29E-03 5.25E-03 Ref NAT 
6 24503590 rs2760118 C T 0.91 0.09 0.82 0.18 7.93 4.85E-03 1.75E-02 Ref NAT 
6 31241109 rs13191343 C T 0.94 0.06 0.87 0.13 6.32 1.20E-02 3.96E-02 Ref AFR 
6 31253444 rs9461684 C T 0.78 0.22 0.91 0.09 35.39 2.70E-09 2.52E-08 Ref NAT 
6 31274380 rs9264942 T C 0.78 0.22 0.57 0.43 29.41 5.86E-08 4.67E-07 Ref AFR 
6 31322559 rs2523608 G A 0.39 0.61 0.49 0.51 6.80 9.11E-03 3.09E-02 Alt EUR 
6 31431691 rs2255221 G T 0.93 0.07 0.97 0.03 6.22 1.26E-02 4.16E-02 Ref NAT 
6 32336187 rs3129934 T C 0.04 0.96 0.10 0.90 6.54 1.06E-02 3.55E-02 Alt NAT 
6 32632832 rs9274407 A T 0.13 0.87 0.26 0.74 15.99 6.38E-05 3.27E-04 Alt EUR 
6 32678999 rs9275572 A G 0.22 0.78 0.32 0.68 7.77 5.32E-03 1.89E-02 Alt NAT 
6 32972404 rs3128935 T C 0.93 0.07 0.85 0.15 7.93 4.87E-03 1.75E-02 Ref EUR 
6 32975014 rs399604 T C 0.64 0.36 0.48 0.52 15.93 6.59E-05 3.37E-04 Ref AFR 
6 33048661 rs1042151 A G 0.72 0.28 0.89 0.11 46.46 9.37E-12 1.14E-10 Ref NAT 
6 33055538 rs9277554 C T 0.65 0.35 0.49 0.51 15.91 6.65E-05 3.40E-04 Ref EUR 
6 33465482 rs9394152 C T 0.34 0.66 0.17 0.83 34.96 3.36E-09 3.11E-08 Alt NAT 
6 35369806 rs1883322 C T 0.15 0.85 0.29 0.71 16.32 5.35E-05 2.79E-04 Alt NAT 
6 35395010 rs3734254 C T 0.15 0.85 0.27 0.73 13.14 2.89E-04 1.33E-03 Alt NAT 
6 35402785 rs4713858 A G 0.09 0.91 0.20 0.80 11.91 5.58E-04 2.43E-03 Alt AFR 
6 39307032 rs9471075 A C 0.94 0.06 0.98 0.02 16.63 4.55E-05 2.40E-04 Ref NAT 
6 39325078 rs20455 A G 0.79 0.21 0.53 0.47 47.81 4.69E-12 5.89E-11 Ref EUR 
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6 45095163 rs9395066 A C 0.58 0.42 0.35 0.65 41.53 1.16E-10 1.27E-09 Ref AFR 
6 53924697 rs9296736 T C 0.69 0.31 0.47 0.53 34.15 5.11E-09 4.64E-08 Ref AFR 
6 55639028 rs41271330 G A 0.92 0.08 0.86 0.14 5.87 1.54E-02 4.98E-02 Ref AFR 
6 79556166 rs16890334 T C 0.99 0.01 0.94 0.06 8.61 3.35E-03 1.25E-02 Ref AFR 
6 81302805 rs10943724 C A 0.44 0.56 0.54 0.46 6.85 8.88E-03 3.03E-02 Alt NAT 
6 107660646 rs2430457 G A 0.02 0.98 0.01 0.99 9.05 2.62E-03 9.98E-03 Alt NAT 
6 110777962 rs6907567 A G 0.80 0.20 0.55 0.45 41.98 9.24E-11 1.02E-09 Ref EUR 
6 110778128 rs714368 T C 0.80 0.20 0.56 0.44 40.11 2.40E-10 2.54E-09 Ref EUR 
6 111922503 rs76228616 G C 0.91 0.09 0.99 0.01 197.16 8.70E-45 5.72E-43 Ref NAT 
6 118574061 rs281868 G A 0.85 0.15 0.68 0.32 21.28 3.97E-06 2.47E-05 Ref NAT 
6 118680374 rs11970286 C T 0.91 0.09 0.70 0.30 36.30 1.69E-09 1.62E-08 Ref AFR 
6 121748542 rs11154022 A G 0.26 0.74 0.49 0.51 34.00 5.52E-09 4.98E-08 Alt AFR 
6 122146034 rs9398652 C A 0.94 0.06 0.65 0.35 62.33 2.91E-15 4.87E-14 Ref EUR 
6 126964510 rs4273712 A G 0.44 0.56 0.55 0.45 8.59 3.38E-03 1.26E-02 Alt NAT 
6 135419018 rs9399137 T C 0.90 0.10 0.72 0.28 26.47 2.68E-07 1.97E-06 Ref AFR 
6 135432552 rs9494145 T C 0.87 0.13 0.76 0.24 11.60 6.58E-04 2.83E-03 Ref AFR 
6 137102365 rs9376230 C A 0.31 0.69 0.42 0.58 8.70 3.19E-03 1.19E-02 Alt AFR 
6 137673302 rs6928289 G A 0.52 0.48 0.32 0.68 31.07 2.49E-08 2.08E-07 Ref EUR 
6 142512136 rs225675 A G 0.87 0.13 0.79 0.21 6.91 8.59E-03 2.94E-02 Ref AFR 
6 147680359 rs9390459 A G 0.42 0.58 0.67 0.33 46.56 8.89E-12 1.09E-10 Alt AFR 
6 154360797 rs1799971 A G 0.80 0.20 0.69 0.31 9.90 1.66E-03 6.64E-03 Ref AFR 
6 154487421 rs2281617 C T 0.93 0.07 0.60 0.40 76.86 1.83E-18 3.88E-17 Ref EUR 
6 160551204 rs683369 G C 0.04 0.96 0.14 0.86 14.02 1.81E-04 8.63E-04 Alt AFR 
6 160557643 rs2282143 C T 0.99 0.01 0.89 0.11 15.91 6.66E-05 3.40E-04 Ref EUR 
6 160670282 rs316019 A C 0.05 0.95 0.13 0.87 8.82 2.97E-03 1.12E-02 Alt EUR 
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6 166579270 rs2305089 C T 0.41 0.59 0.64 0.36 38.89 4.49E-10 4.61E-09 Alt EUR 
7 1976457 rs1801368 C T 0.45 0.55 0.55 0.45 7.71 5.49E-03 1.95E-02 Alt NAT 
7 7313485 rs6953213 G A 0.92 0.08 0.83 0.17 10.64 1.10E-03 4.58E-03 Ref EUR 
7 28004198 rs4722750 C T 0.97 0.03 0.84 0.16 21.31 3.91E-06 2.43E-05 Ref EUR 
7 30699972 rs2270007 G C 0.14 0.86 0.40 0.60 49.63 1.85E-12 2.43E-11 Alt AFR 
7 30726777 rs7793837 A T 0.70 0.30 0.80 0.20 9.21 2.41E-03 9.35E-03 Ref NAT 
7 32444435 rs215738 G A 0.10 0.90 0.02 0.98 43.27 4.77E-11 5.43E-10 Alt NAT 
7 33060946 rs3750117 A G 0.26 0.74 0.49 0.51 37.65 8.45E-10 8.38E-09 Alt AFR 
7 41470093 rs1079866 C G 0.89 0.11 0.80 0.20 9.41 2.16E-03 8.42E-03 Ref AFR 
7 73020337 rs3812316 C G 0.96 0.04 0.88 0.12 11.11 8.60E-04 3.63E-03 Ref AFR 
7 74126034 rs117026326 C T 0.99 0.01 0.91 0.09 15.52 8.15E-05 4.10E-04 Ref AFR 
7 80236014 rs13236689 T G 0.56 0.44 0.44 0.56 11.58 6.66E-04 2.86E-03 Ref EUR 
7 80532112 rs7779029 T C 0.98 0.02 0.89 0.11 16.38 5.19E-05 2.72E-04 Ref EUR 
7 87133366 rs3842 T C 0.84 0.16 0.73 0.27 10.76 1.04E-03 4.32E-03 Ref AFR 
7 87157051 rs7787082 G A 0.73 0.27 0.55 0.45 21.42 3.70E-06 2.31E-05 Ref EUR 
7 87164986 rs10248420 A G 0.73 0.27 0.56 0.44 20.07 7.48E-06 4.47E-05 Ref EUR 
7 87171152 rs4148737 T C 0.43 0.57 0.69 0.31 56.10 6.88E-14 1.02E-12 Alt EUR 
7 87173667 rs1922242 A T 0.43 0.57 0.69 0.31 56.10 6.88E-14 1.02E-12 Alt EUR 
7 87179601 rs1128503 A G 0.33 0.67 0.63 0.37 65.59 5.54E-16 9.80E-15 Alt AFR 
7 87180198 rs10276036 C T 0.33 0.67 0.63 0.37 65.59 5.54E-16 9.80E-15 Alt AFR 
7 87230193 rs3213619 A G 0.99 0.01 0.94 0.06 7.87 5.02E-03 1.80E-02 Ref EUR 
7 92264410 rs2282978 T C 0.62 0.38 0.85 0.15 65.57 5.62E-16 9.94E-15 Ref NAT 
7 94925820 rs854548 A G 0.52 0.48 0.23 0.77 83.19 7.47E-20 1.73E-18 Ref AFR 
7 94930391 rs854555 A C 0.62 0.38 0.52 0.48 7.63 5.73E-03 2.03E-02 Ref AFR 
7 99270539 rs776746 C T 0.88 0.12 0.72 0.28 19.88 8.25E-06 4.89E-05 Ref EUR 
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7 99361466 rs2242480 C T 0.42 0.58 0.76 0.24 109.98 9.91E-26 3.21E-24 Alt AFR 
7 99365083 rs4646437 G A 0.95 0.05 0.85 0.15 13.12 2.92E-04 1.34E-03 Ref EUR 
7 101809851 rs365836 A G 0.73 0.27 0.87 0.13 26.60 2.50E-07 1.85E-06 Ref NAT 
7 123411223 rs4731120 A C 0.97 0.03 0.90 0.10 8.35 3.86E-03 1.42E-02 Ref AFR 
7 127164958 rs6467136 A G 0.56 0.44 0.27 0.73 75.56 3.55E-18 7.35E-17 Ref EUR 
7 150696111 rs1799983 T G 0.09 0.91 0.18 0.82 9.11 2.55E-03 9.85E-03 Alt AFR 
7 152878333 rs4285401 A G 0.80 0.20 0.66 0.34 13.96 1.87E-04 8.87E-04 Ref AFR 
7 154509324 rs12666280 T C 0.34 0.66 0.57 0.43 38.55 5.34E-10 5.43E-09 Alt EUR 
8 1244224 rs17669535 C G 0.98 0.02 0.86 0.14 21.40 3.74E-06 2.33E-05 Ref AFR 
8 2740502 rs641525 T G 0.82 0.18 0.70 0.30 13.41 2.50E-04 1.17E-03 Ref EUR 
8 4078353 rs2407314 G C 0.40 0.60 0.57 0.43 21.68 3.22E-06 2.03E-05 Alt AFR 
8 10683929 rs11776767 G C 0.89 0.11 0.75 0.25 16.73 4.31E-05 2.29E-04 Ref NAT 
8 18257854 rs1801280 T C 0.72 0.28 0.89 0.11 46.46 9.37E-12 1.14E-10 Ref NAT 
8 19819724 rs328 C G 0.98 0.02 0.89 0.11 13.33 2.61E-04 1.21E-03 Ref AFR 
8 19832646 rs17482753 G T 0.98 0.02 0.90 0.10 12.18 4.83E-04 2.13E-03 Ref AFR 
8 19847690 rs10503669 C A 0.98 0.02 0.90 0.10 12.18 4.83E-04 2.13E-03 Ref AFR 
8 23059324 rs20575 C G 0.21 0.79 0.13 0.87 8.82 2.97E-03 1.12E-02 Alt NAT 
8 37096059 rs1015003 G T 0.57 0.43 0.31 0.69 56.10 6.88E-14 1.02E-12 Ref EUR 
8 57095808 rs10958476 T C 0.92 0.08 0.85 0.15 7.67 5.60E-03 1.99E-02 Ref AFR 
8 65999963 rs2980003 C T 0.46 0.54 0.64 0.36 24.57 7.16E-07 4.92E-06 Alt NAT 
8 69389217 rs1517114 C G 0.26 0.74 0.13 0.87 25.27 4.98E-07 3.53E-06 Alt NAT 
8 89993488 rs10429371 C T 0.38 0.62 0.27 0.73 10.76 1.04E-03 4.32E-03 Alt EUR 
8 103200036 rs1265138 A G 0.92 0.08 0.77 0.23 20.80 5.11E-06 3.12E-05 Ref EUR 
8 118184783 rs13266634 C T 0.74 0.26 0.58 0.42 16.35 5.27E-05 2.75E-04 Ref AFR 
8 122275906 rs7834765 G T 0.28 0.72 0.53 0.47 43.72 3.78E-11 4.36E-10 Alt NAT 
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8 122909687 rs956225 A G 0.97 0.03 0.87 0.13 15.09 1.03E-04 5.09E-04 Ref AFR 
8 126486409 rs17321515 A G 0.52 0.48 0.43 0.57 6.96 8.32E-03 2.85E-02 Ref EUR 
8 126490972 rs2954029 A T 0.54 0.46 0.43 0.57 7.75 5.36E-03 1.91E-02 Ref AFR 
8 129787976 rs10956445 T C 0.36 0.64 0.47 0.53 7.65 5.68E-03 2.01E-02 Alt NAT 
8 132330716 rs10108033 T C 0.20 0.80 0.44 0.56 38.29 6.10E-10 6.16E-09 Alt AFR 
8 139884509 rs6988229 C T 0.81 0.19 0.96 0.04 125.95 3.16E-29 1.20E-27 Ref NAT 
8 143999600 rs1799998 A G 0.43 0.57 0.71 0.29 62.59 2.55E-15 4.27E-14 Alt EUR 
9 4744743 rs409801 T C 0.74 0.26 0.41 0.59 76.50 2.20E-18 4.64E-17 Ref AFR 
9 4763176 rs385893 T C 0.55 0.45 0.25 0.75 85.51 2.31E-20 5.52E-19 Ref AFR 
9 4814948 rs13300663 G C 0.78 0.22 0.60 0.40 23.55 1.21E-06 8.12E-06 Ref AFR 
9 21499624 rs7849420 A C 0.39 0.61 0.14 0.86 89.71 2.76E-21 6.99E-20 Alt NAT 
9 35141705 rs10972341 A G 0.22 0.78 0.66 0.34 147.21 7.07E-34 3.28E-32 Alt AFR 
9 35648950 rs3138083 A G 0.55 0.45 0.20 0.80 127.98 1.13E-29 4.41E-28 Ref AFR 
9 86920236 rs7867504 T C 0.25 0.75 0.40 0.60 16.49 4.89E-05 2.58E-04 Alt AFR 
9 93636664 rs290227 G A 0.83 0.17 0.45 0.55 97.24 6.15E-23 1.70E-21 Ref EUR 
9 104223233 rs10819937 C G 0.51 0.49 0.34 0.66 23.75 1.09E-06 7.34E-06 Ref NAT 
9 104378003 rs10121600 C T 0.68 0.32 0.77 0.23 9.79 1.75E-03 6.99E-03 Ref NAT 
9 104867838 rs10989824 C T 0.66 0.34 0.47 0.53 25.71 3.96E-07 2.85E-06 Ref EUR 
9 107562804 rs2230808 T C 0.15 0.85 0.38 0.62 37.89 7.50E-10 7.48E-09 Alt EUR 
9 109632353 rs4743034 G A 0.92 0.08 0.81 0.19 12.47 4.13E-04 1.85E-03 Ref NAT 
9 111455575 rs10512385 A G 0.96 0.04 0.90 0.10 6.54 1.06E-02 3.55E-02 Ref NAT 
9 112521126 rs4978848 G C 0.20 0.80 0.34 0.66 13.96 1.87E-04 8.87E-04 Alt NAT 
9 114293634 rs10980926 A G 0.79 0.21 0.55 0.45 38.07 6.81E-10 6.84E-09 Ref AFR 
9 119249339 rs7852872 C G 0.36 0.64 0.54 0.46 21.28 3.96E-06 2.46E-05 Alt NAT 
9 120472764 rs1927907 C T 0.93 0.07 0.75 0.25 28.46 9.57E-08 7.41E-07 Ref EUR 
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9 124565820 rs10760187 T C 0.55 0.45 0.25 0.75 85.51 2.31E-20 5.52E-19 Ref EUR 
9 125137695 rs10306135 A T 0.92 0.08 0.97 0.03 25.60 4.20E-07 2.99E-06 Ref NAT 
9 128001119 rs430397 C T 0.98 0.02 0.86 0.14 19.41 1.06E-05 6.16E-05 Ref EUR 
9 132501881 rs2302821 A C 0.76 0.24 0.51 0.49 43.53 4.18E-11 4.78E-10 Ref EUR 
10 26734587 rs2992257 C T 0.91 0.09 0.54 0.46 91.06 1.39E-21 3.59E-20 Ref AFR 
10 30834632 rs11008099 G A 0.98 0.02 0.82 0.18 30.93 2.67E-08 2.22E-07 Ref AFR 
10 36885921 rs1360573 A G 0.95 0.05 0.88 0.12 7.82 5.16E-03 1.84E-02 Ref NAT 
10 52010708 rs10508921 C T 0.95 0.05 0.70 0.30 51.79 6.17E-13 8.46E-12 Ref EUR 
10 64963449 rs4379723 T C 0.81 0.19 0.62 0.38 27.13 1.91E-07 1.42E-06 Ref AFR 
10 65027610 rs10761731 A T 0.82 0.18 0.66 0.34 19.08 1.25E-05 7.26E-05 Ref AFR 
10 65104500 rs7896518 A G 0.82 0.18 0.66 0.34 19.08 1.25E-05 7.26E-05 Ref AFR 
10 65133822 rs7923609 A G 0.81 0.19 0.65 0.35 20.19 7.00E-06 4.21E-05 Ref AFR 
10 65658744 rs938036 T C 0.01 0.99 0.06 0.94 8.61 3.35E-03 1.25E-02 Alt EUR 
10 68598292 rs7902091 C A 0.39 0.61 0.66 0.34 52.99 3.35E-13 4.71E-12 Alt AFR 
10 73769507 rs4148943 C T 0.59 0.41 0.82 0.18 56.97 4.43E-14 6.71E-13 Ref NAT 
10 73772762 rs730720 C T 0.59 0.41 0.82 0.18 56.97 4.43E-14 6.71E-13 Ref NAT 
10 79211262 rs603788 G C 0.46 0.54 0.68 0.32 34.83 3.59E-09 3.32E-08 Alt EUR 
10 79680434 rs754466 A T 0.91 0.09 0.77 0.23 19.17 1.20E-05 6.95E-05 Ref AFR 
10 80960828 rs2802369 C A 0.72 0.28 0.62 0.38 7.20 7.30E-03 2.52E-02 Ref AFR 
10 90826779 rs1937332 A G 0.54 0.46 0.73 0.27 30.11 4.08E-08 3.31E-07 Ref NAT 
10 94839642 rs2068888 G A 0.51 0.49 0.25 0.75 64.03 1.22E-15 2.10E-14 Ref AFR 
10 96541616 rs4244285 G A 0.94 0.06 0.70 0.30 47.09 6.79E-12 8.39E-11 Ref EUR 
10 96707202 rs4086116 C T 0.96 0.04 0.89 0.11 8.95 2.78E-03 1.05E-02 Ref NAT 
10 96725535 rs4917639 A C 0.96 0.04 0.89 0.11 8.95 2.78E-03 1.05E-02 Ref NAT 
10 96798548 rs1934951 C T 0.94 0.06 0.63 0.37 68.19 1.48E-16 2.75E-15 Ref EUR 
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10 101542578 rs717620 C T 0.92 0.08 0.78 0.22 19.52 9.95E-06 5.83E-05 Ref AFR 
10 101605693 rs3740065 A G 0.91 0.09 0.72 0.28 30.11 4.08E-08 3.31E-07 Ref EUR 
10 101620771 rs12762549 C G 0.68 0.32 0.44 0.56 38.18 6.47E-10 6.52E-09 Ref AFR 
10 101795361 rs10883437 T A 0.59 0.41 0.71 0.29 11.47 7.08E-04 3.03E-03 Ref NAT 
10 112836503 rs1800544 G C 0.45 0.55 0.58 0.42 11.71 6.23E-04 2.70E-03 Alt EUR 
10 112837538 rs1800545 G A 0.96 0.04 0.82 0.18 21.41 3.70E-06 2.32E-05 Ref EUR 
10 115805056 rs1801253 G C 0.11 0.89 0.23 0.77 14.67 1.28E-04 6.23E-04 Alt NAT 
10 119210375 rs6585436 T C 0.99 0.01 0.95 0.05 7.51 6.14E-03 2.15E-02 Ref EUR 
10 122900623 rs2901286 C A 0.92 0.08 0.85 0.15 6.54 1.06E-02 3.55E-02 Ref AFR 
10 124214448 rs10490924 G T 0.76 0.24 0.62 0.38 14.43 1.45E-04 7.03E-04 Ref EUR 
10 124219275 rs3793917 C G 0.76 0.24 0.61 0.39 15.57 7.96E-05 4.02E-04 Ref EUR 
11 243268 rs505404 T G 0.73 0.27 0.95 0.05 160.61 8.31E-37 4.25E-35 Ref NAT 
11 4159457 rs9937 A G 0.70 0.30 0.60 0.40 7.08 7.78E-03 2.68E-02 Ref AFR 
11 8639200 rs4929923 T C 0.32 0.68 0.57 0.43 44.39 2.69E-11 3.15E-10 Alt EUR 
11 12159661 rs1994318 C A 0.74 0.26 0.50 0.50 39.55 3.19E-10 3.32E-09 Ref AFR 
11 13293905 rs900145 C T 0.52 0.48 0.43 0.57 6.15 1.32E-02 4.31E-02 Ref AFR 
11 20659757 rs2298826 G A 0.64 0.36 0.52 0.48 9.43 2.13E-03 8.37E-03 Ref AFR 
11 27667202 rs925946 T G 0.17 0.83 0.08 0.92 17.51 2.85E-05 1.56E-04 Alt NAT 
11 27670108 rs10501087 T C 0.90 0.10 0.58 0.42 70.52 4.54E-17 8.72E-16 Ref AFR 
11 27677041 rs7124442 C T 0.19 0.81 0.10 0.90 12.18 4.83E-04 2.13E-03 Alt NAT 
11 27679916 rs6265 C T 0.90 0.10 0.56 0.44 80.26 3.28E-19 7.25E-18 Ref AFR 
11 27684517 rs11030104 A G 0.90 0.10 0.55 0.45 82.83 8.92E-20 2.06E-18 Ref AFR 
11 27700125 rs7103411 C T 0.10 0.90 0.45 0.55 82.83 8.92E-20 2.06E-18 Alt AFR 
11 32895664 rs10767971 T C 0.18 0.82 0.52 0.48 76.54 2.16E-18 4.54E-17 Alt AFR 
11 35123051 rs1559759 C A 0.93 0.07 0.70 0.30 42.61 6.70E-11 7.51E-10 Ref AFR 
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11 43648368 rs4237643 T G 0.12 0.88 0.20 0.80 7.21 7.27E-03 2.51E-02 Alt NAT 
11 61557803 rs102275 T C 0.16 0.84 0.65 0.35 173.19 1.48E-39 8.48E-38 Alt AFR 
11 64048912 rs477895 C T 0.08 0.92 0.26 0.74 27.60 1.49E-07 1.14E-06 Alt EUR 
11 64360274 rs11231825 T C 0.78 0.22 0.66 0.34 10.56 1.16E-03 4.78E-03 Ref AFR 
11 69462910 rs9344 G A 0.70 0.30 0.45 0.55 44.00 3.29E-11 3.81E-10 Ref AFR 
11 74907582 rs2306168 C T 0.90 0.10 0.79 0.21 11.66 6.40E-04 2.76E-03 Ref EUR 
11 80377052 rs17140547 C T 0.99 0.01 0.80 0.20 39.18 3.86E-10 3.98E-09 Ref AFR 
11 81235150 rs2032381 G T 0.98 0.02 0.71 0.29 62.59 2.55E-15 4.27E-14 Ref AFR 
11 82564294 rs2229437 T G 0.95 0.05 0.88 0.12 7.82 5.16E-03 1.84E-02 Ref AFR 
11 101771433 rs11225055 T C 0.89 0.11 0.70 0.30 32.03 1.52E-08 1.30E-07 Ref AFR 
11 112026156 rs5744247 G C 0.78 0.22 0.59 0.41 24.87 6.14E-07 4.27E-06 Ref AFR 
11 113306765 rs4436578 C T 0.28 0.72 0.37 0.63 6.46 1.11E-02 3.70E-02 Alt EUR 
11 119099906 rs4938642 G C 0.99 0.01 0.82 0.18 35.51 2.54E-09 2.38E-08 Ref AFR 
11 131807171 rs12098973 A G 0.92 0.08 0.75 0.25 28.02 1.20E-07 9.22E-07 Ref EUR 
11 133120937 rs2078454 C A 0.84 0.16 0.91 0.09 10.53 1.18E-03 4.84E-03 Ref NAT 
12 2757769 rs2239128 T C 0.05 0.95 0.36 0.64 69.14 9.19E-17 1.73E-15 Alt EUR 
12 6291093 rs7342306 G A 0.84 0.16 0.63 0.37 30.89 2.73E-08 2.26E-07 Ref AFR 
12 6451590 rs4149570 A C 0.29 0.71 0.45 0.55 17.35 3.11E-05 1.69E-04 Alt AFR 
12 6953257 rs11064426 A C 0.69 0.31 0.52 0.48 18.49 1.71E-05 9.69E-05 Ref EUR 
12 10170727 rs11053548 A G 0.92 0.08 0.77 0.23 22.49 2.11E-06 1.36E-05 Ref AFR 
12 10471050 rs12303914 A G 0.09 0.91 0.26 0.74 24.04 9.43E-07 6.38E-06 Alt NAT 
12 11547532 rs2900174 A G 0.84 0.16 0.91 0.09 9.94 1.62E-03 6.52E-03 Ref EUR 
12 11855624 rs2187642 A C 0.18 0.82 0.54 0.46 91.26 1.26E-21 3.26E-20 Alt EUR 
12 20860093 rs3794271 G A 0.74 0.26 0.27 0.73 186.00 2.37E-42 1.46E-40 Ref AFR 
12 21283322 rs4149015 G A 0.99 0.01 0.89 0.11 19.20 1.18E-05 6.84E-05 Ref AFR 
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12 21327740 rs4149036 C A 0.81 0.19 0.55 0.45 45.96 1.21E-11 1.45E-10 Ref EUR 
12 21329738 rs2306283 A G 0.53 0.47 0.29 0.71 48.20 3.85E-12 4.88E-11 Ref EUR 
12 21377559 rs4149080 G C 0.81 0.19 0.61 0.39 28.63 8.76E-08 6.81E-07 Ref EUR 
12 21378021 rs4149081 G A 0.81 0.19 0.61 0.39 28.63 8.76E-08 6.81E-07 Ref EUR 
12 25484193 rs7965364 C T 0.36 0.64 0.27 0.73 6.62 1.01E-02 3.40E-02 Alt EUR 
12 50247468 rs7138803 G A 0.80 0.20 0.69 0.31 8.98 2.73E-03 1.04E-02 Ref AFR 
12 50350953 rs296766 T C 0.04 0.96 0.14 0.86 14.53 1.38E-04 6.70E-04 Alt EUR 
12 51357542 rs12304921 A G 0.87 0.13 0.59 0.41 55.95 7.42E-14 1.10E-12 Ref AFR 
12 54270228 rs2120991 C A 0.94 0.06 0.82 0.18 16.19 5.73E-05 2.98E-04 Ref AFR 
12 54736470 rs4326844 A G 0.11 0.89 0.46 0.54 82.47 1.08E-19 2.47E-18 Alt AFR 
12 58144665 rs2069502 C T 0.63 0.37 0.44 0.56 26.06 3.31E-07 2.40E-06 Ref AFR 
12 58145156 rs2270777 C T 0.88 0.12 0.79 0.21 8.10 4.44E-03 1.60E-02 Ref NAT 
12 66359752 rs8756 C A 0.33 0.67 0.17 0.83 30.31 3.69E-08 3.01E-07 Alt NAT 
12 77738005 rs6538140 G A 0.26 0.74 0.43 0.57 18.82 1.43E-05 8.22E-05 Alt AFR 
12 88890671 rs995030 A G 0.08 0.92 0.29 0.71 38.79 4.72E-10 4.83E-09 Alt EUR 
12 88953959 rs4474514 G A 0.08 0.92 0.30 0.70 40.01 2.53E-10 2.66E-09 Alt EUR 
12 96479267 rs2660869 G C 0.88 0.12 0.96 0.04 33.86 5.92E-09 5.29E-08 Ref NAT 
12 102965329 rs7964748 A G 0.89 0.11 0.81 0.19 7.55 6.02E-03 2.12E-02 Ref NAT 
12 112190438 rs6490294 C A 0.78 0.22 0.24 0.76 272.05 4.05E-61 4.04E-59 Ref EUR 
12 112817783 rs11066280 T A 0.99 0.01 0.85 0.15 28.38 9.98E-08 7.72E-07 Ref AFR 
12 115094260 rs11067228 A G 0.32 0.68 0.54 0.46 30.65 3.10E-08 2.55E-07 Alt EUR 
12 117327592 rs7294919 T C 0.93 0.07 0.77 0.23 24.26 8.43E-07 5.74E-06 Ref EUR 
12 124460167 rs4765127 G T 0.74 0.26 0.84 0.16 14.27 1.59E-04 7.64E-04 Ref NAT 
12 125312425 rs10846744 G C 0.81 0.19 0.48 0.52 73.88 8.30E-18 1.67E-16 Ref EUR 
12 125348263 rs4238001 C T 0.94 0.06 0.97 0.03 9.22 2.40E-03 9.32E-03 Ref NAT 
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12 129637348 rs12824981 C T 0.81 0.19 0.88 0.12 6.57 1.03E-02 3.48E-02 Ref NAT 
12 133417802 rs3741489 T C 0.75 0.25 0.66 0.34 5.89 1.52E-02 4.94E-02 Ref EUR 
13 21876096 rs9788333 C G 0.86 0.14 0.70 0.30 20.42 6.22E-06 3.75E-05 Ref AFR 
13 27415673 rs9319321 A T 0.53 0.47 0.32 0.68 35.17 3.02E-09 2.80E-08 Ref NAT 
13 46703142 rs7324845 G A 0.06 0.94 0.13 0.87 8.50 3.56E-03 1.32E-02 Alt EUR 
13 47409034 rs6314 G A 0.94 0.06 0.97 0.03 9.22 2.40E-03 9.32E-03 Ref NAT 
13 47469940 rs6313 G A 0.74 0.26 0.50 0.50 35.79 2.19E-09 2.07E-08 Ref AFR 
13 52566126 rs9535826 T G 0.65 0.35 0.47 0.53 21.25 4.03E-06 2.50E-05 Ref AFR 
13 95863008 rs11568658 C A 0.92 0.08 0.85 0.15 6.75 9.36E-03 3.17E-02 Ref AFR 
13 103528002 rs17655 G C 0.72 0.28 0.57 0.43 15.00 1.07E-04 5.30E-04 Ref EUR 
14 23861811 rs365990 A G 0.88 0.12 0.77 0.23 13.08 2.99E-04 1.37E-03 Ref NAT 
14 23865885 rs452036 G A 0.88 0.12 0.78 0.22 10.98 9.21E-04 3.87E-03 Ref NAT 
14 41523462 rs1959947 A G 0.44 0.56 0.26 0.74 29.47 5.69E-08 4.54E-07 Alt NAT 
14 48015982 rs1160351 A C 0.75 0.25 0.40 0.60 91.66 1.03E-21 2.67E-20 Ref AFR 
14 81598912 rs17111530 T C 0.96 0.04 0.74 0.26 41.98 9.23E-11 1.02E-09 Ref EUR 
14 97171075 rs17244419 C T 0.98 0.02 0.82 0.18 29.51 5.57E-08 4.45E-07 Ref AFR 
14 101159416 rs7149242 T G 0.25 0.75 0.41 0.59 16.49 4.89E-05 2.58E-04 Alt EUR 
14 101679255 rs6575836 G A 0.29 0.71 0.41 0.59 9.71 1.83E-03 7.27E-03 Alt AFR 
14 103040087 rs11628318 T A 0.58 0.42 0.40 0.60 23.55 1.21E-06 8.12E-06 Ref AFR 
14 103566785 rs2297067 C T 0.87 0.13 0.74 0.26 15.99 6.38E-05 3.27E-04 Ref AFR 
14 104165753 rs861539 G A 0.94 0.06 0.87 0.13 7.52 6.11E-03 2.15E-02 Ref NAT 
14 105263608 rs2494752 A G 0.38 0.62 0.64 0.36 49.15 2.37E-12 3.06E-11 Alt EUR 
15 28365618 rs12913832 A G 0.89 0.11 0.94 0.06 8.61 3.35E-03 1.25E-02 Ref AFR 
15 29731444 rs11856574 G A 0.80 0.20 0.67 0.33 13.96 1.87E-04 8.87E-04 Ref EUR 
15 42683787 rs2412710 G A 0.96 0.04 0.99 0.01 8.10 4.44E-03 1.60E-02 Ref NAT 
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15 45500047 rs765787 A G 0.82 0.18 0.70 0.30 11.20 8.16E-04 3.46E-03 Ref AFR 
15 48392165 rs1834640 A G 0.45 0.55 0.26 0.74 31.40 2.10E-08 1.77E-07 Alt AFR 
15 51545454 rs12907866 A G 0.79 0.21 0.54 0.46 43.80 3.63E-11 4.19E-10 Ref AFR 
15 54380200 rs11071033 T C 0.76 0.24 0.58 0.42 21.77 3.08E-06 1.95E-05 Ref AFR 
15 58683366 rs1532085 A G 0.36 0.64 0.46 0.54 6.06 1.38E-02 4.50E-02 Alt EUR 
15 60781513 rs3743266 T C 0.88 0.12 0.75 0.25 15.31 9.15E-05 4.58E-04 Ref NAT 
15 65183801 rs1719271 A G 0.59 0.41 0.39 0.61 26.83 2.23E-07 1.65E-06 Ref EUR 
15 71424009 rs12904863 T C 0.94 0.06 0.69 0.31 46.57 8.83E-12 1.08E-10 Ref AFR 
15 74176557 rs16958445 G A 0.99 0.01 0.88 0.12 18.36 1.83E-05 1.03E-04 Ref AFR 
15 75041341 rs2069526 T G 0.97 0.03 0.92 0.08 6.30 1.20E-02 3.98E-02 Ref EUR 
15 75043281 rs4646425 C T 0.97 0.03 0.92 0.08 6.30 1.20E-02 3.98E-02 Ref AFR 
15 75045692 rs4646427 T C 0.97 0.03 0.92 0.08 6.30 1.20E-02 3.98E-02 Ref EUR 
15 75047426 rs2470890 C T 0.88 0.12 0.80 0.20 6.35 1.17E-02 3.89E-02 Ref AFR 
15 78865425 rs588765 T C 0.09 0.91 0.20 0.80 11.91 5.58E-04 2.43E-03 Alt NAT 
15 79552379 rs8025118 G T 0.71 0.29 0.54 0.46 19.89 8.21E-06 4.87E-05 Ref EUR 
15 87064089 rs12591257 A C 0.99 0.01 0.92 0.08 11.99 5.34E-04 2.33E-03 Ref AFR 
16 14388305 rs1659127 G A 0.86 0.14 0.52 0.48 79.33 5.26E-19 1.15E-17 Ref AFR 
16 16236650 rs212091 T C 0.91 0.09 0.78 0.22 17.93 2.29E-05 1.27E-04 Ref AFR 
16 23909952 rs9922316 T G 0.10 0.90 0.05 0.95 10.63 1.12E-03 4.62E-03 Alt NAT 
16 27375787 rs8832 A G 0.38 0.62 0.56 0.44 21.47 3.59E-06 2.25E-05 Alt EUR 
16 27376217 rs1029489 A G 0.35 0.65 0.55 0.45 27.51 1.56E-07 1.18E-06 Alt EUR 
16 30918487 rs11649653 C G 0.61 0.39 0.16 0.84 261.05 1.01E-58 9.51E-57 Ref AFR 
16 31048079 rs10871454 C T 0.61 0.39 0.17 0.83 246.96 1.19E-55 1.05E-53 Ref AFR 
16 31099011 rs11150606 T C 0.65 0.35 0.33 0.67 76.96 1.74E-18 3.69E-17 Ref AFR 
16 31102321 rs7294 C T 0.44 0.56 0.89 0.11 351.32 2.19E-78 3.01E-76 Alt AFR 
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16 31103796 rs2359612 A G 0.39 0.61 0.83 0.17 246.96 1.19E-55 1.05E-53 Alt AFR 
16 31104509 rs8050894 C G 0.61 0.39 0.16 0.84 246.96 1.19E-55 1.05E-53 Ref AFR 
16 31104878 rs9934438 G A 0.61 0.39 0.17 0.83 233.86 8.59E-53 7.07E-51 Ref AFR 
16 31107689 rs9923231 C T 0.62 0.38 0.17 0.83 240.14 3.67E-54 3.11E-52 Ref AFR 
16 31110981 rs7196161 G A 0.39 0.61 0.84 0.16 261.05 1.01E-58 9.51E-57 Alt EUR 
16 53769677 rs6499640 G A 0.83 0.17 0.74 0.26 6.90 8.62E-03 2.95E-02 Ref NAT 
16 53816275 rs8050136 C A 0.92 0.08 0.80 0.20 13.57 2.29E-04 1.08E-03 Ref NAT 
16 53820527 rs9939609 T A 0.92 0.08 0.80 0.20 14.71 1.26E-04 6.13E-04 Ref NAT 
16 53876751 rs12595985 C A 0.94 0.06 0.74 0.26 34.94 3.41E-09 3.15E-08 Ref EUR 
16 55844609 rs2244613 G T 0.36 0.64 0.54 0.46 21.28 3.96E-06 2.46E-05 Alt EUR 
16 58567238 rs37062 A G 0.48 0.52 0.66 0.34 27.03 2.01E-07 1.49E-06 Alt NAT 
16 65895364 rs1126179 A G 0.35 0.65 0.22 0.78 16.72 4.33E-05 2.30E-04 Alt NAT 
16 72108093 rs2000999 G A 0.89 0.11 0.71 0.29 27.55 1.53E-07 1.16E-06 Ref AFR 
16 75167579 rs7195303 G A 0.07 0.93 0.20 0.80 17.79 2.46E-05 1.36E-04 Alt AFR 
16 80497601 rs4581712 C A 0.81 0.19 0.57 0.43 36.65 1.42E-09 1.37E-08 Ref AFR 
16 84046715 rs11864146 A G 0.81 0.19 0.93 0.07 39.54 3.21E-10 3.33E-09 Ref EUR 
16 84987679 rs2326458 C A 0.55 0.45 0.34 0.66 33.92 5.75E-09 5.16E-08 Ref AFR 
16 85906616 rs11648716 A G 0.96 0.04 0.99 0.01 12.65 3.76E-04 1.69E-03 Ref NAT 
16 85961562 rs17444745 G A 0.92 0.08 0.83 0.17 9.62 1.92E-03 7.63E-03 Ref AFR 
16 89613123 rs2292954 A G 0.97 0.03 0.86 0.14 16.29 5.43E-05 2.83E-04 Ref AFR 
16 89985940 rs2228479 G A 0.99 0.01 0.82 0.18 33.18 8.40E-09 7.41E-08 Ref AFR 
16 89986608 rs2228478 A G 0.96 0.04 0.80 0.20 28.82 7.93E-08 6.19E-07 Ref EUR 
17 7091650 rs314253 T C 0.42 0.58 0.54 0.46 9.46 2.10E-03 8.26E-03 Alt NAT 
17 18232096 rs1979277 G A 0.78 0.22 0.89 0.11 21.39 3.75E-06 2.34E-05 Ref NAT 
17 19804247 rs397969 T C 0.62 0.38 0.79 0.21 27.63 1.47E-07 1.12E-06 Ref NAT 
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17 28525011 rs1042173 A C 0.34 0.66 0.25 0.75 7.11 7.64E-03 2.63E-02 Alt NAT 
17 28564346 rs25531 T C 0.97 0.03 0.90 0.10 8.35 3.86E-03 1.42E-02 Ref EUR 
17 32574448 rs4795893 G A 0.30 0.70 0.40 0.60 6.31 1.20E-02 3.98E-02 Alt AFR 
17 32583132 rs2857657 G C 0.02 0.98 0.09 0.91 10.53 1.18E-03 4.84E-03 Alt AFR 
17 32583269 rs4586 T C 0.31 0.69 0.40 0.60 7.05 7.93E-03 2.73E-02 Alt AFR 
17 43892520 rs242941 A C 0.25 0.75 0.13 0.87 20.88 4.88E-06 2.99E-05 Alt NAT 
17 49960309 rs967676 T C 0.85 0.15 0.73 0.27 12.97 3.17E-04 1.45E-03 Ref AFR 
17 54850329 rs4794665 A G 0.11 0.89 0.19 0.81 6.51 1.08E-02 3.60E-02 Alt NAT 
17 61712964 rs7209435 T C 0.76 0.24 0.88 0.12 22.67 1.93E-06 1.25E-05 Ref NAT 
17 68259446 rs623011 A G 0.24 0.76 0.42 0.58 21.77 3.08E-06 1.95E-05 Alt AFR 
17 68326338 rs312691 T C 0.77 0.23 0.60 0.40 19.31 1.11E-05 6.46E-05 Ref AFR 
17 68976415 rs6501431 C T 0.14 0.86 0.05 0.95 23.00 1.62E-06 1.07E-05 Alt NAT 
17 70098161 rs9913711 G C 0.08 0.92 0.23 0.77 20.80 5.11E-06 3.12E-05 Alt NAT 
17 74499400 rs12948783 G A 0.85 0.15 0.92 0.08 11.99 5.34E-04 2.33E-03 Ref NAT 
17 75313335 rs4788985 A G 0.36 0.64 0.48 0.52 9.42 2.14E-03 8.41E-03 Alt NAT 
17 78324259 rs12051723 G T 0.96 0.04 0.76 0.24 39.37 3.50E-10 3.62E-09 Ref AFR 
17 78348494 rs6565681 A G 0.63 0.37 0.37 0.63 48.82 2.80E-12 3.59E-11 Ref NAT 
18 3512216 rs17724172 T C 0.94 0.06 0.83 0.17 15.01 1.07E-04 5.29E-04 Ref AFR 
18 5978931 rs1539808 C T 0.98 0.02 0.80 0.20 31.62 1.87E-08 1.58E-07 Ref EUR 
18 20720973 rs11082304 G T 0.69 0.31 0.53 0.47 18.51 1.69E-05 9.58E-05 Ref AFR 
18 22044400 rs4483927 G T 0.20 0.80 0.37 0.63 21.21 4.12E-06 2.55E-05 Alt EUR 
18 55816791 rs4149601 G A 0.94 0.06 0.75 0.25 31.88 1.64E-08 1.40E-07 Ref NAT 
18 57673799 rs12964056 A G 0.37 0.63 0.28 0.72 7.53 6.07E-03 2.14E-02 Alt EUR 
18 61176266 rs2032224 C A 0.39 0.61 0.22 0.78 28.50 9.36E-08 7.27E-07 Alt NAT 
18 62898666 rs637644 A G 0.31 0.69 0.20 0.80 13.27 2.69E-04 1.25E-03 Alt NAT 
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18 63031236 rs470490 G T 0.21 0.79 0.37 0.63 18.51 1.69E-05 9.59E-05 Alt AFR 
19 8672000 rs7249094 G A 0.46 0.54 0.21 0.79 65.16 6.91E-16 1.21E-14 Alt NAT 
19 10000322 rs1862471 C G 0.44 0.56 0.65 0.35 33.38 7.57E-09 6.70E-08 Alt EUR 
19 10310392 rs2116940 A G 0.74 0.26 0.63 0.37 9.10 2.55E-03 9.86E-03 Ref EUR 
19 10395683 rs5498 A G 0.28 0.72 0.70 0.30 145.21 1.93E-33 8.77E-32 Alt EUR 
19 10397403 rs3093030 C T 0.28 0.72 0.75 0.25 194.28 3.70E-44 2.39E-42 Alt EUR 
19 11227326 rs2738446 C G 0.49 0.51 0.79 0.21 88.10 6.22E-21 1.54E-19 Alt EUR 
19 15990431 rs2108622 C T 0.88 0.12 0.76 0.24 14.17 1.67E-04 7.99E-04 Ref AFR 
19 29736342 rs11083866 G A 0.69 0.31 0.55 0.45 13.71 2.14E-04 1.01E-03 Ref AFR 
19 39735106 rs8103142 T C 0.62 0.38 0.88 0.12 109.71 1.14E-25 3.65E-24 Ref NAT 
19 39738787 rs12979860 C T 0.62 0.38 0.88 0.12 109.71 1.14E-25 3.65E-24 Ref NAT 
19 41356379 rs28399433 A C 0.91 0.09 0.77 0.23 16.40 5.12E-05 2.69E-04 Ref EUR 
19 41515702 rs2279345 T C 0.10 0.90 0.32 0.68 37.15 1.09E-09 1.07E-08 Alt AFR 
19 41858876 rs1800471 C G 0.98 0.02 0.99 0.01 9.05 2.62E-03 9.98E-03 Ref NAT 
19 41860296 rs1800469 A G 0.57 0.43 0.45 0.55 9.50 2.06E-03 8.11E-03 Ref NAT 
19 45376284 rs519113 C G 0.71 0.29 0.81 0.19 11.13 8.52E-04 3.60E-03 Ref NAT 
19 45403412 rs1160985 C T 0.43 0.57 0.65 0.35 37.48 9.22E-10 9.09E-09 Alt AFR 
19 45412079 rs7412 C T 0.99 0.01 0.90 0.10 16.73 4.30E-05 2.29E-04 Ref EUR 
19 45414451 rs439401 T C 0.76 0.24 0.53 0.47 37.78 7.93E-10 7.89E-09 Ref NAT 
19 45415640 rs445925 G A 0.98 0.02 0.88 0.12 14.51 1.40E-04 6.77E-04 Ref EUR 
19 46172278 rs11671664 G A 0.96 0.04 0.60 0.40 91.20 1.30E-21 3.35E-20 Ref AFR 
20 17122593 rs852069 A G 0.63 0.37 0.72 0.28 6.53 1.06E-02 3.55E-02 Ref NAT 
20 38820805 rs6028945 G T 0.96 0.04 0.88 0.12 9.58 1.97E-03 7.79E-03 Ref AFR 
20 45288453 rs6066043 G A 0.76 0.24 0.51 0.49 41.53 1.16E-10 1.27E-09 Ref AFR 
20 60791404 rs3787429 C T 0.44 0.56 0.59 0.41 17.78 2.48E-05 1.37E-04 Alt AFR 
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20 61981104 rs1044397 C T 0.46 0.54 0.63 0.37 19.77 8.73E-06 5.15E-05 Alt EUR 
20 61981134 rs1044396 G A 0.46 0.54 0.74 0.26 67.74 1.87E-16 3.44E-15 Alt EUR 
21 28217320 rs402007 C G 0.65 0.35 0.50 0.50 14.71 1.26E-04 6.13E-04 Ref NAT 
21 41415044 rs9981861 T C 0.70 0.30 0.79 0.21 7.93 4.86E-03 1.75E-02 Ref NAT 
21 42216955 rs2837857 C T 0.69 0.31 0.77 0.23 6.52 1.07E-02 3.57E-02 Ref EUR 
21 46957794 rs1051266 T C 0.37 0.63 0.49 0.51 9.42 2.15E-03 8.42E-03 Alt NAT 
22 19951207 rs4818 C G 0.85 0.15 0.64 0.36 34.76 3.74E-09 3.44E-08 Ref AFR 
22 19952132 rs4646316 C T 0.89 0.11 0.68 0.32 33.25 8.12E-09 7.17E-08 Ref AFR 
22 19956781 rs165599 G A 0.65 0.35 0.44 0.56 31.01 2.56E-08 2.14E-07 Ref AFR 
22 22512415 rs987710 G A 0.18 0.82 0.30 0.70 13.41 2.50E-04 1.17E-03 Alt NAT 
22 24295286 rs2739330 T C 0.82 0.18 0.60 0.40 37.10 1.12E-09 1.10E-08 Ref AFR 
22 29196757 rs2269577 G C 0.66 0.34 0.46 0.54 29.08 6.94E-08 5.49E-07 Ref EUR 
22 37097564 rs2284018 C T 0.84 0.16 0.71 0.29 14.99 1.08E-04 5.35E-04 Ref AFR 
22 40075400 rs2294369 G A 0.82 0.18 0.91 0.09 15.52 8.15E-05 4.10E-04 Ref AFR 
22 42524947 rs3892097 C T 0.94 0.06 0.97 0.03 7.42 6.46E-03 2.26E-02 Ref NAT 
22 42526694 rs1065852 G A 0.93 0.07 0.49 0.51 136.08 1.92E-31 8.05E-30 Ref AFR 
22 42528976 rs28360521 C T 0.93 0.07 0.49 0.51 132.43 1.21E-30 4.87E-29 Ref EUR 
22 46594035 rs149711321 T C 0.98 0.02 1.00 0.00 9.05 2.62E-03 9.98E-03 Ref NAT 
Puerto Rico 
1 16505320 rs1497406 A G 0.59 0.41 0.46 0.54 14.10 1.73E-04 5.92E-03 Ref AFR 
1 65992625 rs1751492 C T 0.20 0.80 0.37 0.63 26.72 2.35E-07 2.89E-05 Alt EUR 
1 76839536 rs12144344 C T 0.80 0.20 0.67 0.33 15.81 7.00E-05 2.71E-03 Ref AFR 
1 154418879 rs4537545 C T 0.45 0.55 0.55 0.45 9.41 2.15E-03 4.20E-02 Alt AFR 
1 226013355 rs1877724 C T 0.85 0.15 0.76 0.24 9.50 2.05E-03 4.06E-02 Ref AFR 
2 10262920 rs1130609 T G 0.40 0.60 0.29 0.71 12.27 4.60E-04 1.26E-02 Alt AFR 
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2 27742603 rs780093 T C 0.32 0.68 0.42 0.58 8.69 3.21E-03 4.97E-02 Alt AFR 
2 105897740 rs1020064 T G 0.14 0.86 0.23 0.77 8.91 2.84E-03 4.51E-02 Alt AFR 
2 108994808 rs1402467 C G 0.79 0.21 0.68 0.32 12.68 3.69E-04 1.08E-02 Ref NAT 
2 113594867 rs16944 A G 0.53 0.47 0.38 0.62 19.61 9.48E-06 6.14E-04 Ref AFR 
2 113598107 rs4848306 G A 0.66 0.34 0.54 0.46 12.11 5.02E-04 1.32E-02 Ref AFR 
2 130468366 rs10928927 C T 0.31 0.69 0.21 0.79 12.93 3.24E-04 9.81E-03 Alt EUR 
2 152981335 rs16830728 G T 0.91 0.09 0.81 0.19 11.62 6.51E-04 1.64E-02 Ref EUR 
2 201021954 rs1569175 T C 0.19 0.81 0.11 0.89 16.47 4.94E-05 2.39E-03 Alt EUR 
3 2624938 rs2619566 G A 0.36 0.64 0.20 0.80 32.49 1.20E-08 1.93E-06 Alt EUR 
3 45300605 rs33794 A G 0.72 0.28 0.54 0.46 25.11 5.41E-07 5.03E-05 Ref NAT 
3 117574822 rs6438424 A C 0.66 0.34 0.54 0.46 12.09 5.07E-04 1.33E-02 Ref AFR 
3 160429869 rs7624766 A G 0.67 0.33 0.53 0.47 16.23 5.62E-05 2.39E-03 Ref EUR 
4 18017730 rs6830062 T C 0.74 0.26 0.83 0.17 13.74 2.10E-04 6.88E-03 Ref EUR 
4 100239319 rs1229984 T C 0.06 0.94 0.16 0.84 14.41 1.47E-04 5.15E-03 Alt AFR 
5 58713680 rs2547917 G A 0.89 0.11 0.79 0.21 11.73 6.16E-04 1.56E-02 Ref AFR 
5 93810208 rs6869388 T C 0.73 0.27 0.82 0.18 11.62 6.51E-04 1.64E-02 Ref NAT 
5 137707315 rs757647 G A 0.82 0.18 0.66 0.34 24.56 7.22E-07 6.17E-05 Ref EUR 
5 165377699 rs9313296 G C 0.86 0.14 0.92 0.08 9.22 2.39E-03 4.25E-02 Ref NAT 
6 7102084 rs675209 T C 0.31 0.69 0.45 0.55 16.32 5.34E-05 2.39E-03 Alt EUR 
6 18139802 rs12201199 A T 0.81 0.19 0.89 0.11 12.51 4.04E-04 1.14E-02 Ref NAT 
6 32448599 rs7748270 C T 0.40 0.60 0.51 0.49 9.31 2.28E-03 4.25E-02 Alt NAT 
6 32604372 rs9272346 G A 0.35 0.65 0.46 0.54 9.38 2.20E-03 4.25E-02 Alt NAT 
6 32972404 rs3128935 T C 0.80 0.20 0.89 0.11 15.84 6.90E-05 2.67E-03 Ref EUR 
6 124951063 rs504008 A C 0.44 0.56 0.33 0.67 11.56 6.75E-04 1.68E-02 Alt EUR 
6 142512136 rs225675 A G 0.75 0.25 0.64 0.36 12.01 5.29E-04 1.38E-02 Ref AFR 
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6 149329267 rs2500535 A G 0.13 0.87 0.06 0.94 16.08 6.07E-05 2.39E-03 Alt EUR 
6 155929801 rs35229355 C T 1.00 0.00 0.90 0.10 19.97 7.87E-06 5.21E-04 Ref EUR 
6 160113872 rs4880 A G 0.46 0.54 0.61 0.39 22.12 2.56E-06 2.00E-04 Alt EUR 
6 160560845 rs628031 A G 0.25 0.75 0.37 0.63 11.88 5.68E-04 1.46E-02 Alt NAT 
7 32444435 rs215738 G A 0.16 0.84 0.09 0.91 13.03 3.06E-04 9.44E-03 Alt NAT 
7 37266352 rs4723619 T C 0.88 0.12 0.95 0.05 16.22 5.64E-05 2.39E-03 Ref EUR 
7 80236014 rs13236689 T G 0.67 0.33 0.56 0.44 11.23 8.06E-04 1.94E-02 Ref EUR 
7 87152103 rs4148740 A G 0.92 0.08 0.85 0.15 9.45 2.11E-03 4.12E-02 Ref NAT 
7 87153585 rs10280101 A C 0.92 0.08 0.85 0.15 9.45 2.11E-03 4.12E-02 Ref NAT 
7 87157051 rs7787082 G A 0.80 0.20 0.68 0.32 13.76 2.08E-04 6.83E-03 Ref EUR 
7 87160561 rs2032583 A G 0.92 0.08 0.85 0.15 9.45 2.11E-03 4.12E-02 Ref NAT 
7 87161049 rs4148739 T C 0.92 0.08 0.85 0.15 9.45 2.11E-03 4.12E-02 Ref NAT 
7 87161520 rs11983225 T C 0.92 0.08 0.85 0.15 9.45 2.11E-03 4.12E-02 Ref NAT 
7 87164986 rs10248420 A G 0.82 0.18 0.69 0.31 14.23 1.62E-04 5.60E-03 Ref EUR 
7 94925820 rs854548 A G 0.33 0.67 0.24 0.76 9.50 2.05E-03 4.06E-02 Alt EUR 
7 99361466 rs2242480 C T 0.66 0.34 0.77 0.23 14.33 1.54E-04 5.35E-03 Ref EUR 
7 99382096 rs2740574 C T 0.19 0.81 0.12 0.88 10.60 1.13E-03 2.55E-02 Alt NAT 
7 127164958 rs6467136 A G 0.62 0.38 0.42 0.58 31.52 1.98E-08 2.99E-06 Ref EUR 
7 139702593 rs17837497 G A 0.95 0.05 0.99 0.01 21.65 3.28E-06 2.44E-04 Ref NAT 
8 4078353 rs2407314 G C 0.43 0.57 0.57 0.43 15.36 8.91E-05 3.35E-03 Alt AFR 
8 54119214 rs1425902 G A 0.49 0.51 0.39 0.61 8.92 2.83E-03 4.50E-02 Alt NAT 
8 129787976 rs10956445 T C 0.87 0.13 0.78 0.22 11.00 9.14E-04 2.15E-02 Ref AFR 
9 14446001 rs1556032 C T 0.46 0.54 0.60 0.40 19.35 1.09E-05 6.94E-04 Alt NAT 
9 124565820 rs10760187 T C 0.57 0.43 0.39 0.61 27.56 1.52E-07 1.98E-05 Ref EUR 
9 132501881 rs2302821 A C 0.91 0.09 0.80 0.20 14.70 1.26E-04 4.48E-03 Ref EUR 
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10 26734587 rs2992257 C T 0.85 0.15 0.74 0.26 13.23 2.75E-04 8.70E-03 Ref AFR 
10 64963449 rs4379723 T C 0.62 0.38 0.50 0.50 11.08 8.74E-04 2.07E-02 Ref AFR 
10 65133822 rs7923609 A G 0.61 0.39 0.50 0.50 9.31 2.28E-03 4.25E-02 Ref AFR 
11 12159661 rs1994318 C A 0.52 0.48 0.42 0.58 9.56 1.99E-03 3.94E-02 Ref AFR 
11 35123051 rs1559759 C A 0.94 0.06 0.81 0.19 22.56 2.03E-06 1.61E-04 Ref AFR 
11 61557803 rs102275 T C 0.39 0.61 0.63 0.37 49.51 1.97E-12 7.27E-10 Alt AFR 
11 67715028 rs308309 C T 0.12 0.88 0.23 0.77 16.69 4.41E-05 2.24E-03 Alt AFR 
11 133120937 rs2078454 C A 0.67 0.33 0.77 0.23 10.68 1.08E-03 2.47E-02 Ref NAT 
12 2757769 rs2239128 T C 0.21 0.79 0.31 0.69 9.03 2.66E-03 4.28E-02 Alt EUR 
12 6291093 rs7342306 G A 0.80 0.20 0.66 0.34 19.25 1.15E-05 7.30E-04 Ref AFR 
12 20860093 rs3794271 G A 0.49 0.51 0.37 0.63 11.82 5.87E-04 1.50E-02 Alt NAT 
12 58144665 rs2069502 C T 0.83 0.17 0.70 0.30 16.60 4.62E-05 2.29E-03 Ref AFR 
12 77436148 rs310786 C T 0.13 0.88 0.21 0.79 9.34 2.24E-03 4.25E-02 Alt AFR 
12 115094260 rs11067228 A G 0.45 0.55 0.57 0.43 11.28 7.83E-04 1.90E-02 Alt EUR 
12 117002658 rs2089222 G A 0.81 0.19 0.90 0.10 22.13 2.55E-06 1.99E-04 Ref EUR 
13 52566126 rs9535826 T G 0.63 0.37 0.45 0.55 28.08 1.16E-07 1.54E-05 Ref AFR 
14 73721775 rs11628713 C T 0.89 0.11 0.79 0.21 13.95 1.88E-04 6.30E-03 Ref NAT 
14 101679255 rs6575836 G A 0.14 0.86 0.24 0.76 9.64 1.91E-03 3.83E-02 Alt AFR 
14 105263608 rs2494752 A G 0.13 0.87 0.22 0.78 10.08 1.50E-03 3.18E-02 Alt EUR 
15 63333724 rs3809566 A G 0.21 0.79 0.31 0.69 9.03 2.66E-03 4.28E-02 Alt EUR 
15 71424009 rs12904863 T C 0.95 0.05 0.88 0.12 10.23 1.38E-03 2.97E-02 Ref AFR 
15 78894339 rs1051730 G A 0.77 0.23 0.64 0.36 14.18 1.66E-04 5.73E-03 Ref NAT 
16 7164219 rs1478693 T G 0.55 0.45 0.65 0.35 10.28 1.34E-03 2.92E-02 Ref EUR 
16 10188060 rs7203315 G T 0.83 0.17 0.90 0.10 10.38 1.27E-03 2.79E-02 Ref NAT 
16 14041958 rs1799801 T C 0.81 0.19 0.68 0.32 15.00 1.07E-04 3.92E-03 Ref AFR 
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16 31099011 rs11150606 T C 0.94 0.06 0.86 0.14 9.29 2.31E-03 4.25E-02 Ref AFR 
16 51609947 rs2030114 G A 0.68 0.32 0.80 0.20 17.18 3.39E-05 1.80E-03 Ref NAT 
16 84046715 rs11864146 A G 0.83 0.17 0.90 0.10 14.16 1.68E-04 5.77E-03 Ref EUR 
17 49960309 rs967676 T C 0.70 0.30 0.59 0.41 8.81 3.00E-03 4.73E-02 Ref AFR 
18 75605399 rs9961113 T C 0.78 0.22 0.67 0.33 11.47 7.06E-04 1.75E-02 Ref EUR 
19 45403412 rs1160985 C T 0.40 0.60 0.58 0.42 27.05 1.98E-07 2.48E-05 Alt AFR 
19 49206985 rs602662 G A 0.50 0.50 0.61 0.39 10.65 1.10E-03 2.49E-02 Alt AFR 
20 61977556 rs2236196 G A 0.44 0.56 0.31 0.69 16.31 5.37E-05 2.39E-03 Alt NAT 
1Chromosome based on human reference genome hg19/GRCh37 
2Position based on human reference genome hg19/GRCh37 
3dbSNP ID of the SNP 
4Base at the reference position 
5Alternate base at the position 
6Observed reference allele frequency 
7Observed alternate allele frequency 
8Expected reference allele frequency as computed from the ancestry proportions and the corresponding observed frequencies of the 
reference allele in the ancestral populations 
9Expected alternate allele frequency as computed from the ancestry proportions and the corresponding observed frequencies of the 
alternate allele in the ancestral populations 
10Chi-square statistic calculated based on ∑(𝑂𝑏𝑠𝑒𝑟𝑣𝑒𝑑 − 𝐸𝑥𝑝𝑒𝑐𝑡𝑒𝑑)2 for reference and alternate alleles 
11P-value calculated based off the chi-square distribution 
12Corresponding FDR q-value 
13Allele (Reference or Alternate) that is enriched in a specific ancestry 




Table 6. Lists of pathways that show significant enrichment of genes with mapped ancestry-enriched SNPs for each admixed 
Latin American population. 
For each pathway with significant enrichment of genes with mapped ancestry-enriched SNPs in at least one of the four populations the 
overlapping genes and FDR 𝑞-values are given. 
Pathway Description 
Colombia Mexico Peru Puerto Rico 


























































































Table 6 (continued). 
KEGG Type I 
Diabetes 
Mellitus 
































































































































































































































































































































Table 6 (continued). 
KEGG Intestinal 
Immune 
Network For IgA 
Production 
Intestinal immune 



















































































































Table 6 (continued). 
KEGG Retinol 
Metabolism 









































































































































































































































































































































































































































































































































































































































































































































































































8.24E-03 IL1B, IL6, 
HLA-DRB1 




































































































3.95E-03 IL15, IL10, 
IL6, HLA-
DRB1 























































































































6.72E-09 NA NA 
BioCarta G1 
Pathway 



















1.03E-07 NA NA 
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B Cell Activation 
FAS, IL10, 
HLA-DRB1 
4.09E-04 FAS, IL10, 
HLA-DRB1 
1.16E-03 FAS, IL4, IL10, 
HLA-DRB1, 
HLA-DRA 













































Gsk3 by AKT 
causes 
accumulation of b-








5.72E-05 GSK3B, GJA1, 
CCND1, 
AKT1, TLR4 
2.60E-04 NA NA 
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3.04E-04 NA NA 
BioCarta IL2RB 
Pathway 
IL-2 Receptor Beta 




8.13E-03 SYK, BAD, 
AKT1, FAS, 
FOS 
2.55E-04 CBL, SYK, 
BAD, AKT1, 
FAS, FOS 

































































































































Fc epsilon RI 
signaling pathway 





























Influence of Ras 
and Rho proteins 











Table 6 (continued). 
KEGG Focal 
Adhesion 
















































































in local acute 
inflammatory 
response 











Hypertrophy of the 
heart 
(Transcription in 














Cytokine Network NA NA IL18, IL15, 
IL10, IL6 
4.29E-04 IL18, TNF, 
IL1A, IL15, 
IL4, IL10, IL8 































































2.80E-05 NA NA 
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Regulation of the 
Estrogen Receptor 










7.60E-04 NA NA 
KEGG Purine 
Metabolism 
















negative effector of 
















































Signaling in Mast 
Cells 













NA NA IL18, IL4R, 
HLA-DRB1 




5.15E-05 NA NA 
KEGG ABC 
Transporters 












2.95E-06 NA NA 




B cell receptor 
signaling pathway 

















































6.47E-03 NA NA NA NA 
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Monocyte and its 
Surface Molecules 































IL1A, KITLG 1.56E-02 NA NA IGF1, IL1A, 
TGFB1, KITLG 





Involved in Platelet 
Activation 
NA NA PLA2G4A, 
PTGS1, SYK 










NA NA FADS1, 
FADS2, 
ACOX3 




Carbon Pool By 
Folate 
One carbon pool by 
folate 
MTR, MTHFR 1.82E-02 NA NA DHFR, 
SHMT1, MTR, 
ATIC, MTHFR 












































Role of EGF 
Receptor 
Transactivation by 
GPCRs in Cardiac 
Hypertrophy 
NA NA NA NA PRKCB, 
EDN1, AGT, 
AGTR1, FOS 





NA NA NA NA SOD1, XDH, 
TNF, IL8 
6.40E-05 NA NA 
BioCarta ALK 
Pathway 
ALK in cardiac 
myocytes 























NA NA MAP3K1, 
AKT1, BAD, 
FOS 
4.75E-04 NA NA NA NA 
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NA NA FGG, F13A1, 
FGA 





of JNK Pathway 
via Pyk2 dependent 
signaling 









NA NA NA NA PRKCB, SYK, 
MAP3K1, FOS, 
LYN 










2.25E-03 NA NA NA NA NA NA 
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Table 6 (continued). 
KEGG Thyroid 
Cancer 
Thyroid cancer CCND1, 
RXRG, 
PPARG 





Regulation of actin 
cytoskeleton 







Dendritic cells in 
regulating TH1 and 
TH2 Development 
NA NA TLR4, TLR2, 
IL10 





NA NA GNAS, 
AKT1, 
ADRB2 
5.29E-03 NA NA NA NA 
BioCarta HER2 
Pathway 




NA NA IL6R, ESR1, 
IL6 
5.29E-03 NA NA NA NA 
BioCarta IL6 
Pathway 
IL 6 signaling 
pathway 
NA NA IL6R, FOS, 
IL6 






NA NA ALDH2, 
ACADM, 
DPYD 







NA NA GSK3B, 
AKT1, BAD 











6.50E-03 NA NA NA NA 
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Table 6 (continued). 
KEGG Axon 
Guidance 










Endometrial cancer NA NA BAD, AKT1, 
GSK3B, 
CCND1 
6.54E-03 NA NA NA NA 
KEGG Prostate 
Cancer 
















Of The Young 
Maturity onset 
diabetes of the 
young 
NA NA SLC2A2, 
HNF4A, 
PAX4 



























9.75E-03 NA NA NA NA NA NA 
BioCarta BAD 
Pathway 
Regulation of BAD 
phosphorylation 
NA NA KITLG, 
BAD, AKT1 
7.87E-03 NA NA NA NA 
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GNAS, GRK4 1.27E-02 NA NA NA NA NA NA 
KEGG Type Ii 
Diabetes 
Mellitus 









Hypoxia and p53 in 
the Cardiovascular 
system 
































against target cells 
ICAM1, FAS 1.56E-02 NA NA NA NA NA NA 
BioCarta HSP27 
Pathway 
Stress Induction of 
HSP Regulation 
IL1A, FAS 1.56E-02 NA NA NA NA NA NA 
  
 221 




































































of tyrosine kinase 
signals 

























2.77E-02 NA NA NA NA NA NA 
NA = No association / Not significant association 
1Genes in the pathway that are associated with ancestry enriched SNPs 
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Table 7. References and values for phenotypes with significant AMI values and population variance. 
Phenotypes with significant AMI values 






BMI Mexico GIANT 
20935630, 22982992, 23563607, 
23754948, 25673413 
0.27 2.42E-13 0 
Schizophrenia Mexico GWAS Catalog 
19571808, 19571811, 21682944, 
21926974, 22037552, 22037555, 
22688191, 22883433, 23142968, 
23894747, 23974872, 24043878, 
25056061, 26198764 
0.26 6.99E-12 0 
Body mass 
index 
Mexico GWAS Catalog 
17434869, 18454148, 19079260, 
19079261, 20935630, 22344219, 
22344221, 22982992, 23563607, 
23583978, 23669352, 24064335, 
24348519, 24861553, 25673413, 
25953783 
0.24 4.08E-07 0 
Height Peru GWAS Catalog 
17767157, 18193045, 18391950, 
18391951, 18391952, 18952825, 
19343178, 19396169, 19570815, 
19729412, 19893584, 20189936, 
20397748, 20881960, 21998595, 
22021425, 23456168, 23563607, 
25282103, 25429064 
0.13 3.62E-06 0 
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Table 7 (continued). 
Height Peru GIANT 
20881960, 22982992, 23563607, 
23754948, 25282103 
0.12 7.27E-05 0 
BMI Peru GIANT 
20935630, 22982992, 23563607, 
23754948, 25673413 
0.15 1.10E-04 0 
Facial 
Development 
Mexico Custom 24651127 0.22 1.44E-03 1.46E-02 
Height Colombia GIANT 







Peru GWAS Catalog 
17434869, 18454148, 19079260, 
19079261, 20935630, 22344219, 
22344221, 22982992, 23563607, 
23583978, 23669352, 24064335, 
24348519, 24861553, 25673413, 
25953783 
0.15 2.11E-03 0 
Schizophrenia Peru GWAS Catalog 
19571808, 19571811, 21682944, 
21926974, 22037552, 22037555, 
22688191, 22883433, 23142968, 



















Mexico GWAS Catalog 23453885 0.26 2.18E-01 0 
Beard thickness Mexico GWAS Catalog 26926045 0.39 2.18E-01 0 
Bipolar disorder Mexico GWAS Catalog 
17554300, 17486107, 18711365, 
19416921, 21926972, 21353194, 
22205951, 22182935, 21254220, 
24618891 
0.23 2.18E-01 0 
Childhood body 
mass index 
Mexico GWAS Catalog 26604143 0.24 2.18E-01 9.93E-20 
Helix rolling Mexico GWAS Catalog 26105758 0.41 2.18E-01 8.17E-43 
Lobe size Mexico GWAS Catalog 26105758 0.48 2.18E-01 0 
Scalp hair shape Mexico GWAS Catalog 26926045 0.35 2.20E-01 0 
Chronotype Mexico GWAS Catalog 26955885, 26835600 0.25 2.60E-01 0 
Phenotypes with significant AMI population variance 
Phenotype Database1 PMID(s)2 AMI variance7 q-value8 
Freckles GWAS Catalog 23548203 1.41E-01 0 
Sunburns GWAS Catalog 17952075, 18488028 1.41E-01 0 
Addiction GWAS Catalog 23533358 7.23E-02 1.10E-103 
HLA Class I Custom 20356336 6.25E-02 2.20E-68 
HLA Class II Custom 20356336 6.25E-02 2.20E-68 
Opioid sensitivity GWAS Catalog 24143882 6.20E-02 6.53E-67 
Lobe size GWAS Catalog 26105758 5.85E-02 3.23E-56 




Table 7 (continued). 
Eyebrow thickness GWAS Catalog 26926045 5.72E-02 1.67E-52 
Lobe attachment GWAS Catalog 26105758 5.72E-02 1.67E-52 
Monobrow thickness GWAS Catalog 26926045 5.72E-02 1.67E-52 
Height adjusted BMI GWAS Catalog 25044758 5.36E-02 4.79E-43 
Temperament (bipolar disorder) GWAS Catalog 22365631 4.81E-02 6.37E-30 
Drinking behavior GWAS Catalog 21372407, 23364009 4.75E-02 8.38E-29 
Helix rolling GWAS Catalog 26105758 4.44E-02 1.04E-22 
Ear morphology GWAS Catalog 26105758 4.10E-02 6.61E-17 
Body fat percentage GWAS Catalog 26833246 8.83E-04 2.22E-16 
Black vs. red hair color GWAS Catalog 18483556 1.63E-03 2.96E-15 
Vitiligo GWAS Catalog 
21326295, 22561518, 19890347, 
20410501, 20526339, 22951725 
1.94E-03 8.26E-15 
Eye color GWAS Catalog 20585627, 23118974, 23548203 2.27E-03 2.42E-14 
 
1 Database source for the trait SNP-associations and gene sets.  ‘Custom’ refers to SNP-associations mined from the literature.  
2 PubMed identifiers for the publications where the trait SNP-associations are reported. 
3 Value of the assortative mating index (AMI) test statistic for the phenotype gene set. 
4 False discovery rate q-value for the significance of the AMI value. 
5 P-value of the Wilcoxon rank sum test comparing the permuted AMI statistics to the observed AMI statistic 
6 Combined neurological disorders: Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major 
depressive disorder, and schizophrenia (combined) 
7 Variance of the AMI test statistics for the phenotype gene set across all 4 Latin American populations. 
8 False discovery rate q-value for the variance of the AMI test statistics across the 4 Latin American populations. 
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Table 8. Ancestry differences for phenotypes implicated in assortative mating (i.e. mate choice) in admixed Latin American 
populations. 
 Ancestry1   




Height (Male) 167 cm 175 cm 164 cm 34 cm https://en.wikipedia.org/wiki/List_of_avera
ge_human_height_worldwide Height (Female) 160 cm 162 cm 151 cm 38 cm 
Body Mass Index2 (Male) 22.8 27.4 25.7 5.4 http://www.who.int/nmh/publications/ncd-
status-report-2014/en/ Body Mass Index2 (Female) 24.0 26.0 26.9 2.2 
Schizophrenia3 247 186 253 1374 
http://www.who.int/healthinfo/global_burde
n_disease/2004_report_update/en/ 
Educational Attainment4 44% 67% 74% 246.3 
https://www.education-
inequalities.org/indicators/comp_upsec_v2 
1 Ancestry-specific measures are based on values from Nigeria (African), Spain (European), and Peru (Native American).  Nigeria and 
Spain are chosen, as they are known to provide the highest African and European ancestry components to admixed Latin American 
countries.  Peru is chosen as it is known to have the highest Native American ancestry proportion in Latin America (ref 
http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1005602). 
2 Body mass index is measured as a person's mass (weight) divided by the square of their height. 
3 Schizophrenia is measured as the age-standardized disability-adjusted life years (DALY) rates per 100,000 inhabitants (recorded in 
2004). 
4 Educational attainment is the percentage of people aged 3-5 years above upper secondary school graduation age who have completed 
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